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Dermal fibroblasts are responsible for the secretion of extracellular matrix (ECM) components that 
support the structural integrity of the skin. Alterations to the ECM have been implicated in many 
skin diseases including systemic sclerosis and fibrotic disorders, as well as wrinkle formation and 
wound healing in the aged phenotype. The endoplasmic reticulum (ER) is responsible for the 
production and quality control of secreted proteins, and perturbations to its correct function could 
therefore lead to aberrant ECM deposition from dermal fibroblasts. ER stress occurs when 
homeostasis of this organelle is imbalanced, which can be prompted by the effects of redox agents 
that disrupt the careful redox balance within the ER lumen. Previous research has often focused on 
the effects of oxidising agents that lead to oxidative stress within the cells, however little is known 
about the effects of reductants (and therefore reductive stress). Reductants are present in 
pollutants, depilatory creams and some cosmetics yet relatively little is known about their potential 
effects on the skin. This thesis aims to investigate the effect of reductive stress on dermal 
fibroblasts, looking first at signalling responses and then investigating changes that occur at the 
proteomic level. In the final chapter a comparison is made between the proteomic response to 
reductive stress by DTT and oxidative stress by UV-A radiation. The implications of these findings 
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This chapter serves as an introduction to the three main themes of this thesis. First, it will describe 
the structure of the skin, and the function of each of the three main layers of this tissue: epidermis, 
dermis and hypodermis. This will serve to contextualise the role of the dermal fibroblast, the focus 
of this study. Secondly, the function of the endoplasmic reticulum (ER) and the consequences of ER 
stress will be described with reference to its role in dermal fibroblasts. Finally, an introduction to 
proteomics and the importance of this technique in providing a hypothesis-independent 
understanding of cellular responses to stress will be given.  
1.1 Structure and function of human skin 
The skin is widely regarded as the largest organ of the human body, and functions at the interface 
with the external environment. Indeed, every organism on the planet can be thought of as having 
a ‘skin’: a membrane that separates their contents from the outside world, specialised and well 
adapted to each specific environment.  
Human skin functions to maintain homeostasis both with respect to alterations in the external 
environment, as well as retention of sufficient water that could otherwise be lost through 
evaporation (trans-epidermal water loss). Nerve endings within the tissue provide information 
about touch and temperature, which are transmitted to the brain to stimulate appropriate 
responses. The skin must also provide protection against physical (i.e. mechanical injury or 
ultraviolet (UV) radiation), chemical (i.e. irritants or allergens) and microbial (i.e. bacterial, fungal 
or viral) assaults. Incorrect formation of the skin barrier is associated with several human diseases 
including, for example, eczema, psoriasis and the rare but severe ichthyosis disorders characterised 
by the dry, “fish-scale” appearance of skin1. 
The skin is divided in to three layers: the hypodermis at the bottom, immediately above muscular 
tissue; the dermis in the middle and the epidermis at the top. The dermis and epidermis are 
separated by the basement membrane (BM). In addition to the cells within these layers, various 
adnexal structures exist including the hair follicle, sweat and sebaceous glands (Figure 1.1). The 
development of a complete structure, able to maintain homeostasis and prevent excessive water 
loss, occurs at around 34 weeks during embryo development in humans. Therefore, babies born 






Figure 1.1: Structure of the skin. Diagram depicting the many layers of human skin. The upmost 
layer, the epidermis, is made of several layers of differentiating keratinocytes that become flatter 
and cornified as they migrate away from the basement membrane. The dermis lies beneath the 
basement membrane and is the location of the fibroblast cells. The hypodermis is the deepest layer 
of the skin and is associated with the subcutaneous fat. Self-drawn adaptation from: Visscher, M. 
& Narendran, V. Neonatal Infant Skin: Development, Structure and Function. Newborn and Infant 




The main cell-type found in the epidermis is the keratinocyte. These are highly replicative cells that 
go through a process of terminal differentiation as they age. New keratinocytes are generated in 
the deep epidermis, next to the BM and, as differentiation and ageing of these cells occurs, they 
progress to the outermost layer eventually being shed as dead skin. 
Keratinocytes are characterised by their production of keratins, the major intermediate filament 
protein, which can also be used to define the stage of differentiation of each cell in the epidermis. 
As such, they have become popular as biomarkers of skin tumours where they can be used to define 
the exact epidermal location from which the cancer arose, as the tumour cells maintain the 
expression patterns of their origin3. Keratins are comprised of an -helical rod domain, with a head 
and tail domain on either side, and are classified into two groups according to their isoelectric point: 
type I (acidic) and type II (basic). The -helical domain of two keratins, one of each type, come 
together into a coiled-coil formation of the intermediate filament. As such, keratins are usually 
found in pairs. In the basal layer of the epithelium keratins K5 (type II) and K14 (type I) are the most 
strongly expressed and are fixed to desmosomes and hemidesmosomes that attach cells to the 
BM3. During differentiation, keratin expression switches to the production of suprabasal epidermal 
keratins K1 (type II) and K10 (type I). This pair of keratins form particularly dense bundles which are 
associated with the keratinocytes seen in the upper layers of the epidermis4.  
The process of terminal differentiation has been studied in vitro using an experimental model 
where keratinocytes are grown in culture, under conditions in which they form stratified sheets. In 
these sheets the basal layer is attached to the culture substrate and additional layers form on top 
of this, undergoing terminal differentiation before being shed into the culture media5. A reduction 
in cell-substratum contact, as would be the case in a crowded layer of cells on the BM, is thought 
to trigger the process of terminal differentiation within keratinocytes5. The differentiation process 
is also mediated by a strict gradient of calcium, which increases with distance away from the BM. 
Restriction of calcium availability prevents keratinocyte differentiation into a stratified layer in 
vitro6.  
Terminally differentiated cells are replaced by proliferation of a population of stem cells, which may 
replicate in an unlimited fashion, and their daughters, termed transit-amplifying cells (TAC), which 
have a more limited replicative capacity but are pre-destined for terminal differentiation7. These 
cells are large and columnar, forming the stratum basale. The two cell types are distinguished by 
their surface expression of 1-integrin: true keratinocyte stem cells express much higher levels of 
1-integrin than TACs8. Thus, the distribution of stem cells in the epidermis has been evaluated to 
reveal clusters of stem cells, located at specific sites of the epidermal-dermal junction, and these 
are connected by a network of TACs9. 
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Amongst the undifferentiated keratinocytes of the stratum basale are melanocytes. Melanocytes 
are defined by the presence of a unique organelle, the melanosome, which produces the pigment 
melanin that confers photoprotection against UV radiation to the skin10,11. Melanosomes originate 
from the trans-Golgi network and migrate towards the cell periphery as they mature, eventually 
being transferred to surrounding keratinocytes (although the precise mechanism of this transfer is 
still under debate)12–14.  It is melanin, derived from melanosomes produced by the melanocytes that 
is responsible for the pigmentation of skin known as tanning.  
As the columnar epithelial cells detach from the BM and migrate upwards through the epithelium, 
there is a gradual change in shape such that in the stratum corneum the cells are completely 
flattened and densely packed. The differing layers within the epithelium can be defined by the types 
of keratin proteins expressed, and the nature of cell-cell junctions found. The stratum spinosum lies 
above the stratum basale and consists of polyhedral cells, punctuated by protruding desmosomes 
that give cells their characteristic “spiny” appearance. It is in this layer that lipid containing lamellar 
bodies first start to develop15. Also within this layer are the Langerhans cells, which (in healthy 
epidermal tissue) are the major antigen-presenting cell16.  
Langerhans cells are identified by the expression of a C-type lectin receptor named ‘langerin’ on 
their cell surface16,17. They have long been thought of as antigen-presenting cells that, upon receipt 
of danger signals, mature and migrate to the lymph nodes and present antigens to naïve resting T-
cells and lead to stimulation of an immune response16. Since the millennium, new studies that took 
advantage of genetic engineering technologies in mice models have muddied the waters with 
respect to the specific function of Langerhans cells. Allan et al., showed that in cutaneous herpes 
virus infections Langerhans cells were not responsible for the presentation of antigen to T-cells18. 
In addition, Kaplan et al., demonstrated that mice that were depleted of Langerhans cells in fact 
showed enhanced responses to a model of contact dermatitis previously thought to involve 
Langerhans cells19. Kautz-Neu et al., have since implicated Langerhans cells in the dampening of the 
immune response to Leishmania major infection20 suggesting that Langerhans cells may play a more 
complex role in epidermal immune responses than simply in the activation thereof (reviewed by 
Romani et al.16).  
As the cells continue their migration through the epidermis, they undergo a final flattening and loss 
of organelles in the granular layer (stratum granulosum). Cells in this layer are characterised by the 
presence of many keratohyalin granules the main component of which is the giant filaggrin pre-
cursor: pro-filaggrin. As the keratinocytes undergo the final stages of terminal differentiation, pro-
filaggrin is cleaved into filaggrin monomers that are released from these granules and associate 
with keratin intermediate filament proteins to form tightly packed keratin macrofibrils21. These 
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facilitate the flattening of the cells and are crosslinked to form a keratin mesh onto which the 
cornified envelope that characterises the stratum corneum is attached21,22.  
Lamellar bodies, also found within cells of the granular layer, contain folded sheets of lipid layers 
that are secreted by exocytosis during differentiation at the interface between the stratum 
granulosum and the stratum corneum. Phospholipids, stored within the lamellar bodies of the cells, 
are released into the extracellular space and the cell membrane alters to become rich in ceramide 
lipids, cholesterol and fatty acids23. These sheets of hydrophobic phospholipids act as a 
waterproofing barrier that protects the skin from excessive water loss. In addition to lipids, the 
lamellar bodies also release a range of proteins and enzymes into the extracellular space. These 
include proteases important for the correct sloughing of corneocytes from the skin surface as well 
as anti-microbial peptides that enhance the skins protection against pathogen attack24.  
Eventually, the stratum granulosum gives way to the stratum corneum in the upmost layer of the 
epidermis. This is a layer of anuclear cells, which are rich in keratin and surrounded by the cornified 
envelope (CE), immediately below the ceramide lipid-rich layer of the modified cell membrane 
(termed the lipid envelope).  The CE is a layer of cross-linked proteins, most of which are products 
of genes in the epidermal differentiation complex (EDC) on chromosome 1, that is insoluble in both 
detergent and reducing agent25. CE formation is initiated by the expression of envoplakin and 
involucrin which associate around the cell membrane and are crosslinked by transglutaminase 
enzyme 1 (TGase 1) to form the scaffold26. This scaffold is then re-enforced by the recruitment of 
other CE proteins including loricrin and small proline-rich proteins that are crosslinked by 
transglutaminase enzyme 3 and linked to the scaffold by TGase 126. Keratin macrofilaments are also 
crosslinked to this structure, reinforcing its strength and rigidity26.  
Once terminally differentiated keratinocytes, now corneocytes, reach the surface of the skin they 
are shed and lost to the environment. The shedding of corneocytes as dead skin is regulated by the 
breakage of desmosome junctions between cells. In the desmosomes, intracellular intermediate 
filaments are connected to the intercellular desmosomal cadherins by desmoplakin and plakophilin 
proteins27. These are rigid structures that provide strength and stability to the stratum corneum 
that can resist mechanical stress. Perturbations to the desmosome structure or formation is 
implicated in many diseases including, for example, epidermolysis bullosa simplex characterised by 
excessive skin blistering27. Corneodesmosomes exist between corneocytes while transition 
desmosomes exist between corneocytes and the cells of the stratum granulosum. Proteolytic 
cleavage of these junctions regulates when and where cells are lost from the skin surface, the 
proteases being kept inactivated when not required by inhibitors such as LEKT-1. LEKT-1 is a serine 
protease inhibitor implicated in the regulation of shedding the stratum corneum. The importance 
of this regulation is demonstrated by diseases such as Netherton syndrome, where mutations in 
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LEKT-1 result in the premature cleavage of desmosomal junctions leading to the loss of the stratum 
corneum, skin inflammation, allergy and scaling28,29.   
1.1.2 Basement membrane 
The BM is a specialised ECM that forms on the surface of competent epithelial cells and separates 
the epidermis from the dermis. It protects tissue from physical stresses and provides a way to 
mediate the communication of distant signals between compartments. The BM is primarily 
composed of laminins, nidogens, heparin sulfate proteoglycans (HSPG) and type IV collagens. 
Laminins associate with sulfated glycolipids, integrins and dystroglycan on the cell membrane of 
competent cells and this initiates the self-assembly of the BM structure30,31.  Nidogens bind to the 
coiled coil domains of laminin proteins, and to type IV collagens to form a stabilising bridge that 
attaches collagen to the laminin network. The collagen proteins polymerise to form a network 
above the laminins and HSPGs bind to the mesh to form additional contacts with cell surface 
receptors31. Loss of BM components is lethal and prevents complete and correct development of 
the embryo32.  
Laminins exist as heterotrimers of an , , and  chain with each consisting of several globular and 
rod-like domains. Heterotrimer assembly occurs within the cell, although some laminins are subject 
to further proteolytic processing after secretions into the ECM33. Laminin epidermal growth 
factor-like domains, which bind to nidogen-1 and -2, are found in 1 and 3 chains and these are 
thought to be essential for BM assembly. Nidogens are not thought to be essential to the overall 
BM architecture and assembly, rather they act as stabilising molecules and their breakdown is 
implicated as a key event in BM degradation34.  
Historically, type IV collagens have been thought to play a solely structural role in the BM, but in 
the last 18 years evidence of a more active role has become apparent. A role in cell signalling has 
been defined as type IV collagens were shown to activate the G-protein coupled receptor GPR126, 
which is essential for organ development35. In melanoma cells, the level of glycosylation on type IV 
collagen chains has been shown to modulate integrin binding and therefore cell adhesion36. 
Promotion of type IV collagen-integrin interactions via the globular NC1 domain at the end of 
collagen triple-helical chains has also been shown to inhibit angiogenesis and tumour growth in vivo 
suggesting a role for these collagens in the inhibition of tumour growth37. This is supported by 
investigations that demonstrate a loss of type IV collagens in the early stages of cancer invasion and 
remodelling of type IV collagen chains in many cancer cell types. Recently, this has been associated 
with the hypermethylation, and therefore silencing, of the promoter region for two of the type IV 




Epithelial cells are bound to the BM through hemidesmosome (HD) junctions that link the keratin 
intermediate filaments of cells to the BM by integrin-mediated attachments39. In stratified 
epithelia, such as that of the skin, the proteins involved in HD junctions are integrin α6β4, plectin 
isoform 1a, tetraspanin, bullous pemphigoid antigen (BPAG) 1e and type XVII collagen. K5/K14 
intermediate filaments bind to plectin and BPAG1e within the cell, linking to the transmembrane 
complexes of integrin 64, type XVII collagen and tetraspanin that bind laminins on the 
extracellular side of the plasma membrane39. The laminins find anchorage fibrils of type IV collagen 
to create a firm connection between cell and BM. Mutation in any of the components of the HD 
junction are implicated in blistering diseases of the epidermolysis bullosa family (see section 1.1.1).  
1.1.3 Dermis 
The function of the epidermis is supported by the cells and ECM structures of the dermis that lies 
beneath. The dermis is divided into two sections: papillary, which is immediately beneath the BM, 
and reticular that lies deeper in the skin, above the hypodermis. These are separated by a vascular 
plexus termed the rete subpapillare: a structure of blood vessels that supply the cells of the skin 
with the nutrients required to survive. As the epidermis is void of vascular tissue, it obtains the 
essential nutrients from the blood through diffusion from capillaries in the dermis. Indentations 
into the epidermis called dermal papillae extend the surface area for interactions between epithelia 
and dermis, and provide routes into which capillaries can extend, increasing the availability of 
nutrients (Figure 1.2)40. The rete subpapillare that demarcates the boundary between papillary and 
reticular dermis is fed by a further vascular plexus, the rete cutaneum, at the boundary between 
the dermis and hypodermis40.  
Figure 1.2: Structure of the dermis. Diagram depicting the different levels of the dermis. The 
basement membrane is folded into dermal papillae (marked by  ) on top of which lies the 
epidermis. The dermis is divided into papillary and reticular layers by the rete subpapillare and rests 
on the rete cutaneum between the dermis and hypodermis at the bottom of the skin. Self-drawn 
adaptation from: Sorrell, J. M. & Caplan, A. I. Fibroblast heterogeneity: more than skin deep. J. Cell. 
Sci. 117, 667–675 (2004). 
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The dermis is characterised by the expanse of organised ECM found within it that provides skin with 
the ability to resist both compressive and contractive forces, as well as providing tensile strength. 
The two main components of the ECM are glycosaminoglycans (GAG), which are often linked to 
proteins to form proteoglycans, and fibrous proteins that are either structural (e.g. collagen/elastin) 
or adhesive (e.g. fibronectin/laminin). The GAGs and proteoglycans form a hydrated gel that resists 
compressive forces, and the fibrous proteins that provide tensile strength are embedded within 
this4.  
GAGs are unbranched polysaccharide chains of repeating disaccharide units, one residue of which 
is always either N-acetylglucosamine or N-acetylgalactosamine. These polysaccharide chains are 
inflexible and carry many negative charges; as such they occupy a vast amount of space and attract 
many osmotically active cations thus drawing water in to create a hydrated gel. This gel not only 
provides turgor required to resist compression but also allows the rapid diffusion of water soluble 
molecules to provide nutrients and permits migration of cells within the ECM. With the exception 
of hyaluronan, all GAGs are covalently linked to protein in the proteoglycans. These GAGs can bind 
and modulate the effect of signalling molecules and other secreted proteins such as proteases. 
Syndecan is a specific transmembrane proteoglycan on the surface of fibroblasts that acts as a 
receptor for fibronectin and collagen to mediate cell attachment to the matrix, or migration 
through it. It may also bind signalling molecules such as fibroblast growth factor and present this to 
the cell, thus acting as a co-receptor with cell-surface receptor proteins4.  
The structural proteins collagen and elastin form an organised matrix within this gel to provide the 
ECM with tensile strength and stretching capacity. Collagens are synthesised as procollagen -
peptides, three of which come together to form the distinctive triple-helix. The triple helix is 
stabilised by hydroxylation of proline and lysine residues that occurs during protein maturation in 
the ER and permits formation of interchain hydrogen bonds. After secretion, these triple helical 
units mature and assemble into ordered polymers called collagen fibrils, which often further 
associate into bundles termed collagen fibres. The fibrillar collagens (type I, II, III, V and XI) are 
organised into matrices by a combination of fibrillar associated collagens (type IX and XII) and the 
contractile action of fibroblasts attached to the dispersed fibrils. The pressure exerted by fibroblasts 
on the matrix contracts collagen fibres into sheets and draws them into cables to increase the 
matrix density4.  
Elastic fibres formed from the protein elastin provide the skin with a stretching capacity that is 
moderated by the interaction with the collagen fibre network, which controls stretch and prevents 
tearing. Elastin is a hydrophobic protein that, like collagen, is rich in proline and glycine but is not 
glycosylated or hydroxylated. After secretion, elastin monomers become crosslinked to generate a 
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network of fibres and sheets that can be stretched when required to afford skin the flexibility 
required, for example to stretch over moving joints4.  
Cells are connected to the ECM by adhesive proteins such as fibronectin. Fibronectin is a large, 
dimeric glycoprotein made of several functionally distinct domains that bind different entities such 
as collagens and cells. Fibronectin filaments assemble on or near the surface of fibroblasts and 
interact with the intracellular cytoskeleton via integrins. Integrins are transmembrane 
heterodimers that act as cell adhesion proteins to attach cells to the ECM. When integrin binds its 
matrix ligand, assembly of an intracellular attachment complex is triggered that links the integrin 
to the cytoskeleton, most commonly to the actin filaments4. Different combinations of  and  
chains come together to form integrins of differing specificities that will interact with specific ECM 
or cytoskeletal components.  
Fibroblasts are the primary cell type found within the dermis, and can be categorised into three 
distinct subpopulations according to their location: papillary, where they are more densely packed; 
reticular where there are fewer cells amongst a more organised ECM; and those that are associated 
with the hair follicle40. They are responsible for the secretion of ECM components such as collagen 
and glycosaminoglycans and are therefore integral to maintaining the structure and elasticity of the 
skin41. They also play an important role in wound healing and skin repair, which has led to them 
becoming the focus of many studies, including this thesis, regarding the role they may play in 
fibrosis, skin ageing and repair.  
Reticular and papillary fibroblasts demonstrate slightly different morphologies in culture: a squarer 
appearance is associated with the reticular fibroblasts while papillary fibroblasts are said to have a 
spindle shape42.  It has been proposed that these unique subpopulations of fibroblasts help to 
organise the complex microvasculature that lies beneath the avascular epidermis43. Fibroblasts that 
are found in the papillary dermis are thought to provide a microenvironment that supports the 
microvasculature found at this location. The formation of a supportive tubule structure is only 
robustly seen with papillary dermis fibroblasts, while fibroblasts isolated specifically from the 
reticular dermis take longer to produce supportive tubular networks, which are also sparser, 
shorter and less branched43. In addition, the two subpopulations demonstrate different 
characteristics in culture: fibroblasts derived from the papillary region divide at faster rates than 
site-matched reticular fibroblasts, and attain a higher cell density as they are not fully contact 
inhibited44,45.  
More recently, new evidence suggests that papillary and reticular fibroblasts derive from separate 
genetic lineages, as well as being spatially separate46. Studies of gene expression patterns in mouse 
skin throughout development have identified several specific markers for the papillary and reticular 
subpopulations of fibroblasts47 (Figure 1.3). Fibroblasts which differentiate to form the lower, 
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reticular, dermis are identified by expression of delta-like homolog 1 (Dlk1) and Sca1 after 
embryonic day (E) 16.547. Fibroblasts which will form the upper, papillary dermis express 
B-lymphocyte-induced maturation protein 1 (BLIMP1), a transcriptional regulator of terminal 
differentiation48, and CD26, a cell surface serine exopeptidase49, after E16.547. However a more 
recent study has suggested that the expression of CD26 is not necessarily specific to the fibroblast 
location in the dermis, but rather to its role in matrix deposition after injury49. Thus, individual 
fibroblast populations have specific roles as well as locations, which have not yet been fully 
elucidated. It is known, however, that reticular fibroblasts are responsible for the bulk of collagen 
fibril and ECM production within skin tissue, and it is these cells that are recruited initially in wound 
repair, providing an explanation for the ECM rich scar tissue that is observed after wound healing46. 
The reticular and papillary regions differ also in the content and organisation of their extracellular 
matrices. The papillary dermis ECM contains thin collagen fibres of type I and type III that are poorly 
organised, whereas the reticular dermis has much less type III collagen but thicker and well-
organised bundles40.  Decorin, a proteoglycan involved in matrix assembly, is more abundant in the 
papillary dermis whereas versican, a much larger chondroitin sulfate proteoglycan, is more 
abundant in the reticular dermis40.  In addition, collagen type XII and type XVI, and tenascin-C are 
found in the papillary dermis but collagen type IV and tenascin-X are the characteristic types of 
these proteins found in the reticular dermis40.  
Figure 1.3: Biomarkers of different fibroblast lineages Diagram to depict the differentiation of 
fibroblasts from a common progenitor (blue) into upper, papillary (green) and lower, reticular 
(purple) lineages with specific genetic markers shown at each time point, either embryonic (E) or 
postnatal (P) days.  Self-drawn adaptation from: Driskell, R. R. & Watt, F. M. Understanding 




The hypodermis is a layer of fat-storing adipocytes beneath the reticular dermis and rete cutaneum 
of the skin. The term ‘hypodermis’ has historically referred to all white adipose tissue below the 
dermis, but it is now clear that there is a distinction, based on adipocyte morphology and 
physiology, between dermal white adipose tissue (DWAT), the “true” hypodermis immediately 
below the reticular dermis, and subcutaneous white adipose tissue (SWAT) that lies beneath50.  The 
adipocytes in the DWAT develop alongside fibroblast development, but distinct from the 
development of adipocytes in the SWAT50. This distinction had been previously demonstrated by 
Kelley et al., who showed a difference between these two layers with respect to their association 
with insulin resistance, where SWAT was strongly associated but DWAT was not51. Adipocytes are 
necessary for the recruitment of fibroblasts and reconstruction of the dermis following wound 
healing52. The DWAT cells are also involved in the hair follicle cycle, thermal regulation and 
protection again pathogen attack53. Thus, the hypodermis, or more accurately DWAT, has a specific 




1.2 The Endoplasmic Reticulum and ER stress 
1.2.1 Function of the ER 
The ER is a major perinuclear organelle that consists of a network of membrane-bound tube 
structures called cisternae and may be decorated with ribosomes (rough ER) or not (smooth ER). 
The smooth ER is involved in the synthesis of lipids, phospholipids and steroids but is not usually 
abundant, except in specialised hormone secreting cells such as the Leydig cells of the testis for 
testosterone secretion4. Rather, in most cell types, the rough ER has regions of membrane that are 
void of ribosomes, often termed transitional ER.  Rough ER synthesises most secreted, 
transmembrane and luminal-resident proteins. Separated from the cytosol, it provides a unique 
environment to support the correct folding and assembly of secretory proteins, particularly in the 
formation of disulfide bonds.  
Translation of mRNA into proteins by ribosomes releases a nascent polypeptide chain that must 
correctly fold for the protein to assume its active role within the cell. That is, it must assume its 
native state. In 1973 Anfinsen et al., concluded that the native state of a protein was determined 
by the amino acid sequence of its peptide chain, that folded into the most thermodynamically 
stable conformation based on the surrounding solvents54.  Levinthal noted that there were a vast 
array of possible conformations available to the nascent polypeptide and it was not possible that 
all of these were surveyed during a folding process that occurs, for the most part, in a microsecond 
time-frame55. Thus, selection of a native state could not be due to random or systematic sampling 
of all possible conformations, there must be additional factors that influence a proteins ability to 
achieve its native fold. It was later determined that the hydrophobicity of amino acids was a major 
driving force in the correct folding of proteins. Peptides that had the same pattern of hydrophobic 
and hydrophilic amino acids but ultimately differed in their absolute amino acid sequence obtained 
that same folding arrangement56. Hydrophobic residues tend to be buried in a central core of the 
protein, protected from aqueous solvent in the cytosol while hydrophilic residues are open to the 
environment. A range of other intermolecular interactions influence and stabilise the native 
structure: van der Waals forces, hydrogen bonds, disulfide bridges and ionic interactions all play 
their part57. Correct folding of proteins is also mediated by proteins such as the molecular 
chaperones (described in more detail below) which protect exposed hydrophobic sites in folding 
intermediates and aid protein folding by preventing aggregate formation58.  
Secreted and transmembrane proteins utilise a specific folding environment in the ER that 
promotes formation of disulfide bonds and provides a quality control mechanism to prevent 
secretion of terminally misfolded proteins. This is important as there are very few chaperones that 
exist in the extracellular space and as such there is little or no capability to repair misfolded proteins 
following secretion59. Protein folds in secreted proteins tend to have more disulfide bonds than 
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cytosolic proteins and therefore their correct folding is promoted by the ER environment. For 
example, the epidermal growth factor (EGF) – like fold is only found in secreted or transmembrane 
proteins and consists of two, two-stranded  sheets joined by a loop and contains 3 disulfide 
bonds60,61. A carefully maintained redox balance within the ER lumen permits both the oxidation 
and reduction that allows rearrangement of disulfide bonds to occur during protein folding62,63 (see 
section 1.2.2.4).  
1.2.2 Protein folding in the ER 
Most proteins destined for the secretory pathway are identified during translation by a signal 
peptide at their N-terminus. The actual sequence of the signal peptide is highly variable although 
always consists of a series of hydrophobic residues, flanked on the N-terminal side by positively 
charged residues, and on the C-terminal side by polar residues that provide a cleavage site for the 
peptide’s eventual removal64,65. As this sequence emerges from the ribosome it is recognised by the 
signal recognition particle (SRP) which delivers the ribosome, in complex with mRNA and emerging 
nascent chain, to an SRP receptor on the ER membrane (Figure 1.4). SRP binding also inhibits further 
elongation of the peptide emerging from the ribosome until it has been successfully docked to the 
SRP receptor64. This prevents translation of secretory pathway proteins in the wrong cellular 
compartment which might otherwise occur due to a rate-limiting number of SRP receptors on the 
ER membrane66.  
Following binding of SRP/ribosome/nascent peptide complex to the SRP receptor on the ER 
membrane, SRP is recycled having positioned the ribosome on top of the Sec61 translocon, allowing 
translation and elongation of the peptide to resume64. Sec61 is made up of three subunits , , and 
  which assemble to provide an aqueous pore through which peptides can be co-translationally 
translocated into the ER lumen. Alternatively, the hydrophobic domains of transmembrane 
proteins can be inserted into the lipid bilayer of the ER membrane through a lateral movement out 
of the translocon67 (Figure 1.4). A signal sequence peptidase complex is also associated with the 
translocon which cleaves the signal peptide sequence from the emerging peptide chain64.  
As the peptide chain enters the ER lumen it immediately begins to fold, with folding of individual 
protein domains occurring co-translationally68. Post-translational modifications including N-linked 
glycosylation occur and intra-chain disulfide bonds begin to form. Chaperone proteins are recruited 
to ensure correct folding of the nascent polypeptide chains, preventing aggregation and aiding 
isomerisation of disulfide bonds. Aside from the classical chaperones of the Hsp70 and Hsp90 
families, there are also lectin chaperones (calnexin and calreticulin) that interact specifically with 
N-linked glycans, and chaperones that only interact with specific client proteins such as Hsp47 that 





Figure 1.4: Signal peptide dependent protein targeting to the ER. The signal peptide of an 
emerging ER-targeted protein sequence is recognised by the signal recognition particle (SRP) 
causing a temporary pause in translation as the ribosome/mRNA/emerging peptide complex is 
docked to the Sec61 translocon by association between SRP and the SRP receptor. Once docked, 
translation resumes and the signal peptide is cleaved by the signal sequence peptidase complex. 
Proteins are co-translationally translocated to the ER lumen, or transmembrane proteins are co-
translationally inserted into the ER membrane. Self-drawn adaptation from: Guerriero, C. J. & 
Brodsky, J. L. The delicate balance between secreted protein folding and Endoplasmic Reticulum-
associated degradation in human physiology. Physiol Rev 92, 537–576 (2012). 
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1.2.2.1 Classical chaperones 
Hsp70 chaperones have three main domains: an N terminal ATPase domain, a substrate binding 
domain and a C terminal “lid”. The ATPase domain has a low rate of ATP hydrolysis, and substrate 
affinity in the ATP-bound state is low, resulting in a high on/off rate for peptide binding and release 
from the chaperone. ATP activity is stimulated by co-chaperone Hsp40, leading to the hydrolysis of 
ATP to ADP, and a conformational change that increases Hsp70 affinity for the substrate and 
reduces the on/off rate. The chaperone binds to the client protein. Release of ADP by the action of 
a nucleotide exchange factor leads to the replacement of ADP with ATP and subsequent release of 
the bound peptide69. Hsp70 is thought to have three main roles in the ER: “holding” of unfolded 
proteins to prevent aggregation before necessary completion of its translation; “folding” of 
unfolded proteins, and re-solubilisation of misfolded protein aggregates70. Additional functions are 
found in the classical Hsp70 ER resident chaperone BiP. A BiP population resides close to the ER 
membrane and is thought to gate the translocon, the binding and release of the nascent 
polypeptide chain acting as a ratchet mechanism to prevent reverse movement of the polypeptide 
into the cytoplasm71. BiP also acts as a sensor of ER stress and is involved in the targeting of 
terminally misfolded proteins for ER associated degradation (ERAD) (see section 1.2.3). 
Hsp90 chaperones, like Hsp70s, bind and release client proteins with concomitant ATP hydrolysis. 
However, unlike Hsp70s, Hsp90 chaperones function as homodimers and appear to be more 
selective in their protein clients, interacting with proteins that are closer to their native state, 
specifically those involved in signalling pathways such as the oestrogen receptor69. Due to this 
involvement in the maturation of protein clients from important cellular signalling pathways, Hsp90 
chaperones have become popular targets in the development of cancer therapeutics72. The 
ER-resident Hsp90 chaperone is GRP94 and has clients including integrin proteins, insulin-like 
growth factor and toll-like receptors73.  
The precise molecular mechanism by which Hsp70 and Hsp90 chaperones fold their client proteins 
remains unclear. One suggestion is that repetitive binding and release of client proteins may 
actively unfold misfolded segments of the polypeptide chain to give them a second chance at 
folding. Alternatively, by binding client proteins it reduces the concentration of free, unfolded 
copies of the protein and therefore reduces aggregation, allowing the unbound copies to fold into 
the native state70.  A recent study by Luengo et al., suggests that the two classes of chaperone may 
cooperate to stall (Hsp70) and restart (Hsp90) protein folding, not actively folding the proteins but 




1.2.2.2 Lectin chaperones 
Calnexin and calreticulin interact specifically with mono-glucosylated glycans. Oligosaccharides for 
N-linked glycosylation are built on dolichol carrier lipids on the ER membrane, initially cytoplasmic 
facing before “flipping” over into the ER lumen. Oligosaccharide transferase (OST) transfers the 
oligosaccharide to an asparagine residue onto a peptide as it exits the translocon in to the ER. 
Following transfer, the oligosaccharide is trimmed by -glucosidases I and II to yield a 
mono-glucosylated glycan that can be recognised by the lectin chaperones (reviewed by AM 
Benham, 201264). 
Calnexin and calreticulin interact with the folding protein through a cycle of binding and release 
mediated by the opposing actions of glucosidase II and glucosyl transferase. Mono-glucosylated 
glycans are de-glucosylated by glucosidase causing the release of calnexin and calreticulin64. 
Glucosyl transferase recognises exposed hydrophobic patches of incorrectly folded proteins and 
re-attaches a glucose residue allowing the re-binding of the lectin chaperones. These chaperone 
proteins prevent the aggregation of proteins displaying exposed hydrophobic patches, and recruit 
protein disulfide isomerase ERp57 to catalyse the formation of disulfide bonds and promote 
achievement of the native state75,76 (disulfide bond formation is discussed in more detail in section 
1.2.2.4).  
1.2.2.3 Client specific chaperones 
There are some chaperone proteins that only act on a specific protein client. An example of 
particular relevance to this thesis is Hsp47 (otherwise known as SerpinH1), which binds specifically 
to the triple helix of procollagen and has chaperone activity77,78. The physiological function of 
Hsp47, in binding to correctly folded triple-helical structures, is not clear. Triple-helical assemblies 
of three procollagen peptides are stabilised by the hydroxylation of proline residues, catalysed by 
P4H. Distribution of stabilising residues does not occur uniformly along the length of the triple helix 
and the structure is therefore susceptible to local areas of relaxation77,79. It has been suggested by 
Tasab et al., that Hsp47 may function in the stabilisation of these areas that are prone to relaxation, 
prior to lateral association with other triple-helical procollagen units and exit from the ER77.  
Further studies by Duran et al., implicated mutations in the genes for Hsp47 and FKBP65 (another 
procollagen chaperone protein) in osteogenesis imperfecta, a disease characterised by low bone 
mineral density and brittle bones80. Their investigations into the effects of mutations on mouse 
development and collagen production in fibroblasts implicated Hsp47 not only in the stabilisation 
of procollagen but also in its assembly and trafficking from the ER to the Golgi.  They also proposed 
a cooperation between the two chaperone proteins that suggests both proteins are concomitantly 
involved in the functional secretion of procollagen80. 
31 
 
1.2.2.4 Disulfide bond formation in the ER 
Proteins within the secretory pathway often contain at least one disulfide bond that forms within 
or between polypeptide chains. These are thought to increase the stability of the proteins within 
the ECM, or during exposure to acidic endocytic compartments during recycling of membrane 
proteins81. As well as being an important structural component in many secreted proteins, in some 
proteins disulfide bonds have also been found to serve a regulatory function. For example, redox 
buffers such as glutathione have been shown to regulate the function of integrins involved in 
thrombosis by reduction of disulfide bonds in the EGF-like domains of these proteins82.  In the event 
of non-native disulfide bond formation, it is also possible for protein disulfide isomerase (PDI) to 
reduce these disulfides to permit re-configuration of the peptide and allow the folding protein to 
reach its native state81,83 (Figure 1.5).  
Disulfide bond formation is catalysed by the activity of the PDI family of proteins. Typically, PDI 
works in conjunction with endoplasmic reticulum oxidoreductase (Ero1 or Ero1) to provide an 
electron transport chain whereby electrons are passed from client protein to PDI, to Ero1 and finally 
to molecular oxygen (Figure 1.6). Electrons are transferred from the client protein to PDI, resulting 
in the reduction of a labile disulfide bond in PDI. This disulfide is regenerated by the reduction of a 
shuttle disulfide bond in Ero1, which then undergoes an internal disulfide exchange to reduce 
another disulfide near to a bound FAD molecule. Electrons are transferred from this disulfide to 
FAD, reducing it to FADH2. The oxidation of FADH2 to FAD occurs rapidly to regenerate Ero1: FADH2 
transfers electrons to molecular oxygen and releases ROS in the form of hydrogen peroxide81. 
 
Figure 1.5: Disulfide bonds in protein folding. Protein disulfide isomerase (PDI) aids in the 
formation and breakage of disulfide bonds in the nascent polypeptide chain. A cycle of reduction 
and oxidation of the disulfide bonds continues until the protein reaches its native state or is 
targeted for degradation by ERAD. Self-drawn adaptation from Bulleid, N. J. Disulfide Bond 




Ero1 deletion in mice does not completely inhibit disulfide formation or result in a distinctive 
phenotype therefore the existence of compensatory mechanisms has been investigated84. In 
mammals, there are some alternative electron acceptors to Ero1 which can metabolise the 
hydrogen peroxide produced from the Ero1 cycle for example, peroxiredoxin IV (PrxIV) and 
glutathione peroxidases 7 and 8 (Gpx7/8)81. These proteins can also oxidise PDI84. PrxIV and Gpx7/8 
use hydrogen peroxide, instead of molecular oxygen, as the terminal electron acceptor. Cysteine 
residues within these proteins are sulfenylated by hydrogen peroxide, before being resolved to a 
disulfide bond with a further cysteine in another subunit (PrxIV) or by oxidising the residues on PDI 
to regenerate its disulfide bond (Gpx7/8).  In the case of PrxIV, this regeneration occurs from the 
disulfide bond between subunits re-oxidising PDI in a subsequent step81.  
There has been some debate as to whether or not disulfide bond formation requires the complete 
translation of protein domains or if formation is possible before this point63. Robinson et al., used 
a single domain 2M protein to demonstrate that the complete domain sequence must be exposed 
in the ER before formation of the disulfide bond occurred63. Their study indicated that PDI binds as 
the protein is exposed to the ER lumen, but before complete translation, and remains bound until 
correct intramolecular disulfide bond formation is possible, when translation has finished. This 
suggests that folding into native tertiary structure is important to position a cysteine residue for 
correct disulfide formation63. 
  
Figure 1.6 PDI and ERO in disulfide bond formation. Disulfide bond formation is catalysed by an 
electron transport chain from substrate polypeptide to PDI to ERO, with molecular oxygen acting 
as the final electron acceptor. Self-drawn adaptation from Bulleid, N. J. Disulfide Bond Formation 
in the Mammalian Endoplasmic Reticulum. Cold Spring Harb Perspect Biol 4, (2012). 
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1.2.2.5 Peptidyl-prolyl cis-trans isomerases 
Proline residues in the polypeptide chain are always inserted in the trans conformation yet 
frequently exist in the native state as cis isomers. Therefore, the activity of peptidyl-prolyl cis-trans 
isomerase (PPIase) enzymes acts to convert trans proline to cis proline to achieve the native fold85. 
This is an important and rate-limiting step in the correct folding of proteins85. There are three 
families of PPIase proteins: cyclophilins, FK binding proteins (FKBP) and parvulins. The parvulins are 
particularly small PPIase proteins which show tissue specific distribution and do not reside in the 
ER but instead function in the nucleoplasm or cytoplasm of cells86. Therefore, ER-resident PPIases 
are members of the cyclophilin or FKBP families.  
Collagen, one of the key ECM proteins of the dermis, is known to require PPIase activity for efficient 
folding due to the large number of proline residues in the polypeptide sequence. Addition of PPIase 
to denatured collagen type III increased the rate of re-folding 3-fold compared to un-catalysed 
re-folding87. Additionally, treatment with cyclosporin A to inhibit cyclophilin activity greatly reduced 
the folding of type I procollagen in suspended chick embryo fibroblasts and furthermore increased 
intracellular degradation of type I and type III collagens in cultured human fibroblasts88. Intracellular 
degradation can occur as a result of proteins that are deemed unable to reach their native state as 
will be discussed in section 1.2.3.  
Recently, the activity of FKBP65 has also been associated with the regulation of lysyl hydroxylase 2 
(LH2) activity that is important for the hydroxylysine-aldehyde collagen crosslinks (HLCC) between 
the telopeptides of collagen molecules. LH2 is involved in the conversion of lysine to hydroxylysine 
in collagen telopeptides. Depletion of FKBP65 led to a decrease in the ratio of HLCCs to 
lysine-aldehyde collagen crosslinks (LCC), suggesting a loss of LH2 activity89. As LCCs are less stable 
than HLCCs the implication is that this results in an overall reduction in collagen fibril stability.  
Once a protein has reached its native state, including the correct positioning of disulfide bonds, 
glycosylation and isomeration of proline residues, it can exit the ER to the Golgi by transport in 
COPII coated vesicles64. If a protein is unable to reach its native state it may be retained in the ER 
and targeted for degradation through the ERAD pathway. Terminal misfolding of proteins can occur 
due to errors in the protein sequence, insufficient amounts of an essential binding partner, 
overwhelming of the available chaperone machinery or perturbation of ER homeostasis90. The 
following section will discuss the quality control mechanisms by which the cell detects, retains and 




1.2.3 Protein quality control 
Due to the complex nature of protein folding and assembly in a crowded environment such as the 
ER, a certain level of misfolding is inevitable. In fact, it’s known that a significant proportion of 
translated mRNAs may never reach their native state91. To prevent the secretion of misfolded, 
non-functional proteins a series of quality control mechanisms must exist to protect the reliability 
of the cells activities92. Overstretching the quality control mechanisms results in the accumulation 
of misfolded protein aggregates that are implicated in diseases including, for example, Parkinson’s 
disease, Alzheimer’s disease, and Huntington’s disease.  
A first level of quality control exists to retain incorrectly folded proteins in the ER and prevent their 
exit into the secretory pathway. The detection of such proteins relies solely on structural 
characteristics rather than a specific sequence or protein functionality. Thus, misfolded proteins 
that are still functional, but are perhaps likely to form aggregates, can still be retained in the ER. 
Such characteristics include the exposure of hydrophobic residues and unpaired cysteines92. These 
features attract the continuous binding of molecular chaperones that prevents the proteins release 
to the next stage of the secretory pathway. This mechanism is also affected by the stability of 
folding proteins. Following completion of the folding pathway, a protein in its native state may still 
be susceptible to local unfolding of domains before it exits the ER with, for example, fluctuations in 
temperature. The lower a proteins thermal stability, the more frequently this occurs and therefore 
the more inefficient is its secretion92.  
Glycosylated proteins are subject to a specific quality control mechanism with relation to their 
N-linked glycans. Proteins may not exit the ER while their glycans are still glucosylated. Removal of 
glucose by the glucosidase II enzyme releases the protein from the calnexin/calreticulin cycle 
described in section 1.2.2.2; only when this is not counteracted by the action of glucosyl transferase 
is the protein able to continue along the secretory pathway92. Glycosylated proteins that are unable 
to reach their native state are targeted for degradation by the trimming of mannose residues on 
the remaining glycan by ER resident α1,2-mannosidase I and ER degradation-enhancing 
1,2-mannosidase-like protein (EDEM) enzymes93,94. The precise mechanism of action of each of the 
three known EDEM enzymes is still under review but it is thought that, in conjugation with ERdj5 (a 
PDI family member) and BiP (an Hsp70 chaperone), they work to prepare proteins for 
retrotranslocation to the cytosol and target them to ubiquitination machinery95.  
An additional level of quality control exists in the regulation of ER export of particular proteins or 
protein families92. Proteins involved in this regulation have been classified by Hermann et al., as 
“outfitters”, “escorts” or “guides”96. “Outfitters” are those proteins that are involved in maintaining 
secretory competence prior to transport; “Escorts” are those that travel with the secretory proteins 
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to maintain their integrity during transport and “guides” are those that act as transport receptors 
on behalf of client proteins to promote their passage from the ER to the Golgi96.    
1.2.4 Endoplasmic Reticulum Associated Degradation (ERAD) 
The ERAD pathway recognises and degrades terminally misfolded proteins that are unable to leave 
the ER through the secretory pathway. In rare cases ERAD may also accept native and functional 
proteins as substrates as part of a control mechanism such as feedback inhibition. For example, 
3-hydroxy-3-methylglutaryl acetyl-coenzyme-A reductase (HMGR), which is an enzyme involved in 
sterol biosynthesis, is known to be targeted for degradation by ERAD through sterol-induced 
binding of the enzyme to ER membrane E3 ubiquitin ligases97. Ligation of ubiquitin by these 
enzymes to HMGR identifies it for proteasomal degradation. The ERAD pathway can also be taken 
advantage of by viruses for example the human immunodeficiency virus type 1 targets CD4 and 
major histocompatibility complex (MHC) class I proteins for degradation by ERAD to evade 
detection by the hosts immune system90,98.  
Ubiquitin is a small protein that plays a central role in ERAD. It is attached as a post-translational 
modification to proteins and targets them to the proteasomal pathway. Ubiquitin modifications are 
recognised by the proteasome and the conjugated protein is degraded. The role of the 
ubiquitin-proteasome in ERAD was first proposed in a study in yeast where a loss of function 
mutation in the ubiquitin conjugating enzyme Ubc6 prevented the degradation of mutant 
translocation apparatus99. Ubiquitination’s role in ERAD was further established through the study 
of a cell culture cystic fibrosis model where degradation of CFTR was significantly reduced by 
inhibition of the proteasome, and a lot of the accumulated proteins were found to be 
ubiquitin-conjugated90,100.  
ERAD has several branching pathways that are specific to different classes of misfolded proteins101, 
however they all share a common series of events: recognition, retrotranslocation, ubiquitination 
and finally degradation. A membrane embedded protein complex, which contains an E3 ubiquitin 
ligase, is involved in the coordination of these events. Research into these complexes in yeast 
suggests different complexes demonstrate substrate specificity dependant on the location of the 
misfolded domain in the protein. Three classes of complex have been established: ERAD-C, where 
misfolded domains exist on the cytoplasmic side of the membrane; ERAD-M, where the misfolded 
domains exist in the transmembrane region of the protein; and ERAD-L, where the misfolded 
domain is luminal90. However, whether similar levels of substrate specificity exist in the wider array 
of complexes found in mammalian cells is not yet clear90.  
Recognition of misfolded proteins has already been discussed with respect to protein quality 
control mechanisms in the cell (section 1.2.3). Once a misfolded protein has been recognised it 
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must be retrotranslocated back across the ER membrane into the cytoplasm. For soluble proteins 
which have been fully translocated into the ER lumen this requires a complete reversal of this 
process, and ubiquitination can only occur when at least a substantial proportion of the protein has 
been successfully retrotranslocated90.  Conversely, with membrane associated proteins only the ER 
luminal and membrane domains need to be retrotranslocated and therefore ubiquitination can 
often be coupled to retrotranslocation. Once ubiquitinated, cytoplasmic chaperone proteins and 
shuttle factors maintain the solubility of these proteins and transfer them to the proteasome for 
degradation. 
The identity of the retrotranslocation machinery is the subject of great debate in the field: Sec61, 
Derlin-1 and Hrd1 have all been proposed as potential candidates (reviewed by Wu and 
Rapoport102). Sec61, the translocon, had been postulated to also function in reverse however ERAD 
substrates were subsequently shown to interact only weakly with Sec61. In addition, the crystal 
structure of Sec61 revealed a plug domain across the channel that could be displaced by a growing 
polypeptide from the cytoplasmic side, but it is unclear whether it would be possible to displace 
this during retrotranslocation. Derlin-1 is a multi-spanning membrane protein that was proposed 
to be involved due to its interaction with p97, a cytosolic ATPase known to be critical for successful 
retrotranslocation of proteins. However, Hrd1 has recently been identified as another likely 
candidate for the retrotranslocon. Proteolysosomes containing Hrd1 were used to model protein 
retrotranslocation on a small scale and the autoubiquitination of Hrd1 was demonstrated to permit 
a misfolded luminal protein domain to cross the membrane103. It was therefore proposed that Hrd1 
forms a ubiquitin-gated protein channel in the ER membrane through which proteins may be 
retrotranslocated103.  
Aggregates of misfolded proteins are inaccessible to the ERAD machinery and must therefore be 
cleared from the ER by an alternative mechanism. Clearance of these proteins is proposed to occur 
by a sequence of events similar to autophagy termed ER-phagy. Terminally misfolded protein 
aggregates (TMPA) are segregated to a specific area of the ER, which buds off to form a vesicle of 
ER membrane that contains the TMPA cargo. This vesicle is transported to the lysosome and fuses, 
exposing the cargo to the destructive lysosomal enzymes and completing TMPA degradation104. 
This mechanism is also thought to play a role in ER homeostasis. Under conditions of ER stress (see 
section 1.2.5) the ER expands, and it is thought that a similar mechanism is employed to return the 
ER to its pre-stress size, where vesicles of excess ER bud off and are transported to the lysosome 
where fusion and degradation can occur104.   
37 
 
1.2.5 The Unfolded Protein Response and ER stress 
ER stress can be broadly defined as conditions under which the normal physiological functions of 
the ER are perturbed105. Disruption of any of the main functions of the ER leads to ER stress. This 
may include inhibition of disulfide bond formation, N-linked glycosylation or the ability of 
chaperone proteins to aid protein folding at a more basic level. ER stress may also be induced by 
perturbations in lipid metabolism pathways, although the precise mechanism by which this occurs 
has been less well characterised105.  
The conditions of the ER are monitored by a specific set of signalling molecules that detect high 
levels of unfolded proteins that accumulate in the ER lumen under conditions of ER stress. 
Activation of these signalling components triggers a transcriptional response within the cell to 
downregulate general protein translation, while increasing the size and folding capacity of the ER. 
This response is termed the unfolded protein response (UPR). Prolonged activation of this pathway 
occurs when this response is insufficient to re-establish ER homeostasis and results in cell death106. 
The UPR has three main branches, named after their signalling component: inositol requiring 
enzyme 1 (IRE1) (Figure 1.7), double-stranded RNA-activated protein kinase (PKR)–like ER kinase 
(PERK) (Figure 1.8) and activating transcription factor 6 (ATF6) (Figure 1.9)106. All three pathways 
lead to the upregulation of specific UPR genes that act to increase the protein folding machinery, 
size of the ER, and ERAD associated proteins to clear unfolded proteins from the ER and return it to 
a state of homeostasis.  IRE1 is the most highly conserved among eukaryotes, with PERK and ATF6 
only present in the higher eukaryote metazoans106. There is some suggestion that, due to the 
number of different genes encoding ATF6 family members and IRE1 paralogs, there is a certain 




IRE1 is a type I transmembrane membrane protein that has both an ER luminal domain, and a 
cytosolic domain that has kinase and RNase activity107. Under conditions of ER stress, IRE1 
monomers oligomerise via their luminal domains leading to activation and autophosphorylation of 
the cytosolic domains. Conformational changes that occur during this activation lead to the 
stimulation of RNase activity that unconventionally splices XBP1 transcripts to remove an inhibitory 
hairpin loop intron. Ligation of the two exons by tRNA ligase RtcB results in an mRNA transcript that 
produces the active XBP1 transcription factor, which moves to the nucleus and promotes 
transcription of UPR genes (Figure 1.7).  XBP1 targets typically include ER chaperons and ERAD 
components such as EDEM1, but it has also been shown to act on genes involved in lipid metabolism 
and additional tissue-specific targets such as pro-inflammatory cytokines in macrophages108.  
 
Recently, IRE1 has also been implicated in the degradation of mRNA associated with the ER (i.e. 
mRNA being read by ribosomes docked to the translocon for co-translational peptide translocation) 
called regulated IRE1-dependent decay (RIDD). A study by Tam et al., described a mechanism 
whereby different oligomeric states of IRE1 determined its activity109. Oligomeric IRE1 maintained 
splicing activity against XBP1, whereas IRE1 that existed only in a dimeric form acted on ER-
associated mRNA as part of RIDD109.  RIDD is thought to reduce the translational load of the ER, 
reducing the number of newly synthesised polypeptides that must be folded106. However, it has 
also been associated with promotion of cell death suggesting a more complex fine-tuning of IRE1 
signalling that is yet to be fully understood109.  
Figure 1.7: The IRE1 pathway in the unfolded protein response. Accumulation of unfolded proteins 
triggered by conditions of ER stress lead to the oligomerisation of IRE1, and activation of its cytosolic 
RNase domain. This domain splices and removes an inhibitory hairpin loop from XBP1 mRNA 
transcripts resulting in translation of functional XBP1 transcription factor that moves to the nucleus 
and promotes transcription of genes involved in chaperone production, lipid synthesis and ERAF 
proteins. Self-drawn adaptation from Walter, P. & Ron, D. The Unfolded Protein Response: From 
Stress Pathway to Homeostatic Regulation. Science 334, 1081–1086 (2011). 
39 
 
Under normal conditions, oligomerisation of IRE1 is commonly thought to be prevented by the 
association of its ER luminal domain with Hsp70 chaperone BiP. During ER stress, BiP is titrated 
away from these signalling components by an increased load of unfolded proteins with which it 
interacts. This releases IRE1, allowing its oligomerisation and activation of the respective signalling 
pathways of the UPR (reviewed by Schröder and Kaufman105). The PERK pathway also involves 
oligomerisation of the PERK signalling component (Figure 1.8), which is inhibited by BiP association 
in a similar manner to IRE1.  
In recent years, evidence to suggest that dissociation of BiP from IRE1 may in fact not be the trigger 
leading to IRE1 oligomerisation has accumulated. Crystal structures of the yeast IRE1 protein 
revealed a deep groove similar to the peptide-binding groove of MHC proteins, and it was therefore 
proposed that unfolded proteins may bind directly to IRE1, triggering its oligomerisation107. 
Although similar, the human IRE1 crystal structure did not demonstrate such a deep putative 
ligand-binding groove and therefore there is still some doubt as to the precise mechanism of IRE1 
activation. Regardless, the overarching theory remains that an accumulation of unfolded proteins 




PERK is also a type I transmembrane protein and is structurally and functionally similar to IRE1. It 
has both an ER luminal stress sensing domain, and a cytosolic kinase domain that 
autophosphorylates upon ER stress-induced dimerisation. PERK does not, however, possess RNase 
activity but instead functions by phosphorylating eukaryotic Initiation Factor (eIF) 2 leading to a 
general reduction in protein synthesis, reducing the ER protein folding load107. Phosphorylated 
eIF2 binds nucleotide exchange factor eIF2B, stopping its activity and preventing the formation of 
an active eIF2 transcription complex. Although this reduces transcription of most mRNAs, the 
transcription of a select number of mRNAs with a specific structure is stimulated110. One such mRNA 
is that of activating transcription factor 4 (ATF4) which accumulates following PERK activation and 
functions to promote the transcription of UPR response genes including GADD34 and CHOP107 
(Figure 1.8).  
 
GADD34 transcription represents a negative feedback loop that acts as a pro-survival mechanism 
initiated by PERK. This gene encodes a regulatory subunit of a phosphatase enzyme that functions 
to dephosphorylate eIF2 and therefore relieve the generalised decrease in protein transcription 
within the cell107. In contrast to this, the transcription of CHOP represents a pro-apoptotic side to 
the PERK signalling pathway as this gene encodes a transcription factor that in turn functions to 
promote the transcription of pro-apoptotic factors. The opposing actions of GADD34 and CHOP 
demonstrates a balance point in ER stress signalling whereby at moderate levels the signalling 
pathways function to protect the cell and promote survival, but extended exposure to these 
conditions can result in the activation of apoptosis and cell death106,107.  
Figure 1.8: The PERK pathway in the unfolded protein response. ER stress leads to accumulation 
of unfolded proteins in the ER lumen. This causes dimerisation and trans-autophosphorylation of 
PERK cytosolic domain. Activated PERK phosphorylated eIF2 which reduces general protein 
synthesis and leads to an increase in translation of ATF4 transcription factor. Increased ATF4 
promotes transcription of unfolded protein response genes, particularly CHOP and GADD34. Self-
drawn adaptation from Walter, P. & Ron, D. The Unfolded Protein Response: From Stress Pathway 
to Homeostatic Regulation. Science 334, 1081–1086 (2011). 
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PERK also activates the Nrf2 transcription factor. Phosphorylation of Nrf2 by PERK releases it from 
the constraint of Keap1, allowing Nrf2 to travel to the nucleus where it mediates the transcription 
of genes regulated by the antioxidant response element (ARE). These genes include protective 
detoxifying enzymes such as heme oxygenase-1 (HO-1), which functions to degrade heme into 
bilirubin that can scavenge and detoxify peroxy radicals, and glutathione S transferase (GST), which 
functions to conjugate harmful electrophilic substrates to glutathione rendering them less reactive 
and more soluble111,112. Additionally, Nrf2 can also upregulate transcription of genes for chaperones 
proteins involved in proteasomal degradation demonstrating a role for the transcription factor in 




The final branch of the UPR is the ATF6 signalling pathway. ATF6 is a type II transmembrane protein, 
distinct from PERK and IRE1, whose cytosolic domain functions as a bZIP transcription factor. When 
an accumulation of unfolded proteins is detected under conditions of ER stress, ATF6 is delivered 
to the Golgi where the luminal domain and transmembrane anchor are sequentially cleaved by 
site-specific proteases. This releases the cytosolic transcription factor domain which moves to the 
nucleus and promotes transcription of UPR genes including chaperone proteins and components of 
the ERAD pathway106,107 (Figure 1.9).  
If successful, the activation of these pathways allows the cell to regain ER homeostasis and survive. 
However, under conditions of extreme ER stress where the UPR is not sufficient to regain 
homeostasis programmed cell death and apoptotic pathways are activated to remove inalterably 
damaged cells from the system. This process involves the activation of pro-apoptotic transcription 
factors such as CHOP, as described in the PERK pathway, and calcium ion (Ca2+) release from the ER 
by activation of pro-apoptotic proteins Bak and Bax. Activated Bak and Bax proteins form a pore in 
the ER membrane that permits Ca2+ release into the cytosol. This activates calpain that converts 
pro-caspase 12 to caspase 12 and triggers a caspase cascade that results in apoptosis105.  
  
Figure 1.9: The ATF6 pathway in the unfolded protein response. Under conditions of ER stress, 
unfolded proteins accumulate in the ER lumen. This leads to the transport of ATF6 to the Golgi 
where the N-terminal domain is cleaved, releasing a bZIP transcription factor to the cytosol. The 
transcription factor moves to the nucleus where it promotes transcription of genes involved in the 
unfolded protein response. Self-drawn adaptation from Walter, P. & Ron, D. The Unfolded Protein 
Response: From Stress Pathway to Homeostatic Regulation. Science 334, 1081–1086 (2011). 
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1.3 Physiological impact of ER stress in dermal fibroblasts 
The role of ER stress in human dermal fibroblasts is of interest due to their secretory function that 
suggests a high protein capacity of the ER, and the importance of protein quality control in healthy 
and diseased skin. For example, aged skin often suffers from fragmented collagen fibres that result 
in wrinkle formation and the loss of skin elasticity. Investigations into the cellular responses to ER 
stress may provide insight into potential therapeutic options for the treatment of damaged skin. 
The global anti-ageing market is estimated to be worth US$122.3 billion and is set to increase113; 
nearly a quarter of P&G’s $82.6bn net sales in 2011 came from beauty products, including many 
anti-ageing cosmetics, demonstrating the potential impact of novel insights may have on the 
skincare market alone.  
The effects of ER stress induced by tunicamycin and glucose starvation, which both impair N-linked 
glycosylation leading to an accumulation of misfolded secretory proteins, were studied by Vonk et 
al., to determine the effects on collagen biosynthesis both in chondrocytes (responsible for 
secretion of bone and cartilage ECM) and dermal fibroblasts. Quantitative PCR and immunoblotting 
techniques allowed the comparison of gene and protein expression of collagen, and collagen 
modifying enzymes and chaperones, between treated and untreated cells. This revealed a decrease 
in collagen production that was not associated with a similar change in expression of the collagen 
chaperones, suggesting the decrease in collagen production was not linked to the expression of 
proteins involved in its biosynthesis114.  
ER stress can be induced by several treatments, particularly those that disturb the cellular redox 
balance. Oxidative stress occurs when accumulation of reactive oxygen species (ROS) overwhelm 
the cellular anti-oxidant machinery. Disulfide bond formation in the ER is supported by the oxidising 
environment of the ER lumen115. An excess of oxidising or reductants in the ER therefore disrupts 
disulfide bond formation and protein folding. This demonstrates a close link between oxidative and 
ER stresses, whereby the redox state of the ER can be perturbed by treatment with redox agents 
that in turn lead ER stress and triggering of the UPR116.   
Oxidative stress also results in the oxidation of proteins, which particularly effects tyrosine residues 
to form tyrosyl radicals. A method to detect oxidised proteins was developed by van der Vlies et al., 
that harnessed the coupling ability of a fluorescein-labelled tyrosine analogue, tyramine, to 
proteins containing tyrosyl radicals117. Acetylation of the tyramine probe rendered it membrane 
permeable and allowed the specific labelling of oxidised proteins in response to oxidative stress117. 
This group used the acetylated tyramine probe (termed acetylTyrFluo), coupled with 
[35S]Methionine labelling to identify proteins specifically oxidised in response to oxidative stress 
induced by hydrogen peroxide (H2O2)118. Protein samples from each labelling technique were 
pooled and separated by 2D polyacrylamide gel electrophoresis (2D-PAGE). The proteins could then 
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be visualised by autoradiography ([35S]Methionine labelled) and western blot with an anti-
fluorescein antibody (acetylTyrFluo labelled). Comparison of the results to a map of the separation 
of previously identified [35S]Methionine labelled proteins, allowed the identification of oxidised 
proteins. This revealed a subset of ER resident proteins, including PDI, BiP and Calnexin, that were 
specific targets of oxidative stress118 thus providing further evidence of the relationship between 
oxidative and ER stress.   
The free radical theory of ageing dictates that ageing occurs because of aerobic metabolism that 
generates ROS in excess of the cellular antioxidant machinery119. This therefore provides a 
mechanism by which oxidative stress, and by association ER stress, is linked to cellular ageing. A 
study by Fisher et al., determined that fragmentation of collagen fibrils seen in aged skin is 
associated with an increased expression of matrix metalloproteinase-1 (MMP-1) that, when not 
inhibited, functions as a collagenase enzyme in the ECM120. By culturing young fibroblasts on 
fragmented collagen lattices, Fisher et al., described a positive feedback mechanism whereby 
cellular oxidation state and MMP-1 expression is elevated by fragmented collagen, which drives 
further collagen fragmentation of the ECM120. This suggests an association between oxidative stress 
and development of an aged skin phenotype.  
A well-known cause of oxidative stress in the skin is UV-radiation from the sun. As well as causing 
UV-induced DNA damage, it is also known to induce H2O2 ROS that triggers oxidative stress within 
exposed cells121. UV radiation emitted from the sun is divided into three categories based on 
wavelength: UV-A (315–400 nm), UV-B (280–315 nm) and UV-C (200–280 nm). Most of the UV-C 
radiation is absorbed by the earth’s ozone layer, leaving UV-B and UV-A waves making up the 
majority of UV radiation that reaches the skin. Whilst the shorter wavelength radiation UV-B is 
thought only to affect the cells of the epidermal skin layers, UV-A is known to reach and damage 
the cells of the dermis. In fact, UV-A radiation has been demonstrated to activate both IRE1 and 
PERK UPR pathways in normal human dermal fibroblasts122.   
Further evidence of the sensitisation of cells to oxidative stress by ECM proteins comes from 
Wondrak et al., who demonstrated that treatment of fibroblasts with collagen that had been pre-
irradiated with UV triggered an oxidative stress response that was relieved by antioxidants123. 
Whilst in vivo there would never be a situation where only the ECM, and not the inhabiting cells, 
was exposed to UV this does suggest that ECM proteins may further promote oxidative stress in 
UV-exposed cells, beyond the response that might be seen in cells isolated from the ECM.  
There is some evidence that provision of antioxidants can relieve the detrimental effects of 
oxidative stress on cells. Hydrogen peroxide (H2O2) treatment can be used to induce oxidative stress 
in vitro with lipid peroxidation, another side-effect of oxidative stress, often used as a tangible 
biomarker of its effects. Calabrese et al., demonstrated that treatment of cells with 25 μmol/L 
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ferulic acid ethyl ester, a nutritional antioxidant, decreased lipid peroxidation in response to 
500 µmol/L H2O2 and promoted the expression of genes known to be involved in cellular responses 
to oxidative stress including HO-1 and Hsp70124. An additional study by Giampieri et al., determined 
that the antioxidant components of strawberry extract were active in protecting cells from H2O2, 
both in terms of cell viability and reduction of lipid peroxidation125. These groups proposed this as 
evidence for the protective benefit of nutritional antioxidants; however, the ability of ingested 
antioxidants to be absorbed in the gut and conveyed to the dermis was not addressed in these 
preliminary studies.  
Many studies in the literature have used targeted or biased approaches to look at the effects of ER 
and oxidative stress on specific proteins that were thought to be of interest or had been previously 
identified in a mapping experiment. The development of “-omics” technologies has increased the 
ability to use untargeted and unbiased approaches to map global changes across an accessible 
genome, proteome, or metabolome. This provides opportunity to identify novel responses to 
treatments in biological pathways that may have previously been considered irrelevant.  
The promise of proteomic techniques in the investigation of dermal fibroblast responses to 
oxidative stress was demonstrated by Wu et al., who used a redox sensitive 2D difference gel 
electrophoresis (2D DiGE) method to identify proteomic responses of skin fibroblast cells to UV-B 
radiation126. Although it is unclear whether UV-B radiation has significant physiological relevance to 
fibroblast cells, as it is thought most UV-B radiation from sunlight is absorbed by the epidermis, this 
still serves to demonstrate the power of the technique. Free thiol groups of cysteine residues not 
involved in disulfide bonds are vulnerable to attack by reactive oxygen species during oxidative 
stress, leading to the formation of sulfenic (-RSOH), sulfinic (-RSOOH) or sulfonic (-R(=O)2OH) acid 
groups. Wu et al., used a fluorescent dye to label free cysteine groups in cell lysates. Comparison 
of the labelling before and after UV-B radiation allowed to identification of proteins that had been 
subject to thiol modification following oxidative stress. A lysine label was also used to determine 
changes in protein amounts independently of redox modifications. This technique identified 
hundreds of differentially labelled proteins from both expected and unexpected protein groups. 
For example, Hsp27, a chaperone that might have otherwise been thought to increase with 
oxidative stress was in fact shown to decrease, suggesting a role for this protein in the dermal 
photo-aged phenotype. Additionally proteins involved in regulating actin filament dynamics were 
upregulated in response to UV-B, a response that has been less well studied and may provide 
mechanistic insight in to the metastasis of cells that have undergone carcinogenesis following 




1.4 The value of proteomics 
1.4.1 Defining proteomics and the importance of proteomic information 
The “-omic” technologies have been developed to study the genes (genomics), which are 
transcribed into transcripts (transcriptomics) and then translated into proteins (proteomics) of 
individual cell types in different tissues and organisms. A further “-omic” approach exists in the 
study of metabolites (metabolomics). In an ideal world, to gain the maximum benefit from “-omic” 
studies, information gathered from all the technologies would be recorded and interpreted 
together, without prior bias or favour towards a single information source127. Unfortunately, such 
large-scale, cross-discipline studies would likely be associated with inhibitory costs, time and 
technology requirements for a single laboratory to perform. As such, development of complex 
mathematical and computational tools to integrate information, and sufficient sharing of data sets 
in accessible databases is being encouraged to optimise the potential benefits these investigations 
can have on current scientific knowledge127. For now, most laboratories either collaborate as 
consortia or focus their efforts in gaining as much insight as possible from just one or two of these 
“-omic” technologies.  
The proteome is defined as all the protein products of the genome: it relies heavily on genomic data 
(see section 1.4.2) yet provides additional information that is of great importance in the study of 
cell and tissue behaviour128. Whilst genomic and transcriptomic data may provide insight into DNA 
damage and regulation of gene expression in response to environmental stimuli, the protein copy 
number within a cell often differs markedly from the transcript copy number. In addition, proteins 
may be regulated by post-translational modifications and therefore a change in protein activity 
cannot always be directly implied from a change in gene expression. Proteomic techniques enable 
investigation into changes in protein abundance in response to a stimulus, as well as facilitating the 
detection of post-translational modifications and protein-protein interactions that shed more light 
on cellular responses than can be gleaned from genomic and transcriptomic approaches alone.  
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1.4.2 Proteomic methodology 
Mass spectrometry has become the main method by which scientists investigate the proteome. 
This methodology indirectly relies on gene sequence data, which can, in turn, provide information 
on the amino acid sequences of known gene products. In any organism, most amino acid sequences 
greater than 6 residues are unique. That is, the same 6 amino acid sequence is unlikely to be found 
in the sequence of another gene product, unless they are closely related and therefore the 
sequences highly conserved129. This means that if the sequence of at least one or two peptides from 
a protein can be confidently identified, it is possible to identify the protein from which they came. 
To do this, peptides must be generated from proteins in the sample before their sequences can be 
determined using mass spectrometry. As peptide sequences are usually determined by comparing 
the measured mass of peptides to the mass of predicted peptides based on the protein sequence, 
the proteolytic enzyme used must have predictable cleavage sites. This allows the in-silico 
determination of cleavage sites in protein sequences, and prediction of peptide masses, for 
comparison to measured data. Usually, proteins are digested into peptides with trypsin, a protease 
enzyme whose cleavage sites are specific and predictable, namely C-terminal to arginine and lysine 
residues.  
Mass spectrometers are made of three main components: the ion source, mass analyser, and 
detector. Peptides must be in the gas phase to be analysed, therefore the ion source serves to ionise 
peptides. Peptides are large, polar molecules which are not easily ionised without fragmentation or 
decomposition130. Electrospray ionisation (ESI) and matrix assisted laser desorption/ionisation 
(MALDI) are termed “soft” ionisation techniques and they have enabled the ionisation of these 
molecules without damage131,132. In the liquid chromatography-coupled mass spectrometry, to be 
employed in this thesis, electrospray ionisation is used. This works by passing a sample solution 
through a narrow, electrically charged needle tip to release small droplets carrying a positive 
charge. As these droplets spray from the needle, solvent evaporation leads to droplet 
disintegration, increasing the surface charge to a maximum at which point the ions are emitted into 
the gas phase133. 
Once in the gas phase, ions can be analysed in the mass analyser. Several different types of mass 
analyser are currently in use including, for example, the time-of-flight (TOF), quadrupole, ion trap 
and Fourier transform ion cyclotron (FT-MS) analysers. For peptide analysis, tandem mass 
spectrometry is usually employed whereby the mass of the parent (or precursor) ion is first 
measured before fragmentation in a collision cell and then masses of the resulting daughter (or 
fragment) ions are measured in a second mass analyser. The machines used for the analysis 
presented in this thesis have two mass detectors: both a quadrupole, and a time of flight. In this set 
up, a quadrupole selects ions with a specific mass to charge ratio (m/z) which then enter a collision 
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cell for fragmentation before measurement on a final TOF analyser134. The m/z value 
(dimensionless) is the unit displayed on the x-axis of mass spectra and is determined by the 
molecular mass divided by the charge of a given ion.  
Quadrupoles are made up of four parallel rods, through which ions travel. An electrical field is 
applied to the rods consisting of a constant voltage, and a radiofrequency voltage. This voltage 
causes ions to fly in a corkscrew-like flight path, which will only be stable with ions of a specific, and 
narrow, mass range for any given voltage setting. Ions which are not within the permitted m/z range 
spin out and hit the rods, whereas ions that are can fly through the rods and reach the detector or 
collision cell135. A TOF analyser works on a much simpler principle: that if ions of the same charge 
are accelerated by the same force, smaller ions will fly faster than bigger ions. Thus, by measuring 
the time taken for an ion to travel through a flight tube and hit a detector, its size can be 
calculated135. The detector is the final component of the mass spectrometer, and this measures the 
intensity of the signal, which is relative to the number of ions at the m/z value.  
Tandem mass spectrometry produces two sets of spectra: first the MS1 data which provides 
information on the weight and intensity of the parent ions, and second the MS2 data, which 
provides information on the weight and intensity of the daughter ions. Peptides fragment in a 
predictable manner and it is therefore possible to use this information to determine the sequence 
of amino acids in the peptides identified. When peptide ions collide with the gas ions in the collision 
cell, the bonds along the backbone break to produce “y” and “b” ions (Figure 1.10). The “b” ions 
are the N-terminal side of the peptide, with a positive charge on the carbon of the carboxyl group; 
the “y” ions are the C-terminal side of the peptide, with a positive charge on the nitrogen of the 
amino group. With efficient ionisation of peptide parent ions, it is possible to see a complete series 
of y and b ions in the MS2 spectra. Comparing the masses identified to the known masses of amino 










Figure 1.10: Peptide ionisation into y and b ions. When peptides fragment, the peptide bond 
breaks to generate b ions, containing the now positively charged carboxyl group, and y ions 
containing the now positively charged amide group. A well ionised peptide should produce a series 




When analysing proteins in cell lysates, the resulting spectra consist of daughter ions from several 
parent peptides. These spectra are often too complex to identify the parent peptides manually, and 
thus these are analysed in silico by searching databases of known fragmentation patterns. To fully 
analyse such a complex sample of proteins, it is usually necessary to separate the mixture e.g. by 
strong cation exchange chromatography, to reduce complexity, and therefore maximise the 
number of identifications seen. If the sample becomes too complex, it increases the chance of 
under sampling where the same proteins aren’t identified in repeats136. Fractionation also improves 
the dynamic range of analysis, allowing for a greater range in protein abundances to be identified. 
In an unfractionated sample, only those parent ions with the greatest intensity (and therefore 
highest abundance in the sample) will be selected for fractionation. By separating the mix of 
peptides, the intensity threshold that must be met for parent ions to be fragmented is reduced. The 
identifications derived from spectra from all the fractions can be combined to create a fuller picture 
of the samples proteome. 
Fractionation can use either gel-free or gel-based techniques. Proteins can be separated using 
2D-PAGE, which resolves proteins into distinct spots on the gel, based on isoelectric point and 
molecular weight. These spots can then be cut out of the gel and proteins extracted and digested 
for mass spectrometry analysis. Alternatively, proteins or peptides can be separated by liquid 
chromatography, which resolves them based on their chemistry. For example, strong cation 
exchange (SCX) is commonly used to separate peptides based on their charge. SCX material usually 
contains many sulfonic acid groups, which are negatively charged in solution, and interact with 
positively charged cations. Washing with increasingly basic solvent will gradually elute peptides by 
neutralising these ionic interactions137.  SCX will be used for fractionation of relevant samples in this 




1.5 Thesis aims 
Although there is a clear link between ER stress and oxidative stress, and several proteomic 
responses have been determined in dermal fibroblasts, relatively little is known about the effects 
of perturbing cellular redox balance in the opposite direction, namely, how reductants affect the 
human dermal fibroblast proteome. The skin may be exposed to reductants from a range of 
sources: from sulfur dioxide in the atmosphere released from burning fossil fuels to thioglycolate 
used in cosmetic depilatory creams. This thesis aims to investigate the proteomic effects of 
reductive stress on human dermal fibroblasts by: 
1. Developing tools, protocols and procedures for the identification of protein responses to 
environmental stimuli from dermal fibroblast cell lysates and conditioned cell growth media. 
2. Using a range of biochemical and proteomic techniques to investigate the dermal fibroblast 
response to reductive stress.  
3. Using the same methodology to profile the proteomic response of these cells to oxidative 








Chapter 2: Materials and Methods 
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2 Materials and Methods 
All chemicals used in the work pertaining to this thesis were obtained from Sigma Aldrich unless 
otherwise stated. Where catalogue numbers are given without a company descriptor these 
correspond to Sigma products.  
2.1 Cell culture 
Cultures of human dermal fibroblasts were maintained in a humidified incubator at 37 C and 
5% CO2. Adherent fibroblasts were sub-cultured twice a week in T75 flasks (TPP, 90076) and 
passaged under sterile conditions in a CL2 flow hood (SteriGUARD, The Baker company, Sanford, 
Maine 04073 USA). BJ fibroblast cells (ATCC® CRL-2522™) and normal human dermal fibroblasts 
(nHDF) (neonatal) (gifted by Pamela Ritchie, Durham University) were grown in Eagle’s Minimum 
Essential Medium (MEM) (Gibco, 41966-029) supplemented with 100 units/ml Penicillin, 100 µg/ml 
Streptomycin (Gibco 15410), glutamax (Gibco, 35050-038) and 10% Foetal calf serum (FCS) (F7524). 
142BR fibroblast cells (ECACC 90011806) were grown in MEM (Gibco, 41966-029) supplemented 
with 100 units/ml Penicillin, 100 µg/ml Streptomycin (Gibco 15410), glutamax (Gibco, 35050-038), 
1% non-essential amino acids and 15% FCS (F7524). Prior to passaging, the medium was warmed 
to 37C for 15 mins in a water bath. During this time, the spent media from the flask was removed 
and the cells were washed twice with 10 ml sterile phosphate buffered saline (PBS; 0.2 g/L KCl, 
0.2 g/L KH2PO4, 8 g/L NaCl, 1.15 g/L Na2HPO4 (anhydrous), D8537). 1 ml of trypsin (0.05% Gibco, 
15400-054) was applied to the cells for 1 min, 0.5 ml was then removed, and cells were incubated 
at 37 C for five minutes. A single cell suspension was created by adding an appropriate volume of 
media (10 ml for a T75 flask) and aspirating. Fresh media was added to a new sterile T75 flask 
sufficient to create the desired dilution (5 ml for a standard 1:2 passage) and then the 
corresponding volume of cells (5 ml for a standard 1:2 passage) added and mixed by aspirating. The 
sub-cultured cells were returned to the incubator to incubate for 3-4 days.  
2.2 Cell lysis 
Cells grown to 90% confluence were washed twice with PBS (D8537), and then placed on ice after 
aspiration of the PBS. To solubilise ER and cytosolic proteins, 300 µl (T25 flask) or 600 µl (T75 flask) 
MNT lysis buffer was added to the cells. 1x MNT buffer was comprised of 20 mM MES (M8250), 30 
mM Tris-HCl (T3253), 100 mM NaCl (S7653), pH 7.4, with 1% v/v Triton X-100 (X100) and 10 µg/ml 
each of protease inhibitors chymostatin, leupeptin, antipain, pepstatin A. The cells were left to lyse 
on ice for 20 minutes prior to scraping thoroughly with a cell lifter (TPP, 99003T). The resulting 
lysate was then transferred to a 1.5 ml Eppendorf tube, vortexed and centrifuged at 16 000 g, 4 C 
for 10 minutes to pellet the nuclei, and the post nuclear supernatant transferred to a fresh tube. 
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Pellets were discarded or retained if required. Lysates were flash frozen in liquid nitrogen and 
stored at -20 C for further analysis. 
Alternatively, cells were lysed in RIPA buffer to retain nuclear proteins. 600 µl RIPA lysis buffer (1% 
v/v Triton X-100 (X100), 50 mM Tris HCl (T3253), pH 8, 150 mM NaCl (S7653), 0.5% w/v 
Na-deoxycholate (D6750), 0.1% w/v SDS (74255)) supplemented with 10 µg/ml each of protease 
inhibitors antipain, chymostatin, leupeptin and pepstatin A and 1x phosSTOP from a 10x stock of 1 
tablet in 1ml dH2O (against acid, alkaline, serine/threonine, tyrosine and dual-specificity 
phosphatases; Roche 04906845001) was used per T75 flask of PBS-washed cells as described above. 
The cells were left to lyse at room temperature to avoid precipitation of SDS for 1 minute prior to 
scraping thoroughly with a cell lifter. Lysates were transferred to a 1.5 ml Eppendorf tube and 
vortexed for 30 seconds before being centrifuged at 16 000 g, 4 C for 10 minutes to clear any debris 
from the sample. Supernatants were transferred to a fresh tube and pellets discarded. Lysates were 
flash frozen in liquid nitrogen and stored at -20 C. 
2.3 Cell treatments 
2.3.1 Chemical treatments 
Unless otherwise stated, cells were treated in serum free MEM. Cells were grown to 70% 
confluency, washed once with PBS and incubated with serum free media. Chemicals were added to 
media to give final concentrations of 5 ng/ml platelet derived growth factor (PDGF) -bb (Gibco, 
PH90045), 5 mM dithiothreitol (DTT) (D9779), 2 µM Thapsigargin (T9033), 12.5 µM Etoposide 
(E1383), 5 mM Peroxide (H1009), 5 mM Taurine (T8691), 5 mM Potassium Thioglycolate (Acros 
organics, 384702500). Cells were kept at 37 C in a humidified incubator for the duration of 
treatment, before washing and lysing as described above.  
2.3.2 UV radiation 
Cells were grown to 70 % confluency, spent media set aside and cells washed once with PBS. All 
fluid was removed, and control cells wrapped in foil before inversion on a transilluminator set to 
an intensity of 8000 µW/cm2 for 10 minutes (to give final dose of 5 J/cm2). Spent media was then 
replaced and cells returned to a humidified incubator at 37 C to recover for 18 hours before lysis 




2.4 Orangu™ cell proliferation assay 
Cell proliferation was measured using the Orangu™ cell counting solution (Cell Guidance systems, 
OR01-500) according to manufacturer’s instructions. Briefly, cells were seeded into a 96-well plate 
and allowed to settle overnight. Following treatment, cells were washed and replaced in to fresh 
media. On each day that readings were taken, 10 µl Orangu™ reagent was added and incubated for 
2 hours before reading at 450 nm on a plate reader (BioTek, ELx800 Absorbance Reader). 
2.5 Tissue sample lysis 
Murine liver tissue was cut into small pieces and snap frozen in liquid nitrogen until use. After 
defrosting, tissue was cut into small pieces and pushed through a 40 µm cell strainer (BD 
biosciences) with 1X MNT lysis buffer. The resulting lysate was vortexed and then centrifuged at 
16 000 g, 4 C for 10 minutes. The supernatant was transferred to a fresh tube and the pellet stored 
at -20 C. The protein concentration of the tissue lysate supernatant was estimated by Bradford 
assay (section 2.6.1) and diluted to 10 µg/µl before use.  
2.6 Protein concentration estimation 
2.6.1 Bradford Assay 
A standard curve was prepared using Bovine Serum Albumin (BSA) (A9647) at concentrations of 0, 
1, 2, 5, 8, and 10 µg protein by dilution of 1 mg/ml BSA in lysis buffer corresponding to the samples 
being measured and each mixed with 10 µl 0.1 M HCl, 80 µl H2O and 900 µl Bradford dye (BioRad, 
Hercules, CA, USA). Samples to be tested were prepared with 2 µl sample in 8 µl lysis buffer, with 
10 µl 0.1 M HCl, 80 µl H2O and 900 µl Bradford dye (BioRad, Hercules, CA, USA). After addition of 
dye, samples and standards were incubated at room temperature for 10 minutes before the 
absorbance was read at 595 nm using an Eppendorf Biophotometer (Eppendorf AG, Hamburg, 
Germany). A standard curve of protein concentration against absorbance was plotted and used to 
estimate protein concentrations from the unknown samples.  
2.6.2 BCA Assay 
The BCA assay is thought to be more detergent compatible than the Bradford assay, and was used 
for protein estimation of samples being prepared for mass spectrometry analysis by the TripleTOF 
6600 mass spectrometer. The BCA assay was performed using the Peirce™ BCA Protein Assay Kit 
(ThermoFisher Scientific, 23225) according to kit instructions in a microplate. Briefly, standards at 
0, 25, 125, 250, 500, 750, 1000, 1500, and 2000 µg/ml were prepared from a 2 mg/ml BSA stock. 
Aliquots of 25 µl from each standard and sample being tested were added to wells of a 96-well 
flat-bottomed microplate in duplicates. 200 µl working reagent was added to each well and 
incubated at 37 C for 30 minutes before reading in a plate reader at 562 nm. Standards were used 
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to plot a standard curve of protein concentration against absorbance, from which the protein 
concentrations of unknown samples could be measured.  
2.7 SDS PAGE 
SDS PAGE 10% gels (6 ml dH2O, 4.95 ml 30% Acrylamide, 3.75 ml 1.5 M Tris pH 8.8, 150 µl 10% SDS, 
150 µl 10% APS, 6 µl TEMED) were cast using the Hoefer® Dual Gel Caster for mini gels (Hoefer Inc., 
USA), with a stacking gel (1.42 ml dH2O, 0.33 ml 30% Acrylamide, 0.25 ml 1 M Tris pH 6.8, 
20 µl 10% SDS, 15 µl 10% APS, 2 µl TEMED) containing wells for protein loading cast on top. A 
maximum volume of 15 µl of sample mixed 1:1 with 2 x Laemmli sample loading buffer containing 
65.8 mM Tris-HCl, pH 6.8, 26.3% (w/v) glycerol, 2.1% SDS and 0.01% bromophenol blue (Biorad, 
#1610737) and reduced with 50 mM DTT before loading against a stained or unstained marker, 
depending on future work to be carried out with the gel. The gel was run in a tank containing 1 x 
Tris-Glycine electrophoresis buffer containing 25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3 
(diluted from 10 x stock, BioRad, #1610772) at between 10 and 50 mA. Gels were then stained with 
colloidal Coomassie (section 2.8) or transferred for western blotting (section 2.9). 
2.8 Coomassie Staining 
Gels were fixed in 1x fixing solution containing 12% trichloroacetic acid and 3.5% 5-sulfosalicyclic 
acid (diluted from 5 x stock, F7264) for 10 minutes with gentle shaking before being transferred to 
colloidal Coomassie solution containing 0.1% (w/v) Brilliant Blue G, 0.29 M phosphoric acid and 16% 
saturated ammonium sulfate (B2025) for 1.5 hours or overnight. After staining gels were placed in 
the first de-stain solution (5 ml acetic acid, 12.5 ml methanol, 32.5 ml distilled water) for 10 minutes 
and finally transferred to 25% methanol destain solution. The gel was incubated at room 
temperature with gentle rocking until such a time as the gel was analysed by scanning, with regular 
refreshing of the final de-stain solution until the excess blue colour was removed. 
2.9 Western blotting 
Proteins separated by SDS-PAGE gel were transferred to a methanol-primed PVDF membrane 
(Immobilon) using the BioRad Mini Trans-blot® system. Transfer was performed at 4 C in transfer 
buffer (25 mM Tris, 1.5 M Glycine and 20% methanol) for 2.5 hours at 150 mA or overnight at 30 V. 
After transfer, membranes were blocked in 5 % milk in Tris buffered saline with Tween (TBS-T) 
(10 mM Tris pH 8, 150 mM NaCl, 0.1% Tween-20 (P1379)) for 1 hour at room temperature before 
incubation with primary antibody at 4 C overnight. Primary antibodies were diluted according to 
dilutions detailed in Table 2.1, either in 1 % milk in TBS-T (PDI, pan-Akt, -actin) or 5% BSA in TBS-T 
(all other antibodies listed in Table 2.1). After antibody incubation, membranes were washed for 5 
minutes in TBS-T 5 times and then incubated with secondary antibody for 1 hour at room 
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temperature. HRP-conjugated secondary antibodies were diluted in 1% milk in TBS-T at 1:3000. 
Swine anti rabbit (SARPO: Dako, P0217) or goat anti mouse (GAMPO: Dako, P0447) were used 
depending on animal of origin (see Table 2.1). Membranes were washed a final 5 times in TBS-T as 
before, prior to visualisation of target proteins with ECL (GE Healthcare, RPN2232) and light 
sensitive film. 
2.10 Immunoprecipitation 
A 200 µl aliquot of cell lysate was incubated with 0.5 µl antibody against target overnight at 4 C on 
a rotor. A 100 µl volume of sepharose beads coated with protein A was then added and the samples 
and incubated for a further 4 hours at 4 C. The sepharose beads were then pelleted by spinning at 
1500 g and the supernatant removed. The pellet was washed 2 times with lysis buffer, and then a 
further 4 times with 1 x MNT buffer before elution with 50 mM NH4HCO3, 50 mM DTT, 1% SDS by 
boiling for 5 minutes. The eluate was collected and analysed by Bradford assay to determine protein 
content. Samples were then taken forward for analysis by in-solution digestion and mass 
spectrometry as previously described.  
2.11 Immunofluorescence 
Cells for analysis by immunofluorescence were seeded onto 18 mm coverslips in 6 cm dishes before 
treatment. Treatments were performed once cells had reached suitable confluency on these cover 
slips, after which the cells were washed twice with PBS containing 1 mM CaCl2 and 0.5 mM MgCl2 
(PBS++). Cells were fixed for 15 minutes in 4% paraformaldehyde, washed again in PBS++ and the free 
aldehyde groups quenched with 50 mM NH4Cl2 by incubation for 10 minutes. Cells were then 
permeabilised using 0.1% Triton X-100 (X100), washed once for 5 minutes with PBS++ and a further 
two times, for 5 minutes each, with 0.2% BSA in PBS++. Coverslips were inverted onto parafilm for 
incubation with 20 µl anti-PDI antibody diluted appropriately with 0.2% BSA in PBS++ (see Table 2.1) 
for 20 minutes, protected from the light. Following primary antibody incubation, the coverslips 
were returned to 6 cm dishes for three, 5-minute washes with 0.2% BSA in PBS++. The coverslips 
were then inverted on parafilm again for incubation with 2 µg/ml fluorescent conjugated donkey 
anti-rabbit AlexaFluor 594 secondary antibody (Invitrogen, A21207). Finally, coverslips were 
washed twice with 0.2% BSA in PBS++ before incubation with 50 µl 1x DAPI (Invitrogen) for 5 minutes 
in the dark. Coverslips were rinsed briefly in dH2O to remove excess DAPI and PBS++ before 
mounting onto microscope slides with Vectashield (Vector, H-1400) and sealing with clear nail 





All antibodies used were commercially available except for anti-PDI and anti-Ero1. The polyclonal 
anti-sera against PDI was generated by immunising rabbits with a purified rat PDI protein 
preparation as described by Benham et al138. The 2G4 antibody against Ero1 was a kind gift from 
Professor Roberto Sitia. The antibodies, their application (use), supplier and dilutions are detailed 
in Table 2.1.  
Table 2.1: Antibodies. The type, usage and supplier for all antibodies used in this thesis. 
Antibody Animal/Type Use Dilution Supplier/Catalogue Number 
-Actin Mouse mAb WB 1:10000 Abcam #8224 
PDI 
Rabbit pAb IF 1:200 
Benham laboratory (Benham et 
al., 2000138) 
phospho-Akt (Ser473) 
Rabbit pAb WB 1:1000 




Rabbit mAb WB 1:2000 





Detection Cocktail II 
Rabbit pAb WB 1:200 
Cell Signalling Technology® 
#5304 
phospho-eIF2 
Rabbit pAb WB 1:500 
Cell Signalling Technology® 
#9721 
pan-Akt 
Mouse mAb WB 1:2000 
Cell Signalling Technology® 
#2920 
Ero1 (2G4) 
Mouse mAb IP 1:2500 






2.13 Concanavalin A  
An aliquot of 50 µl concanavalin A-coated sepharose beads were washed and resuspended in lysis 
buffer to 70% solution. Approximately 50 µl of this bead solution was then added to 500 µl lysate 
and incubated on rotor at 4 C for 30 minutes. Following incubation, the sample was centrifuged 
for 1 minute at 6000 rpm and the supernatant removed. The remaining beads were washed twice 
with lysis buffer before re-suspending in 2 x Laemmli sample loading buffer containing 65.8 mM 
Tris-HCl, pH 6.8, 26.3% (w/v) glycerol, 2.1% SDS and 0.01% bromophenol blue (Biorad, #1610737), 
boiled for 3 minutes and centrifuged at 13 000 rpm to pellet beads. Supernatants were loaded onto 
10% SDS-PAGE gels for analysis.  
2.14 2D PAGE 
Protein samples for 2D PAGE were prepared in a buffer of 9M Urea, 2M Thiourea, 4% CHAPS either 
by cell lysis directly into the buffer or by acetone precipitation of protein sample and re-suspension. 
Immobiline DryStrips (7cm pH 3-11 non-linear; GE Healthcare) were set to re-swell overnight in a 
groove of a re-swelling tray containing 100 µg protein sample to be separated, 2.5 µl IPG buffer, 
2.5 µl 50% DTT, 20 µl lysis buffer spiked with bromophenol blue, and sufficient lysis buffer to make 
this up to a volume of 125 µl. The strips were covered in Immobiline™ DryStrip Cover Fluid (GE 
Healthcare) during re-swelling and left on a level surface overnight. After re-swelling, the strips 
were removed, rinsed in water and blotted on damp filter paper before loading onto Multiphor™ II 
Electrophoresis system (GE Healthcare) and connected to the MultiTemp™ III thermostatic 
circulator for isoelectric focussing (IEF). Two wicks soaked in water were placed at either end of the 
gel strip, overlapping the gel and backing strip. Focussing was run in three phases: 200 V, 1 mA, 5 
W, 10 kWh; 3500 V, 1 mA, 5 W, 2700 kWh; 3500 V, 1 mA, 5 W, 2800 kWh. Following isoelectric 
focussing, the IEF strips were equilibrated in buffer (50 mM TrisCl pH 8.8, 6 M Urea, 30% Glycerol, 
10% SDS) with 10 mg/ml DTT for 15 minutes, and then again in equilibration buffer with 48 mg/ml 
iodoacetamide for a further 15 minutes. Following equilibration, the gel strips were loaded onto 
10% SDS PAGE resolving gels with a molecular weight marker and sealed using 0.5% agarose spiked 
with bromophenol blue. The second dimension resolving gels were run at 30 mA before Coomassie 
staining as described above (section 2.8). 
2.15 Senescence-Associated Beta Galactosidase assay 
Staining for senescence-associate -galactosidase activity was performed using the Senescence 
β-Galactosidase Staining Kit from Cell Signalling technology® (9860) according to manufacturer’s 
instructions. Briefly, spent media from treated cells was removed and cells washed once with PBS 
before fixing in a proprietary fixative solution for 10-15 minutes at room temperature. Cells were 
then washed a further two times before application of pH-adjusted -galactosidase staining 
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solution and incubation overnight in a dry incubator at 37 C. Staining solution was then removed, 
and cells washed twice with PBS. Following staining, dishes of stained cells were either stored in 
glycerol at 4 C or cover slips DAPI stained and mounted on microscope slides for analysis. Images 
were taken using a CMEX WiFi 5 camera (Euromex, DC.5000‑WIFI) attached to an inverted light 
microscope or inverted wide field fluorescence microscope for DAPI stained cells (Zeiss Apotome).  
2.16 RNA extraction and RT-PCR 
Following two PBS washes, cell lysates for RT-PCR analysis were obtained using 250 µl TRI reagent 
(T9424) and scraping with a cell lifter before transfer to Eppendorf tubes. Cell lysates were 
incubated for 10 minutes on ice with 50 µl chloroform (Fisher Bioreagents, BP1145-1) after 
vortexing. Lysates were then centrifuged at 16 000 g for 15 minutes at 4 C and the aqueous phase 
removed to a fresh Eppendorf tube. 125 µl isopropanol (BDH, 1525265) was added to this aqueous 
phase, vortexed and incubated on ice for a further 10 minutes. Samples were again centrifuged for 
10 minutes at 16 000 g, 4 C, supernatants discarded, and the pellets washed with 75% ethanol. 
Air-dried washed pellets were re-suspended in nuclease-free water to a final concentration of 
50 ng/µl (concentrations were determined using a nanodrop spectrophotometer (ND-1000 
LabTech international)).  
RT-PCR was performed using the AccessQuick™ RT-PCR system from Promega (A1701) according to 
the manufacturer’s instructions. The primers for -actin were: CCACACCTTCTACAATGAGC 
(forward) and ACTCCTGCTTGCTGATCCAC (reverse) and the primers for XBP1 were: 
GAAACTGAAAAACAGAGTAGCAGC (forward) and GCTTCCAGCTTGGCTGATG (reverse). The protocol 
used in the thermal cycler was: 1 hour at 45 C; 2 minutes at 94 C; 30 cycles of {30 seconds at 
94 C, 1 minute at 60 C, 1 minute at 72 C}; 5 minutes at 72 C and finally reduced to 4 C where 
the temperature was maintained until retrieval of samples. XBP1 products were subject to digestion 
with 10 U/µl PstI (Thermo, ERO611) for 2 hours by incubation in 37 C waterbath. The products 
were cleaned up using a PCR purification kit from Qiagen (QIAquick, Qiagen, 28104) before analysis. 
RT-PCR products were analysed on a 1% (-actin) or 2% (XBP1) agarose gel. Agarose (Melford, 
MB1200) was dissolved at the appropriate w/v ratio in 0.5% TAE buffer with 5.5 µl ethidium 
bromide. Gels were run using a Bio-Rad Sub-Cell® GT Horizontal Electrophoresis System (#1704401) 
at 100 mV for 40 minutes before visualising under UV light.   
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2.17 Liquid chromatography – tandem mass spectrometry 
(LC-MS/MS) Sample preparation 
2.17.1 In-gel digests  
Gel spots for protein identification were taken using a pipette tip and transferred to an Eppendorf 
tube containing dH2O until de-stained.  The water was then removed, and the gel spots incubated 
3 times for 10 minutes in 100 mM ammonium bicarbonate and 40% v/v acetonitrile. Following 
aspiration of the final ammonium bicarbonate/acetonitrile wash, the gel spots were incubated for 
10 minutes in HPLC grade acetonitrile and then 10 minutes in HPLC grade H2O; these two 
incubations were repeated sequentially twice before a final 10-minute incubation with HPLC grade 
acetonitrile. The spots were then vacuum dried for 10 minutes at 60 C before adding 50 µl 40 mM 
ammonium bicarbonate, 9% v/v acetonitrile with 20 ng/µl sequencing grade trypsin (Promega, 
V511A) for 30 minutes. A further 200 µl 40 mM ammonium bicarbonate, 9%v/v acetonitrile was 
then added, and spots incubated for 16 hours at 37 C before acidification with 25 µl 1% 
trifluoroacetic acid (TFA). Samples were then taken for mass spectrometry analysis as described 
below (section 2.18). 
2.17.2 In-solution digest 
Samples for in-solution digestion were incubated with 0.01 volumes of 0.5 M DTT for 20 minutes at 
56 C, cooled to room temperature and then incubated with 0.025 volumes 0.5 M iodoacetamide 
for 20 minutes at room temperature in the dark. Modified sequencing grade trypsin (Promega, 
V511A), re-suspended in 10% acetonitrile, 2 mM HCl, was added at a ratio of 20-40:1 w/w 
protein:enzyme and incubated at 37 C overnight. 
2.17.3 Filter Aided Sample Preparation 
Filter aided sample preparation (FASP) was carried out using the Expedeon FASP kit (Expedeon Ltd, 
44255) according to manufacturer’s instructions. Briefly, 30 µl or 0.4 mg protein sample (whichever 
was least), previously reduced with 0.05 volumes 0.1 M DTT, was combined with 200 µl urea sample 
solution for protein loading on to filter membrane. The sample was loaded on to the spin filter by 
centrifugation at 14 000 g for 15 minutes and washed with 200 µl urea sample solution before 
centrifuging for a further 15 minutes at 14 000 g. Reduced disulfide bonds were alkylated by 
incubation with 10 µl 10 X iodoacetamide solution in 90 µl urea sample solution for 20 minutes in 
the dark. After removal of the iodoacetamide solution by  centrifugation, samples were washed 
three times with urea sample solution and three times with 50 mM ammonium bicarbonate 
solution before incubation with 1:100 enzyme-to-protein ratio of mass spectrometry grade trypsin 
(Promega, V528A) for 18 hours at 37 C. Spin filters (with bound freshly-digested peptides) were 
transferred to a fresh tube and peptides collected by two sequential washes with 40 µl 50 mM 
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ammonium bicarbonate and a further wash with 50 µl 0.5 M NaCl which will also inhibit further 
trypsin activity. Samples were then acidified with 1 µl 1% TFA and freeze-dried to reduce their 
volume before re-suspension in 3% acetonitrile, 0.1% formic acid for LC-MS/MS analysis.   
2.17.4 Sample fractionation 
2.17.4.1 StageTip Fractionation 
StageTips were prepared and used as described by Rappsilber et al139. Briefly, a strong cation 
exchange disk was loaded into pipette tips below a C18 disk. The StageTips were primed with 20 µl 
methanol before sample loading and then elutions performed with varying concentrations of 
NH4AcO in 0.5% formic acid, 20% acetonitrile to generate 6 fractions (20 mM, 50 mM, 100 mM, 
200 mM, 400 mM, 1 M NH4AcO). Elutions were de-salted using a C18-only StageTip prior to loading 
on the mass spectrometer.  
2.17.4.2 Liquid chromatography 
Liquid chromatography and QSTAR LC-MS/MS methods were performed as described by Smith et 
al.140 and are briefly outlined below. Samples were separated on a Poly-LC strong cation exchange 
column (200 x 2.1 mm) at 200 µl/min by an Ettan LC (GE Healthcare) HPLC system. Peptide 
separation was performed using a biphasic gradient of 0-150 mM KCl over 11.25 column volumes 
and 150-500 mM KCl in buffer A (10 mM K2HPO4, 25% acetonitrile, pH 2.8) over 3.25 column 
volumes. A total of 30 fractions were collected and dried down before re-suspension in 2% 
acetonitrile/0.1% formic acid. Aliquots were then analysed by LC-MS/MS by the QSTAR system 
outlined below.   
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2.18 LC-MS/MS Analysis 
2.18.1 QSTAR 
Sample fractions were analysed using an ultimate 3000 UHPLC system (Dionex) attached to a hybrid 
quadrupole-TOF mass spectrometer (QStar Pulsar i, MDS-Sciex/Applied Biosystems) coupled to a 
nanospray source (Protana) and a PicoTip silica emitter FS360-20-10-D-20 (New Objective). Samples 
were loaded and washed on a Zorbax 300SB-C18,5 x 0.3 mm, 5-micron trap column (Agilent) and 
online chromatographic separation performed over 2 h on a PepMap™ 75 µm x 150 mm C18, 3 µm, 
100 Å column (Thermo Scientific) with a linear gradient of 5-32% acetonitrile, 0.1% formic acid at a 
flow rate of 300 nl/minute. Analyst software version 1.1 (Applied Biosystems) was used acquire all 
MS and MS/MS data. Protein identifications were obtained by searching against the SwissProt 
2015_04 or 2015_09 database with MASCOT version 2.5.1. Peptide mass tolerance of 50 ppm and 
fragment mass tolerance of 0.6 Da was used with 1 missed cleavage permitted, and variable 
modifications of Carbamidomethyl (C), and Oxidation (M) considered. Peptide False discovery rate 
was set at 1%.    
2.18.2 TripleTOF 6600 
2.18.2.1 Nano-flow LC-MS/MS 
Sample fractions containing 1 µg peptides were analysed using an ekspert™ nanoLC 425 with nano 
gradient flow module (Eksigent) attached to a quadrupole Time-Of-Flight (QTOF) mass analyzer 
(TripleTOF 6600, SCIEX) via a nanospray III source (SCIEX) with a PicoTip emitter FS360-20-10-C12 
(New Objective). Samples were loaded and washed on an Acquity M-class symmetry C18 100 Å, 
180 µm x 20 mm, 5-micron trap column (Waters) and online chromatographic separation 
performed over 105 minutes on a Picofrit column filled with Reprosil-PUR 3 µm, 75 µm x 250 mm 
(New Objective) at a flow rate of 300 nl/min with a linear gradient of 30-40% acetonitrile, 0.1% 
formic acid over 70 minutes, then to 80% acetonitrile, 0.1% formic acid over 2 minutes, held for 6 
minutes before returning to 3% acetonitrile, 0.1% formic acid and re-equilibrated. Analyst software 
version 1.7.1 (Applied Biosystems) was used acquire all MS and MS/MS data. 
2.18.2.2 Micro-flow LC-MS/MS 
Sample fractions containing 5 µg peptides were analysed using an ekspert™ nanoLC 425 with low 
micro gradient flow module (Eksigent) attached to a quadrupole Time-Of-Flight (QTOF) mass 
analyzer (TripleTOF 6600, SCIEX) coupled to a DuoSpray source (SCIEX) and a 50-micron ESI 
electrode (Eksigent). Samples were loaded and washed on a TriArt C18 Capillary guard column 
1/32", 5 µm, 5 x 0.5 mm trap column (YMC) and online chromatographic separation performed over 
57 minutes on a Triart C18 Capillary column 1/32", 12 nm, S-3 µm, 150 x 0.3 mm (YMC) at a flow 
rate of 5 µl/min with a linear gradient of 3-32% acetonitrile, 0.1% formic acid over 43 minutes, then 
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to 80% acetonitrile, 0.1% formic acid over 2 minutes, held for 3 minutes before returning to 3% 
acetonitrile, 0.1% formic acid and re-equilibrated. Analyst software version 1.7.1 (Applied 
Biosystems) was used acquire all MS and MS/MS data. 
2.18.2.3 Data-Dependant acquisition 
Protein identifications were obtained by searching against the SwissProt 2017_02 database in 
ProteinPilot™ version 5.0.1 using the Paragon search algorithm, with peptide mass tolerance 10 
ppm, fragment mass tolerance 0.6 Da, 1 missed cleavage permitted and variable modification of 
carbamidomethyl (C) considered. 
2.18.2.4 Data-Independent acquisition 
Samples were spiked with iRT peptides (Biognosys) at a ratio of 1 µg protein to 0.1 µl 10 x RT peptide 
mix. Protein identifications were obtained by searching spectra against the panhuman 10000 
protein 2014 spectral library141 in PeakView version 2.2 with the SWATH acquisition microapp 
version 2.0. Chromatographic retention time calibration was performed using iRT peptides, and 
SWATH data processing carried out with the following filters: 300 peptides per protein, 5 transitions 
per peptide, 95% peptide confidence threshold, 1% false discovery rate threshold and XIC width 
75 ppm. Further analysis was carried out using MarkerView version 1.2.1 before export to Microsoft 
office Excel and R.  
2.19 Bioinformatics 
The R scripts for the bioinformatic analysis described here were written by the author of this thesis 
and can be found in appendix 1.  
Protein identifications were mapped to the gene ontology (GO) terms for biological process and 
cellular compartment either manually, using terms listed on UniProt, or by ClusterProfiler142 
through Bioconductor/R. Statistical testing for overrepresentation or enrichment of GO terms was 
performed using the Panther tools available at pantherdb.org143,144.  
Basic comparative analysis, including PCA and t-test analysis was performed in MarkerView version 
1.2.1. ANOVA was performed using GraphPad Prism 7. More complex analysis and graphics 
generation that was not accessible by Microsoft office Excel was performed in R. Volcano plots and 
heat maps were created using ggplot2. Venn diagrams were created using the draw.pairwise.venn 
and draw.quadruple.venn functions. P-values used in quantitative analysis were adjusted using the 
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3 Mass spectrometry as a tool for proteomic analysis: 
method development and the secretome  
3.1 Introduction 
This chapter describes the method development lying behind much of the proteomic investigations 
described in later chapters. This includes the investigation into different fractionation techniques 
and the use of different detergents to modulate the proteomic identifications possible using 
tandem mass spectrometry. The QSTAR Pulsar (Applied Biosystems) machine, a hybrid 
quadrupole/TOF mass spectrometer, was used to collect most of the data discussed in this chapter 
(Figure 3.1). It contains three quadrupole units: the first (Q0) acts only as a channel to transmit and 
focus the ions following ionisation at the point of injection; the second (Q1) acts as a mass filter to 
select precursor ions of specific sizes; the third (Q2) acts as the collision cell, fragmenting the parent 
ions by collision induced dissociation145.  
Also discussed in this chapter is the use of mass spectrometry for secretome analysis, which often 
proves to be very challenging. One of the major hurdles in secretome analysis is that cells are grown 
in complete media, containing 10% FCS of which one of the main constituents is BSA. This means 
that when analysing the mass spectrometry data, it is very hard to identify secreted proteins, which 
may be at relatively low concentrations in the volume of media, above a background of serum 
peptides. This is particularly the case with data-dependant acquisition (DDA), as used by mass 
spectrometers such as the QSTAR. Here, only the most abundant peptides are selected for 
fractionation in MS2 and therefore identification. Thus, if nearly all the most abundant peptides 
come from FCS, the possible identifications from secreted proteins is limited. Several methods used 
Figure 3.1: Components of QSTAR Pulsar mass spectrometer. After the ESI injection orifice, ions 
pass through a series of three quadrupoles: the first to channel and direct ions; the second acts as 
a mass filter to elect ions of certain masses; the third acts as a collision cell to fragment ions before 
they pass through the time of flight drift region. The time taken to travel through the time of flight 
tube, and the intensity of those ions, are recorded in the detector to generate mass spectra. 
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to reduce FCS peptide abundance are discussed in this chapter and, in the final section, the use of 
data-independent acquisition (DIA) by a TripleTOF 6600 (AB SCIEX) mass spectrometer for 
secretome investigations is described.  
The TripleTOF mass spectrometer is a more advanced machine that is similar in set up to the QSTAR 
but has improved ion production, capture, focussing, and detection to improve the overall 
sensitivity of the machine. In addition, it permits the use of DIA, which can increase the number of 
successful protein identifications. DIA is a method whereby, instead of selecting precursor ions for 
fragmentation, fragment ion spectra are generated for all precursor ions within the MS1 space146. 
The spectra are then aligned using calibration peptides, which are spiked into samples at a known 
and consistent concentration and have a known retention time. The remaining unknown peaks can 
then be identified by comparison to a spectral library which is generated using the DDA method146. 
Relative quantification is achieved by measuring summed peak areas of all fragment ions from a 
peptide.  Two such techniques currently exist: MSE (also known as MSAll) developed by Waters and 
sequential window acquisition of all theoretical fragment ion spectra (SWATH), which was 





3.2 LC-MS/MS sample preparation 
 
In general, to analyse the composition of proteins in any given sample of cells, lysates were 
generated by disrupting cell membranes with detergents, such as Triton X-100 (TX100) or SDS, and 
the proteins solubilised with buffers designed to maintain protein integrity. Protease inhibitors 
were also used to inhibit the activity of intracellular proteolytic enzymes, which are released from 
the cell upon lysis. Following cell lysis, the samples were digested in-solution using trypsin to 
generate peptides that could be identified by mass spectrometry (MS).  
A series of initial experiments were performed using HT1080 cells, derived from a human 
fibrosarcoma, to determine the best method for sample preparation. First, differing methods of 
fractionating the sample were compared before analysing the identifications found with different 




3.2.1 StageTip™ fractionation of samples 
StageTips™ have been identified as a method to fractionate samples on a small scale, using small 
discs of SCX material placed within pipette tips139. To assess the fractionation efficiency of 
StageTips™, a flask of HT1080 cells, grown to 80% confluency in MEM with 5% BSA, was lysed in 1 
x MNT lysis buffer with 1% v/v Triton X-100 and protease inhibitors. The sample was digested in 
solution with trypsin, and some set aside for analysis without fractionation. The remaining sample 
was then fractionated with strong cation exchange StageTips™. StageTips™ are designed to work 
like a small-scale chromatography column, allowing the fractionation of peptides according to their 
charge, through a pipette tip139. Samples were fractionated into six fractions, with peptides eluted 
with ammonium acetate at concentrations of 20 mM, 50 mM, 100 mM, 200 mM, 400 mM, and 1 M. 
After the elution, the ammonium acetate salts require removal before MS, therefore each fraction 
was put through another StageTip™, this time with a C18 desalting disk.  All fractions, as well as the 
unfractionated sample, were then analysed in the mass spectrometer and the number of 
identifications compared between the unfractionated and fractionated sample. Many more 
identifications were possible with fractionation (Figure 3.2). Identifications were deemed 
significant when more than one peptide was matched and the false discovery rate (FDR) was less 
than 5%. The FDR is calculated using a decoy database where the sequences in the database are 
reversed and results searched against this. Any true positive matches ought to only match in the 
target database, and not the decoy database. The FDR is the total number of false positives (i.e. 
those which also matched against the decoy database), divided by the sum of all matches against 

































Comparison of Fractionated vs 
Unfractionated Samples
Figure 3.2: Chart depicting the difference in the number of significant proteins identified in 
samples that were fractionated or left unfractionated prior to MS analysis. Significant 
identifications were determined as those with more than 1 peptide match per protein, with a false 
discovery rate of <5%.  
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3.2.2 StageTip™ vs strong cation exchange column fractionation 
Samples may also be fractionated using a strong cation exchange column on a liquid 
chromatography machine. This generates many more fractions, across a longer gradient, which may 
increase protein identifications further than the numbers seen with StageTip™ fractionation. 
Whereas with StageTips™ 6 fractions were collected, the liquid chromatography column generated 
30 fractions along an elution gradient. The total number of identifications from each fractionation 
technique, and the number of significant identifications were compared (Figure 3.3). Whilst there 
were nearly 100 more total proteins identified with column fractionation, there were only four 
more significant IDs. Although maximising the number of identifications is important, the increase 
in time both in person hours, and time on the MS machine to run many more fractions, was deemed 







Figure 3.3: Chart depicting the difference in the number of proteins identified with different 
fractionation techniques. Total number of IDs (light grey) includes both significant and 
insignificant results. Significant IDs (dark grey) are just those with more than one peptide match, 



























Comparison of StageTip vs SCX fractionation
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3.2.3 Detergent comparison of cell lysis 
TX100 is a typical detergent used for mammalian cell lysis, however this detergent cannot, on its 
own, be used in mass spectrometry as the PEG components lead to a repeating series of high 
intensity peaks, 44 Da apart on the spectrum147. In data-dependant mass spectrometry, like that 
used in these experiments for protein identification, only the peaks with the highest intensities are 
selected for MS2 analysis, and therefore the presence of PEG peaks leads to the exclusion of many, 
if not all, peaks from legitimate peptide precursor ions. In order to avoid this issue, when preparing 
protein samples from cell lysates produced using TX100, cell lysis was followed with an acetone 
precipitation step and the resulting protein pellets were then resuspended in 50 mM ammonium 
bicarbonate (ABC) with 2% SDS to aid re-solubilisation148.  A range of other detergent conditions 
were also trialled to investigate the effect on protein identifications. These conditions were: Lauryl 
Maltose Neopentyl Glycol (LMNG) with and without acetone precipitation, and sodium dodecyl 
sulfate (SDS).  
LMNG is a member of the Maltose–neopentyl glycol (MNG) family of amphiphiles, which were 
developed to aid the solubilisation and crystallisation of integral membrane proteins149. MNGs were 
determined to be better than conventional detergents at conserving native protein structure, and 
also have a very low critical micelle concentration (cmc) value149. This means that the number of 
detergent molecules required to form micelles150 around the proteins to be solubilised is much 
lower than with conventional detergents whose cmc value may be much higher. This is beneficial 
for mass spectrometry because it means lower concentrations of detergents can be used, therefore 
reducing the potential interference with the machine. LMNG was used to investigate whether it 
aided the recovery of a subset of proteins that were not seen with other detergents.  
SDS is a strong anionic detergent that rapidly lyses cells, but will also partially denature proteins151. 
This provides good solubilisation of proteins; however, it does not allow efficient digestion by 
trypsin in the next stage of sample preparation. Analysis by LC-MS/MS can generally tolerate SDS 
concentrations of around 0.01%152, however this is considerably lower than the concentrations 
typically used in cell lysis (around 10%). Therefore, when lysing samples in SDS, acetone 
precipitation was also performed as for TX100 samples, and resuspended in ammonium 
bicarbonate with a lower SDS concentration, in a volume that could be diluted to tolerable levels. 
To assess if there was a difference in the profile of proteins identified with different detergents, a 
series of HT1080 cell lysates were generated using the different detergent conditions outlined 
above (section 3.2), fractionated using StageTip™ fractionation (section 3.2.1), and the 
identifications from each fraction combined into a single list. GO terms were then assigned to each 
protein by using the GO terms listed on the UniProt database and assigning the term that most 
wholly described the proteins function to a list of protein identifications. The distribution of these 
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terms is represented graphically in Figure 3.4. Comparison of the graphs produced demonstrated 
that there was no obvious difference in the set of proteins identified with the different detergents. 
That is that, across the different detergent conditions, a similarly broad range of biological 
processes and balance of cellular compartments was seen with no condition leading to the 
identification of more proteins annotated to a specific ontology term. With the SDS detergent, more 
nuclear proteins were identified (5% of identifications compared to 3 or 4% in other conditions). 
However, this is expected because SDS can lyse the nuclear membrane.  
This experiment confirmed that the acetone precipitation of lysates prepared with TX100, prior to 
digestion, was a suitable method that led to sufficient protein identification without unexpected 
bias towards subsets of proteins at the location or function level. In addition, lysis with TX100 
appeared to identify a higher proportion of ER associated proteins compared to other detergent 
conditions, which will be an advantage in the investigation in to the effect of ER stress. SDS would 
be an alternative to use in order to gain recovery of nuclear proteins, while LMNG does not offer 




Figure 3.4: Subcellular distribution, and biological functions of proteins identified from lysates 
with different detergents. Proteins manually annotated with GO terms from Uniprot. Pie chart (left) 
depicts subcellular location distribution while bar chart (right) shows function distributions. 
Different detergent conditions shown in each panel were as follows:  A.  LMNG with acetone 




























































































































































































































































































































































































































































































































































































































































































































































































































3.3 Sensitivity and Reproducibility analysis 
3.3.1 Immunoprecipitation  
While investigating the capabilities of the QSTAR machine, and optimising protocols, 
immunoprecipitation was used as a technique to test the MS sensitivity. The specificity of an 
immunoprecipitation means that there will be fewer proteins, and therefore fewer peptides in the 
sample. A more sensitive machine should be able to identify more peptides under these conditions.  
In addition, this technique is a useful tool to potentially identify unknown interactions between 
proteins. HT1080 cells were lysed in TX100 lysis buffer, and the lysate then immunoprecipitated 
with an antibody to Ero1. This was designed to isolate Ero1, along with any interacting proteins, 
from the cell lysate. Ero1 was used as the target in these experiments as its interaction with PDI 
is well known and therefore could act to validate the results. These proteins reside in the ER, and 
are required for the correct formation of disulfide bonds during the folding of proteins in the early 
secretory pathway153 (see section 1.2.2.4).   
Typically, immunoprecipitation requires several stringent washing steps, which must include 
detergent, in order to remove proteins which are bound to the target protein by non-specific 
interactions154. Unfortunately, these detergents then lead to problems downstream at the 
LC-MS/MS stage (in the same way as discussed in reference to TX100 above, section 3.2.3). 
Therefore, the initial protocol was modified to alleviate the problems caused by the necessity for 
detergent in the washing steps.  
Firstly, samples were washed twice with the same buffer as that used for cell lysis namely MNT 
buffer with 1% TX100, before four further washes with MNT buffer containing no detergent. Next, 
the proteins were eluted in a buffer containing 1% SDS and DTT, instead of high levels of detergent. 
The eluted samples could then be diluted and directly digested with trypsin and identifications 
made by LC-MS/MS, without detergent interference. 
The protein concentration of the eluates following immunoprecipitation with Ero1 was estimated 
by Bradford assay to be much less than 1 µg/µl. A standard injection to the mass spectrometer is 
1 µl, so this technique therefore tested the sensitivity of the machine as any proteins identified 
above a background of antibody and protein A were inevitably present at low levels.  
From these immunoprecipitation experiments, the target protein (Ero1), and protein A which is 
bound to the sepharose beads, were confidently identified with more than one peptide match 
(Table 3.1; Figure 3.5). Unfortunately, however, it was not possible to identify other interacting 
proteins. This suggests that there were limitations to the either the protocol or sensitivity of this 
machine, and it was not possible to confidently identify co-immunoprecipitating proteins that were 
not abundant in the samples.  
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Table 3.1: Identifications from Immunoprecipitation with Ero1. Identifications from mass 
spectrometry analysis of immunoprecipitation eluent were protein A (SPA_STAA8), and the target 
protein Ero1 (ERO1A_HUMAN). 
 
 
Another way to identify protein interactions following immunoprecipitation is to separate the 
eluent on a 2D gel, select the spots, digest the proteins from within the gel and analyse these by 
mass spectrometry. To test this approach, and the possibility of using a 2D method to identify novel 
interactions, a liver tissue sample was lysed and immunoprecipitated with an antibody raised 
against PDI. Liver tissue provided a large, easily obtainable sample that is rich in protein. 
Three 2D gels were run: one each for mock PDI antibody, liver tissue lysate, and the 
immunoprecipitation eluate (Figure 3.6). From the eluate gel, three spots were removed, and 
proteins digested for identification by mass spectrometry, which were initially assumed to be PDI, 
antibody heavy chain and antibody light chain.  
  






SPA_STAA8 56403 5 4 
Immunoglobulin G-binding protein A 
OS=Staphylococcus aureus (strain NCTC 
8325) GN=spa PE=1 SV=3 
ERO1A_HUMAN 54358 2 2 
ERO1-like protein alpha OS=Homo 
sapiens GN=ERO1L PE=1 SV=2 
A 1 MKKKNIYSIR KLGVGIASVT LGTLLISGGV TPAANAAQHD EAQQNAFYQV
51 LNMPNLNADQ RNGFIQSLKD DPSQSANVLG EAQKLNDSQA PKADAQQNNF
101 NKDQQSAFYE ILNMPNLNEA QRNGFIQSLK DDPSQSTNVL GEAKKLNESQ
151 APKADNNFNK EQQNAFYEIL NMPNLNEEQR NGFIQSLKDD PSQSANLLSE
201 AKKLNESQAP KADNKFNKEQ QNAFYEILHL PNLNEEQRNG FIQSLKDDPS
251 QSANLLAEAK KLNDAQAPKA DNKFNKEQQN AFYEILHLPN LTEEQRNGFI
301 QSLKDDPSVS KEILAEAKKL NDAQAPKEED NNKPGKEDNN KPGKEDNNKP
351 GKEDNNKPGK EDNNKPGKED GNKPGKEDNK KPGKEDGNKP GKEDNKKPGK
401 EDGNKPGKED GNKPGKEDGN GVHVVKPGDT VNDIAKANGT TADKIAADNK
451 LADKNMIKPG QELVVDKKQP ANHADANKAQ ALPETGEENP FIGTTVFGGL
501 SLALGAALLA GRRREL
B 1 MGRGWGFLFG LLGAVWLLSS GHGEEQPPET AAQRCFCQVS GYLDDCTCDV
51 ETIDRFNNYR LFPRLQKLLE SDYFRYYKVN LKRPCPFWND ISQCGRRDCA
101 VKPCQSDEVP DGIKSASYKY SEEANNLIEE CEQAERLGAV DESLSEETQK
151 AVLQWTKHDD SSDNFCEADD IQSPEAEYVD LLLNPERYTG YKGPDAWKIW
201 NVIYEENCFK PQTIKRPLNP LASGQGTSEE NTFYSWLEGL CVEKRAFYRL
251 ISGLHASINV HLSARYLLQE TWLEKKWGHN ITEFQQRFDG ILTEGEGPRR
301 LKNLYFLYLI ELRALSKVLP FFERPDFQLF TGNKIQDEEN KMLLLEILHE
351 IKSFPLHFDE NSFFAGDKKE AHKLKEDFRL HFRNISRIMD CVGCFKCRLW
401 GKLQTQGLGT ALKILFSEKL IANMPESGPS YEFHLTRQEI VSLFNAFGRI
451 STSVKELENF RNLLQNIH
Figure 3.5: Amino acid sequences of identified proteins of interest. Peptides which were 




Figure 3.6: 2D gel analysis of liver tissue. Proteins were separated first on a pH 4-11 IEF strip, then 
on 10% SDS PAGE gels and stained with colloidal Coomassie for the visualisation of protein spots. 
Inputs were: A. PDI antibody only; B. liver tissue lysate only; C. liver tissue immunoprecipitated with 
anti-PDI. D. 2D Gel Post spot picking to display location of spots picked from eluate gel that were 
digested for protein identification by mass spectrometry. 
Following analysis, PDI was not identified in any of the spots; the only expected protein was IgG 
gamma chain. Interestingly, fibrinogen beta chain was also identified in spot 1 and fibrinogen alpha 
chain was detected in spot 2 (Table 3.2). Fibrinogen is a glycoprotein that circulates in the blood 
with prothrombin. At a wound site, factor VIII aids the conversion of prothrombin to thrombin 
which then catalyses the proteolysis of fibrinogen into fibrin monomers which form a blood clot155. 
Although a direct interaction between PDI and fibrinogen has not yet been identified, several recent 
publications have established a role for PDI in blood clot formation 156–159 indicating that this could 
be a true, and novel interaction. Specifically, Swiatkowska et al., demonstrated that Ero1 is 
present on the platelet surface with PDI, and blocking Ero1 with specific antibodies abolished 
platelet responses including fibrinogen binding. Immunoprecipitations from their studies also 
demonstrated an interaction between Ero1 and fibrinogen159. Further investigations would be 
required to determine whether the interaction between PDI and fibrinogen seen in our work is 
direct or indirect, perhaps involving Ero1. 
In addition to detecting a novel PDI interacting protein, many expected contaminating keratin 
proteins were identified. Trypsin was also identified as a remnant from the digestion process. 
Several species isoforms were also detected for proteins. Where there is homology in the protein 
sequences of a given protein between species, it is possible for peptides to be identified as the 
same protein in more than one species. For example, in spot 3 argininosuccinate synthase was 
identified with 14 peptides as mouse and 7 peptides as human (Table 3.2). This is a common 
occurrence in database searches where taxonomy has not been specified, as was the case in this 
database search to permit identification of rabbit IgG, which confirms successful elution.   
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Table 3.2: Mass spectrometry identifications from proteins in spots taken from 2D Gel of PDI 
immunoprecipitation eluate. Spot numbers correspond to those in Figure 3.6D. Accession number, 
number of peptide sequences identified, number of significant peptide sequences identified, and 
descriptions are given for each protein identification. Significant sequences are those that are 
deemed to have met a scoring threshold based on the number of y and b ions in a peptide spectral 
match, as well as the number of peptide spectral matches per sequence. Proteins referred to in the 











K2C1_HUMAN 9 9 Keratin, type II cytoskeletal 1 
K22E_HUMAN 9 9 
Keratin, type II cytoskeletal 2 
epidermal 
FIBB_MOUSE 10 10 Fibrinogen beta chain 
FIBB_HUMAN 8 8 Fibrinogen beta chain 
FIBB_CHICK 3 3 
Fibrinogen beta chain 
(Fragment) 
K1C10_HUMAN 10 10 Keratin, type I cytoskeletal 10 
K1C9_HUMAN 6 6 Keratin, type I cytoskeletal 9 
FIBB_RABIT 3 3 
Fibrinogen beta chain 
(Fragment) 
TRYP_PIG 2 2 Trypsin 
CASA1_BOVIN 3 3 Alpha-S1-casein 
HORN_HUMAN 2 2 Hornerin 
IGHG_RABIT 3 3 Ig gamma chain C region 
CASB_BOVIN 2 2 Beta-casein 
2 
K2C1_HUMAN 9 9 Keratin, type II cytoskeletal 1 
K1C10_HUMAN 6 6 Keratin, type I cytoskeletal 10 
TRYP_PIG 2 2 Trypsin 
IGHG_RABIT 5 5 Ig gamma chain C region 
FIBA_MOUSE 3 3 Fibrinogen alpha chain 
FIBA_HUMAN 3 3 Fibrinogen alpha chain 
3 
K22E_HUMAN 18 18 
Keratin, type II cytoskeletal 2 
epidermal 
K2C1_HUMAN 15 15 Keratin, type II cytoskeletal 1 
K2C5_HUMAN 5 5 Keratin, type II cytoskeletal 5 
K1C10_HUMAN 16 16 Keratin, type I cytoskeletal 10 
ASSY_MOUSE 14 14 Argininosuccinate synthase 
ASSY_HUMAN 7 7 Argininosuccinate synthase 
K1C9_HUMAN 10 10 Keratin, type I cytoskeletal 9 





K1C17_MOUSE 2 2 Keratin, type I cytoskeletal 17  
CPSM_MOUSE 2 2 
Carbamoyl-phosphate synthase 





3.3.2 Interaction networks to assess reproducibility 
Bioinformatics tools can be used to assess protein-protein interactions. STRING.db, for example, 160 
is an online tool, into which protein identification(s) can be inputted and it will suggest interacting 
proteins, based on a range of peer-reviewed sources. SERPINH1, otherwise known as heat shock 
protein 47 (HSP47) was a protein identified from the proteomic analysis of whole cell lysates 
described previously (section 3.2). SERPINH1 is an ER resident chaperone that aids in the formation 
of mature collagen fibrils. It is thought to bind procollagen fibrillar domains, in order to provide 
thermal stability in their immature state prior to mature collagen fibril assembly77. Using the 
STRING.db programme, several proteins thought to interact with SERPINH1 were identified (Figure 
3.7).  These included the beta subunit of prolyl 4 hydroxylase (P4HB), which is PDI, and other ER 
resident chaperone proteins (see Table 3.3) which likely play roles in the correct folding of 
collagens, or other secretory proteins found within the ER lumen.  
 
  
Figure 3.7: STRING-db.org suggested interaction map of SERPINH1.  Coloured lines represent 
different types of known or predicted interactions as follows: Turquoise demonstrates a known 
interaction from curated databases; pink demonstrates a known interaction that has been 
experimentally determined; green demonstrates a predicted interaction based on the gene 
neighbourhood; red demonstrates a predicted interaction based on gene fusions; blue
demonstrated predicted interaction based on gene co-occurrence; lime demonstrates a 
suggested interaction based on text mining evidence; black demonstrates a suggested 
interaction based on co-expression and finally lilac demonstrates a suggested interaction based 
on protein homology.  
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To assess the reproducibility of the results from the QSTAR mass spectrometer, these network 
identifications were used. The protocols established for cell lysis and sample digestion for 
proteomic analysis were transferred to nHDF cells, and an experiment was performed to establish 
how many proteins in the SERPINH1 network shown in Figure 3.7 could be identified in fibroblast 
cell lysates. Three biological replicate samples of nHDF cells were grown to confluence and lysed in 
MNT lysis buffer containing 1% TX100. The lysates were digested in solution and fractionated using 
StageTips™ before protein identification by mass spectrometry. Results from all fractions of a given 
sample were combined to give one data set for each biological replicate. By comparing how many 
of the proteins in the network were identified in three repeat samples (Table 3.3), it was possible 
to gain some insight into reproducibility. This demonstrated that, of the proteins identified in the 
network, 5 of them were identified in three repeat samples, and none were detected only once, 








































































1            
2            
3            
Table 3.3: Reproducibility analysis of SERPINH1 STRING-db network. Data sets from protein 
identifications from nHDF cell lysates in three biological replicates (samples 1 – 3) were mined for 
the identification of proteins found in the SERPINH1 network on String-db. Successful 
identifications are denoted with a tick, while unsuccessful identifications are greyed out.  
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3.4 Secretome analysis 
 
Collagen is also of interest when analysing fibroblast secretory function in the dermis. Fibroblasts 
are responsible for the provision of the extracellular matrix proteins to support the surrounding 
tissue. Various proteins and chemokines are released into the cells environment to enable 
interactions and communication with other cell types. For example, stromal cell-derived factor-1 
(SDF-1) is secreted by fibroblasts in the dermis to stimulate epidermal keratinocyte proliferation161. 
ECM proteins are secreted to support the function of the skin as described in chapter 1. Therefore, 
when assessing the impact of different stressors on dermal fibroblast cells, it would be interesting 
to look at the secretory profile of these cells, as well as the intracellular proteome.  
As described in the introduction to this chapter, one of the major hurdles in secretome analysis is 
that cells are grown in complete media, containing 10% FCS of which one of the main constituents 
is BSA. A series of different methods were used to assess the possibility of overcoming the 




3.4.1 Concanavalin A affinity purification 
Firstly, concanavalin A (conA), was used to affinity purify N-linked glycoproteins. Proteins are only 
N-glycosylated when they enter the secretory pathway, therefore the only proteins eluting from a 
conA pull-down should be secreted N-linked (unmodified) glycoproteins, or secretory pathway 
resident glycoproteins that have been released into the media by dead cells. Samples of 
conditioned media were collected from nHDF cells, grown to confluency in media containing 10% 
FCS, and subjected to conA affinity purification. The conditioned media, affinity purification 
supernatant, and the eluent were then run on a 1D SDS-PAGE gel (Figure 3.8). A large band was 
visible at around 50 kDa which corresponds to BSA. This band was not present in the eluent. In the 
eluent lane, there were some less intense bands in the higher molecular weight region of the gel, 
which appeared to be absent, or less abundant in the other two lanes. This suggests that this 
method successfully concentrated secreted proteins and reduced the BSA concentration. The 
25 kD band which is present only in the eluent lane is thought to be conA itself, released from the 













































Figure 3.8: SDS-PAGE gel of conditioned media, supernatant and eluate from concanavalin A 
affinity purification. Stained with colloidal Coomassie stain. BSA is shown, present in both 
conditioned media and supernatant from the affinity purification.  
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To test whether this method could be used for the identification of secreted proteins, the conA 
purification was repeated with three biological replicates of conditioned media from nHDF cultures. 
The eluents were again run on a 10% SDS-PAGE gel and six bands from the higher molecular weight 
region of gel were excised for protein identification by mass spectrometry (Figure 3.9). These were 
identified as bovine complement C3 and alpha -2-macroglobulin (2M) (Table 3.4). This protein is 
also found in FCS and may therefore be a bovine serum contaminant. Although conA does not bind 
to the BSA, other serum proteins remained in the ConA eluted samples and may give false positives 
in the identification of proteins from conditioned media samples.  A media only control in this 
experiment may aid in the identification of proteins unique only to conditioned media eluents.  
Figure 3.9: SDS PAGE gel of conA eluents, indicating location of excised bands for mass 
spectrometry analysis. Eluents from the conA affinity purification of three biological replicates of 
conditioned media from nHDF cultures were run on a 10% SDS PAGE gel. The bands which were 
excised for protein identification by mass spectrometry are highlighted with a box and numbered. 
The numbers correspond to table 4 below.  
Table 3.4: Protein identification from excised gel bands displayed in Figure 3.9. Protein 
identifications from the mass spectrometry analysis of peptides digested from excised gel bands 








1 CO3_BOVIN 70 56 Complement C3 OS=Bos taurus GN=C3 
PE=1 SV=2 
2 CO3_BOVIN 69 39 Complement C3 OS=Bos taurus GN=C3 
PE=1 SV=2 
3 A2MG_BOVIN 36 3 Alpha-2-macroglobulin OS=Bos taurus 
GN=A2M PE=1 SV=2 
4 A2MG_BOVIN 53 39 Alpha-2-macroglobulin OS=Bos taurus 
GN=A2M PE=1 SV=2 
5 A2MG_BOVIN 63 46 Alpha-2-macroglobulin OS=Bos taurus 
GN=A2M PE=1 SV=2 
6 A2MG_BOVIN 67 59 Alpha-2-macroglobulin OS=Bos taurus 
GN=A2M PE=1 SV=2 
1. 2. 
3. 4. 











3.4.2 Molecular weight cut off spin columns 
Next, ways to increase the concentration of secreted proteins were investigated to increase the 
likelihood of detecting secreted proteins in the relatively low volumes used for mass spectrometry. 
Spin columns with a 3000-molecular weight cut off were used to concentrate proteins in the 
conditioned media. Liquid and any molecules with a molecular weight of less than 3000 can pass 
through the filter, leaving proteins in a lower volume on top of the filter. The concentrated samples 
can be removed from the column and analysed.  
Samples of conditioned media from nHDF cells, both before and after concentration in a spin 
column, were subject to a Bradford assay to determine protein concentrations (Table 3.5) and then 
proteins separated on 1D SDS-PAGE gels (Figure 3.10). It was clear that the spin columns greatly 
increased the concentration of protein detectable in the conditioned media. However, as was seen 
by comparing the band patterns on the two gel images, the serum proteins were also greatly 
concentrated and therefore the QSTAR mass spectrometer was still unable to detect secreted 
proteins above the background of serum. It was concluded that to facilitate secretome analysis in 
the future, it will likely be necessary to grow cells in serum free conditions, develop methods to 
specifically deplete serum or use a more sensitive mass spectrometer.  
Table 3.5: Estimation of protein concentrations of media samples. A Bradford assay was used to 
determine the concentration of protein in conditioned media before and after concentration using 
3000 MWCO tubes, and the flow through from these tubes.  
Sample Absorbance 
Protein Concentration  
(µg µl-1) 
Media 0.433 <<1 
Concentrated media 0.984 2.46 
Flow through 0.022 <<1 
 
 
Figure 3.10: Comparison of proteins following use of a molecular weight cut off spin column. SDS-
PAGE gels were stained with colloidal Coomassie. A. SDS-PAGE gel of conditioned media before 




























3.5 Secretome analysis with a TripleTOF 6600 
The investigations so far have relied heavily upon shotgun proteomics approaches, where precursor 
ions are selected from MS1 spectra for fragmentation and fragment ion spectra are then matched 
against a database for peptide identification, termed data-dependant acquisition (DDA). Using 
more powerful mass spectrometers, with better sensitivity and improved chromatography, 
increases the number of identifications, and permits quantification of peptides by more complex 
mass spectrometric techniques.  
This improvement in mass spectrometry capability facilitated re-analysis of the fibroblast 
secretome previously discussed (section 3.4). It also permitted the relative quantitation of results, 
enabling the analysis of data not only by identifying proteins, but also by comparing the relative 
abundances of proteins between different treatment conditions. Having established analytical 
methods in HDF cells, BJ fibroblasts were used for subsequent experiments. These are a 
commercially available, telomerase negative cell line with a longer lifespan than other human 
dermal fibroblast cell lines, meaning they can be cultured for more population doublings before 
senescence occurs162. They are also well characterised by the industrial partners to this project, 
Procter & Gamble (P&G).  
To harness the quantitative capability of the TripleTOF mass spectrometer, cells were treated with 
either DTT, etoposide or control medium. DTT is a reducing agent that induces an ER stress response 
within cells and will be used in subsequent experiments in this thesis to elucidate proteomic 
responses to reductive stress. Etoposide is a chemical that induces DNA damage within the cells 
and drives them into senescence. Senescent cells are neither apoptotic, nor active, and they are no 
longer able to divide or grow. They also possess a well-defined senescence-associated secretory 
phenotype (SASP)163.  BJ fibroblasts were grown to 70% confluency were treated for 6 hours with 
5 mM DTT, 12.5 µM etoposide, or left untreated (mock) before being given fresh media. After 4 
days of recovery, the spent media was collected for analysis. Etoposide served as a positive control 
to determine whether 4 days in the same media drove cells to senescence without treatment. There 
is no knowledge in the literature that suggests reductive stress leads cells to senescence, and 
therefore it was of interest to determine whether DTT treated cells shared any characteristics with 
etoposide treated cells.  
The conditioned media was collected and prepared for mass spectrometry analysis. As the 
TripleTOF machine was much more sensitive to detergents, digests were carried out using FASP. 
This sample preparation technique was described by Wiśniewski et. al., as a method that 
successfully depletes detergent from a sample by buffer exchange into urea164. Essentially proteins 
are bound onto an ultrafiltration device, washed and concentrated into a urea buffer.  Whilst on 
the filter, reduction, alkylation and digestion occur, after which peptides can be spun through the 
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filter into a collection tube and the digestion stopped by acidification (see section 2.17.3). This was 
the standard sample preparation method used with the TripleTOF mass spectrometer, and so this 
method was also employed for the preparation of conditioned media for comparability.  
A single biological replicate was used with three technical replicates of the SWATH acquisition. 
Using this method, 776 proteins were successfully identified, and their relative intensities 
quantified in all three treatment categories: untreated, DTT, and etoposide.  
Looking firstly at only the identifications from the DIA data, without consideration for the quantified 
values, it was obvious that many more secreted proteins were identified than in the DDA data. GO 
annotations were assigned to the identifications using the groupGO function of ClusterProfiler in 
R165. The GO annotation for cellular compartment reveals that approximately 50% of proteins were 
annotated to extracellular regions, with other frequently observed annotations including 
membrane and cell-junction proteins (Figure 3.11). There were fewer terms associated with 
intracellular compartments, indicating that many of the proteins identified were “true” secretome 
identifications. It is important to remember here that, using this method for GO annotation, 
proteins are mapped to several GO terms, which could cause substantial overestimation of the 
numbers of proteins identified that are found in particular cellular compartments. For example, ER 
proteins such as PDI are annotated both with membrane-enclosed lumen [ER] and extracellular 
region, due to their association with the secretory pathway.   
The identifications were therefore also tested for statistical overrepresentation of GO terms, 
compared to the human genome. Using Pantherdb.org tool for statistical overrepresentation test, 
the list of identifications was tested against a reference list of all known human genome proteins 
using the Panther GO-Slim Cellular component data set for annotation, and the Fisher's Exact with 
FDR multiple test correction test143,166. This determined statistically significant overrepresentation 
of several terms, including extracellular matrix (fold enrichment 2.56, p=6.83 × 10 ) and 
extracellular space (fold enrichment 1.66, p=1.41 × 10 ) (Table 3.6). The ECM proteins identified 
included collagens COL1A2, and COL3A1, as well as neutrophil collagenase matrix 
metalloproteinase 8 (MMP8), and metalloproteinase inhibitor tissue inhibitor of 
metalloproteinases 1 (TIMP1), which may both be associated with regulation of ECM re-modelling. 
All the ECM proteins associated with this overrepresentation are listed in Table 3.7.  Whilst collagen 
proteins are important in conferring structural integrity to the ECM, the degradation of collagen 
fibres is tightly regulated to modulate the freedom with which cells such as fibroblasts can migrate 
through the matrix. For example, greater motility is required during wound healing so that 
fibroblasts can reach the wound site and deposit new ECM. The quantitative data from this 
experiment will determine whether these proteins are regulated by specific treatments or are part 




Table 3.6: Results from overrepresentation test of secretome DIA  identifications against human 
genome. DIA secretome identifications were tested for overrepresentation against human genome 
using PANTHER GO-Slim Cellular Component annotation database, and the Fisher's Exact with FDR 
multiple test correction test. Fold enrichment of statistically significant overrepresented terms, 
with FDR <0.05 are shown with associated p-value. Data ranked by fold change.  
  
 
PANTHER GO-Slim Cellular Component Fold enrichment p-value 
nuclear envelope (GO:0005635) 3.25 5.33E-03 
cell junction (GO:0030054) 3.18 2.53E-03 
cytosol (GO:0005829) 2.87 5.69E-10 
actin cytoskeleton (GO:0015629) 2.81 3.78E-04 
extracellular matrix (GO:0031012) 2.34 4.48E-02 
ribonucleoprotein complex (GO:0030529) 2.03 1.72E-03 
cytoplasm (GO:0005737) 1.75 1.48E-13 
mitochondrion (GO:0005739) 1.73 4.22E-02 
macromolecular complex (GO:0032991) 1.60 3.38E-06 
protein complex (GO:0043234) 1.54 1.81E-04 
intracellular (GO:0005622) 1.52 2.29E-13 
cell part (GO:0044464) 1.47 5.27E-12 
organelle (GO:0043226) 1.37 2.46E-05 
nucleus (GO:0005634) 1.37 9.33E-03 
plasma membrane (GO:0005886) 0.65 2.30E-02 
integral to membrane (GO:0016021) 0.41 9.27E-04 



























Cellular component annotations of DIA 
Secretome data
Figure 3.11: 46% of proteins identified from secretome samples by DIA are annotated to 
extracellular region. Results are displayed as percentage of total IDs annotated to each GO cellular 
compartment with terms.  
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Table 3.7: Proteins associated with GO term extracellular matrix, implicated in 
overrepresentation of this term. DIA secretome identifications were tested for overrepresentation 
against human genome using PANTHER GO-Slim Cellular Component annotation database, and the 
Fisher's Exact with FDR multiple test correction test. Those proteins associated with the 
overrepresentation of ‘extracellular matrix (GO:0031012) are listed here. 
Protein Name Gene Name 
Metalloproteinase inhibitor 1 TIMP1 
Periostin POSTN 
von Willebrand factor VWF 
Collagen alpha-2(IX) chain COL9A2 
Leucine-rich repeat and WD repeat-containing protein 1 LRWD1 
Hemopexin HPX 
Laminin subunit alpha-5 LAMA5 
Transforming growth factor-beta-induced protein ig-h3 TGFBI 
Collagen alpha-2(I) chain COL1A2 
Laminin subunit beta-1 LAMB1 
Neutrophil collagenase MMP8 
Collagen alpha-1(III) chain COL3A1 
 
Comparing the peak areas of DTT to untreated, etoposide to untreated and DTT to etoposide, 
t-tests were performed in MarkerView™ to determine the significance score of the fold change of 
those proteins identified. Only a small fraction of those identified had a p-value score of less than 
0.05 to indicate significance (Figure 3.12). 
The p-values were adjusted using the p.adjust function in R with the Benjamini-Hochberg method. 
Without adjustment, a p-value of less than 0.05 indicates that the probability of obtaining the same 
value being tested (in this case the fold change) by chance, i.e. in a case where the null hypothesis 
is in fact correct, is 5%. If for each test there is a 5% chance it is a false positive, there may be 
acceptable numbers of false positives when only a few tests are being performed, but as the 
number of tests increases, so then does the number of false positives. The Benjamini-Hochberg 
method for multiple testing describes a way to control the FDR, which enforces a limit on the 
number of identifications within a set that it is acceptable to be false167. This method involves 
ranking the p-value scores from smallest to largest and comparing these to the Benjamini-Hochberg 
critical value, defined as (𝑖 𝑚⁄ )𝑄 where 𝑖 is the rank, 𝑚 is the total number of tests and 𝑄 is the 
FDR chosen. When using this method to adjust the p-values, P is multiplied by 𝑚 𝑖⁄ , or the adjusted 
value for the next higher p-value, whichever is smallest. A result is deemed significant if the 





Following p-value adjustment, there were three proteins identified as significant after multiple test 
correction when comparing DTT treatment to Etoposide, although only one with a fold change 
greater than 2 (Figure 3.12; Table 3.8). However, these were proteins that were unexpected. G-rich 
sequence factor 1 (GRSF1; fold change: 6.99; adjusted p-value: 0.03) is involved in the regulation of 
post translational mitochondrial gene expression and was greatly increased in the DTT treated 
sample compared to etoposide treated. This is a mitochondria/cytoplasm located protein and, 
although it is possible that alternatively spliced forms of this protein may be unconventionally 
secreted, it is more likely that it is present in the media sample collected due to cell death. Bcl2 like 
protein 1 (BCL2L1; fold change: 0.81; adjusted p-value: 0.047) is an inhibitor of cell death, slightly 
increased in the etoposide treated sample compared to DTT. This suggests that etoposide may 
induce more of a protective response than DTT which may be more apoptotic. It would also 
corroborate with etoposide driving cells to senescence rather than apoptosis. Finally, 
Neurobeachin-like protein 2 (NBEAL2; fold change: 1.59; adjusted p-value: 0.047) is a ubiquitous ER 
localised protein that is known to be involved in thrombopoiesis and platelet biogenesis, however 
it has also been implicated in dermal wound healing and myofibroblast differentiation. 
Deppermann et al., showed that NBEAL2 knockout mice had a reduced ability to heal dermal 
wounds due to reduced ECM secretion169. NBEAL2 was implicated in the correct formation of 
mature TGF- by platelets that is released on wounding to trigger healing events including 
fibroblast differentiation and ECM deposition169. DTT treatment appeared to increase the release 
of this protein, which may suggest a role for reductive stress in the triggering of wound healing 






Table 3.8: Significant proteins in DTT to Etoposide comparison. Gene names, average summed 
peak area of all fragment ions, fold change and adjusted p-values are given for proteins that differed 
between DTT and etoposide treatments, where the differences were determined to be statistically 
significant (Student’s t-test, n=3 technical replicates). 
Gene Name 
Average peak Area 
Fold Change Adjusted p-value 
DTT Etoposide 
GRSF1 22651.13292 3237.228423 6.997 0.030 
BCL2L1 60509.04458 74254.1249 0.815 0.047 












































Comparison of significantly changing 





Figure 3.12: Comparison of identification counts in different treatment comparisons. The number 
of identifications deemed significant (p-value < 0.05) were counted in each of three treatment 
comparisons: etoposide to untreated, DTT to untreated, and DTT to etoposide. ≤ half of these 
identifications were also found to have a fold change (FC) of greater than 2. These numbers were 
again compared following adjustment of the p-value for multiple testing, which greatly reduced the 
counts in all cases. 
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3.6 Discussion and Conclusion 
This chapter has described the development of methods to investigate the response of human 
dermal fibroblasts to ER stress at the proteome level. Methods for cell lysis, protein digestion and 
sample fractionation have been explored, establishing a platform for the robust proteomic analysis 
of fibroblasts that are discussed in chapters 5 and 6. To analyse the proteome of a group of cells, a 
lysate is first generated and acetone precipitated to remove TX100. Samples are then digested with 
trypsin and fractionated using SCX StageTips™. Immunoprecipitation and STRING-db have also been 
explored as ways to identify protein-protein interactions with some success. Analysis of conditioned 
media from fibroblasts proved more challenging with FCS masking the identification of proteins 
using DDA. The use of higher specification mass spectrometers, which provided the opportunity for 
DIA, greatly improved the number of identifications possible from secretome samples. However, 
under these experimental conditions, no known markers of senescence could be detected as 
significantly increased in the conditioned media of either the etoposide (senescence inducing) or 
DTT treated cells.  
The analysis so far has used an FDR of 5%, or 0.05, which permits 5% of the values to be false 
positives. This is the standard FDR used in biological analysis but is quite a stringent parameter: if 
further tests were to be performed to validate the identifications it may well be acceptable for 10 
or 15% of the hits to be false positives. Adjusting the FDR would increase the number of 
identifications deemed to be significant and therefore increase the opportunity for analysis, 
although this would increase the demand for validation of all results, which is beyond the scope of 
this thesis.  
The investigations in this chapter have mostly relied on technical replicates, and not fully controlled 
for biological variability. In the proteomic investigations described in chapters 5 and 6, biological 
replicates have been performed, together with technical replicates. By controlling for both sources 
of variability it is possible to increase the significance of the results. For example, if a set of three 
peak areas from technical replicates had a single outlier, the mean peak area would be much more 
affected than if there was a single outlier in a set of three biological replicate and three technical 
replicate values (nine values in total).   
There is some debate in the proteomics community over the best method for quantitative 
proteomic analysis, and whether this should be done using a label-free approach as discussed in 
this thesis or a label-based approach such as 2D differential gel electrophoresis (2D DiGE) or isobaric 
tags for relative and absolute quantification (iTRAQ). Quantitation is important for the comparison 
of data from different treatment groups, and 2D DiGE has traditionally been the most popular 
method for these types of investigation. However, the advent of gel-free approaches provides a 
clear advantage in the ability to retrieve a complete and unbiased data set that can be 
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re-interrogated at any time in the future, to answer new questions without generating new 
samples. Proteins on a 2D DiGE gel that has been stored for months or years may have degraded to 
some extent and will have been subject to increased contamination from its storage environment. 
Identification of spots selected on return to a gel may therefore be more difficult than simply 
re-interrogating a data set stored on a computer.  
Labelling approaches are often considered more accurate than label-free techniques such as 
SWATH, but they require more expensive reagents, and there is a limit to the number of different 
samples that can be run simultaneously170.  In addition, the use of labels which may require 
metabolic or chemical adjustments to proteins within the cells while they are still growing may 
mean that label-based quantitation methods are not appropriate for all experimental scenarios and 
labelling efficiency is not uniform across all proteins170. 
A 2009 study by Patel et. al. analysed the cytoplasmic proteome of Methylocella silvestris bacterium 
using three different quantitative approaches to compare the results171. The methods used were 
gel-based, iTRAQ, and label-free DIA. There was significant overlap between all three methods; 
however, each method also identified its own unique set of proteins that were not seen with any 
other technique171. This suggests that no one method for quantitation of mass spectrometry based 
proteomic data is perfect, and a balance must be made to adopt the technique that makes best use 
of the resources available to obtain suitable data for the experiment in hand.   
An important consideration is the amount of sample required for analysis. Whilst a gel-based 
method such as 2D DiGE may require tens or hundreds of micrograms of total protein, SWATH 
analysis requires a maximum of only 4 µg per technical replicate. Label-free quantitation 
approaches are reported as being among the least accurate because both systematic and non-
systematic errors are reported in the final data172. However, these errors can be controlled for by 
using sufficient biological and technical replicates. In addition, the dynamic range of SWATH data is 
much greater than with label-based quantitation techniques which may allow for the quantitation 
of larger changes between experimental conditions172. 
Ultimately, there are arguments for and against all methods of quantitation in proteomic 
experiments and it is unlikely that there is a perfect solution to all the issues. The SWATH method 
used for the proteomic investigations discussed in this chapter has proved an invaluable tool in the 
development of protocols to analyse the secreted proteome with increased sensitivity and lack of 
bias. In the remaining chapters of this thesis, the data that SWATH analysis provides demonstrates 
the ability of this label-free quantitation approach to give a useful and obtainable balance between 
all the factors that may influence the results. It provides the facility to obtain both a broad 
understanding of the dermal fibroblast proteome, as well as to investigate specific responses to ER 
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4 Reductive stress induces a novel signalling response in 
human dermal fibroblasts 
 
4.1 Introduction 
It is well documented that fibroblast cells enter a quiescent state when exposed to situations of 
contact-inhibition or confluency: a reversible cell cycle arrest where proliferation and their 
secretory profile is reduced173–175. During the culture of dermal fibroblast cells on 2D plastic surfaces 
there is likely to be a substantial proportion of cells in a quiescent state once confluency has 
exceeded 50%. However, due to their rapid growth time and limited levels of protein recovery from 
sub-confluent cultures, it is usually necessary to grow cells to confluency levels above 50% to allow 
for experimental procedures and obtain adequate protein yields in cell lysates.  In vitro it is possible 
to stimulate fibroblasts to resume proliferation and secretion by exposure to growth factors 
including epidermal growth factor (EGF), basic fibroblast growth factor (b-FGF) and platelet derived 
growth factor (PDGF)176. In the studies in this Chapter, PDGF was used to stimulate fibroblasts as 
the cell biology and dose response of the cells to this treatment had been well characterised by 
P&G.  
PDGF was first described in 1974 by Ross et. al., who observed that platelet containing serum, but 
not platelet poor plasma, was essential for the promotion of proliferation in smooth muscle cells177.  
It is now known that there are four polypeptide chains within the PDGF gene family, the products 
of which produce four cysteine-knot-type growth factors PDGF A, B, C and D, the last two forms of 
which have only been discovered in the last 20 years178 . PDGFs are active as homo- or 
hetero-dimers of the following combinations of polypeptide chains: AA, BB, AB, CC and DD. All the 
polypeptides are synthesised as precursors, which must be proteolytically processed prior to 
dimerization and activation. It is believed that this processing occurs prior to secretion with A and 
B chains179, but C and D chains are thought to be processed within the extracellular space180.  
Dimerised PDGF binds to one of the two PDGF receptors (PDGFR): PDGFR or PDGFR, which are 
class III receptor tyrosine kinases (RTK), bringing about receptor dimerisation such that one PDGF 
dimer is bound to a PDGFR dimer. Receptor dimerisation may produce homo- or hetero-dimers in 
the form  which may bind AA, BB, CC, or AB PDGF;  which may bind BB or DD PDGF or  
which may bind BB or AB PDGF178. Following receptor dimerisation, conformational changes release 
autoinhibition of the intracellular kinase domain allowing for the autophosphorylation of 
intracellular tyrosine residues. These phosphorylated tyrosine residues then permit the docking of 




PDGF signalling is primarily involved in the promotion of cell growth and proliferation, as well as 
the inhibition of apoptosis, actin reorganisation and cell migration (Figure 4.1). These signalling 
events are also important for the correct development of various organs and tissues (PDGFR) and 
for angiogenesis and haematopoiesis (PDGFR)182. It is therefore not surprising that extended or 
excessive signalling from these molecules is implicated in a range of diseases that involve undue 
cell proliferation including, for example, cancer and fibrosis178. In the past few years there has also 
been growing evidence for the role of PDGFRs in the autoimmune disease systemic sclerosis (SSc) 
for which fibrosis is the major symptom183. This has led to investigations into the use of PDGFR 
inhibitors as a treatment for fibrosis. For example, treatment of SSc fibroblasts with a PDGFR 
inhibitor Imatinib prevents excessive ECM deposition and also inhibits SSc-like fibrosis in mice184.  It 
Src, PI3K, PLC, SHP2, GAP and 
































Figure 4.1: PDGF Signalling pathway. Binding of PDGF induces receptor dimerisation and the 
resulting conformational changes in PDGFR allow autophosphorylation and the binding of 
intracellular adaptor molecules that trigger downstream signalling cascades. These signalling 
events ultimately lead to increases in cell migration, growth, proliferation and differentiation 
amongst a range of transcriptional changes.  
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is therefore also possible that proteomic investigations into the downstream effects of PDGF 
signalling may provide useful insight into other potential drug targets for the treatment of disease.  
Alterations to the redox state of cells have also been implicated in disease states such as SSc and 
other fibrotic disorders. The importance of redox homeostasis for correct ER function has already 
been discussed in the introduction to this thesis and much research has been done on the impact 
of oxidative stress on fibrotic diseases (reviewed by Gabrielli et. al.185). However, comparatively 
little is known about the impact of reductive stress. The highly secretory function of fibroblasts may 
well make them particularly sensitive to redox imbalances, which could come from conditions of 
either oxidative or reductive stress. Reductants, which may impose a reductive stress upon the skin, 
are prevalent in everyday life: sulfur dioxide pollutes our air, and thioglycolate is the major 
component of depilation creams and hair permanents or straightening treatments. It is therefore 
of interest to investigate the specific effects of reductive stress on dermal fibroblast cells.  
DTT is a potent reducing agent first described by Cleland in 1964 as having a very low redox 
potential, and able to reduce all disulfides186. Reduction of disulfide bonds happens through two 
sequential reactions, with the concurrent oxidation of DTT into a cyclic compound (Figure 4.2). This 
chemical can cross membranes and inhibit formation of disulfide bonds within the ER leading to 
significant stress within cells187.  The effects of DTT in cell culture have been well characterised, with 
treatment times of as little as 10 minutes inducing an ER stress response188.  
This chapter will describe the signalling responses of BJ fibroblast cells to PDGF with and without 
reductive stress induced by DTT. The potential consequences of these responses with respect to 
cell viability and proliferation will also be discussed to gain insight in to the physiological relevance 
of these findings.  
  
Figure 4.2: Mechanism of action of DTT. DTT reduces disulfide bonds with the concomitant formation 
of a cyclic disulfide through two reaction steps. All biologically accessible disulfides are reduced by 
this action.  
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4.2 Determination of a response to stimulation with PDGF-bb 
Before characterising the fibroblast responses to reductive stress, establishing the response of the 
cells to PDGF stimulation was first required. Due to the presence of growth factors in FCS, cells were 
treated with PDGF under serum free conditions so that any growth factor-associated responses 
could be deemed specific to the PDGF treatment. The PDGF B isoform was used (PDGF-bb) to treat 
the cells so that results were comparable to data held by P&G. Human dermal fibroblasts (HDF) 
were first used to establish the protocol, and their response to PDGF-bb examined by 
immunofluorescence and western blot. The protocol was then transferred to the BJ fibroblasts used 
in the remaining experiments of this thesis, and the expected signalling responses confirmed by 
western blot.  
4.2.1 Response of human dermal fibroblasts to PDGF-bb 
Immunofluorescence was used to investigate whether there was any change to the ER morphology 
following stimulation of fibroblasts with PDGF-bb (Figure 4.3).  HDF cells were seeded onto cover 
slips and treated for 24 hours with media containing 10 % FCS, serum free media or serum free 
media containing 10 ng ml-1 PDGF-bb. Cells were then fixed with paraformaldehyde and 
permeabilised with TX100 before staining for PDI (red), and the nuclear stain DAPI (blue). PDI was 
used as this ubiquitous ER resident protein gives an indication of the gross morphology of the ER. 
No substantial differences were seen in the ER morphology between the three conditions, 









Figure 4.3 Culturing HDFs in serum free media with or without PDGF-bb does not affect the gross 
morphology of the ER. nHDF cells were grown on cover slips and transferred to serum free media 
for 24 h with or without PDGF-bb, before fixing and staining for PDI (red) and nuclei (DAPI - blue). 
Images taken using Zeiss Apotome microscope at 63 x magnification. A. Cells grown in media + 




Western blotting was next used to confirm that the growth factor treatment elicited a response 
from the cells.  HDFs were grown to 70% confluency before treatment with 10 ng ml-1 PDGF-bb, in 
serum free media, for either 10 minutes, or 24 hours after which they were lysed with RIPA buffer 
containing protease and phosphatase inhibitors (Figure 4.4). RIPA buffer was used because the 
combination of SDS, sodium deoxycholate, and TX100 allowed for maximum recovery of all protein 
subpopulations, including those that are nuclear resident. Lysates were analysed by SDS-PAGE 
followed by western blotting with the PathScan® PDGFR Activity Assay cocktail to detect: 





Figure 4.4: Scheme of treatment of cells with PDGF. When fibroblast cells reached approximately 
70% confluency they were transferred to serum free media. At this time 10 ng/ml PDGF-bb was 
also added to the sample to be exposed to PDGF for 24 hours. 10 ng/ml PDGF-bb was added to a 
further dish 10 minutes before the end of treatment (at t= 23 h, 50 m) and a final dish left without 
exposure to PDGF. At t=24 h, all cells were lysed in RIPA buffer.  
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At 10 minutes an obvious response to PDGF-bb was seen, with PDGF receptor phosphorylation at 
Tyr751, as well as phosphorylation at Ser473 of its downstream effector Akt (Figure 4.5, lane 2). 
After 24 hours stimulation, the phosphorylation of these proteins had reduced indicating an 
acclimatisation to the stimulation (Figure 4.5, lane 3). The phosphorylation state of p44/42 
remained relatively constant across the three conditions. Thus, an adequate dose of PDGF was used 
















Figure 4.5 Treatment with PDGF-bb triggers a signalling response in fibroblasts. Lysates from
normal human dermal fibroblasts treated with 10 ng ml-1 PDGF-bb for 10 minutes or 24 hours in 
serum free media were analysed by 10% SDS-PAGE followed by immunoblotting with PDGFR 
activity assay western antibody cocktail containing antibodies against p-PDGFR, p-Akt, p-p44/42 
and eIF4e. 
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4.2.2 The signalling response to PDGF stimulation is similar in BJ fibroblasts 
The same treatment set up described in section 4.2.1 (Figure 4.4) was then used to test the 
signalling responses to PDGF-bb in BJ fibroblasts. A very similar response was seen, with 
phosphorylation of the PDGF receptor and Akt appearing at 10 minutes (Figure 4.6, lane 2). 
However, at 24 hours there was still a signal from p-Akt, although less that at 10 minutes, which 
was not seen in the HDF treatments (Figure 4.6, lane 3). This suggests that the BJ fibroblasts may 
acclimatise to stimulation less quickly than HDF cells and therefore, whilst responses are likely to 
be broadly similar there will likely be some variability in responses between different cell lines. For 
simplicity, and comparability with data from P&G, BJ fibroblasts were used for the remaining 
experiments in this thesis.   
Figure 4.6 Treatment with PDGF-bb also triggers a signalling response in BJ fibroblasts. Lysates 
from BJ fibroblasts treated with 10 ng ml-1 PDGF-bb for 10 minutes or 24 hours in serum free media 
were analysed by 10% SDS-PAGE followed by immunoblotting with PDGFR activity assay western 
antibody cocktail containing antibodies against p-PDGFR, p-Akt, p-p44/42 and eIF4e.
Representative image of 3 biological replicates. 
1        2       3  










250 –  
150 –    
75 –  
50 –  
37 –  
 
25 –  
100 
 
4.3 Effects of reductive stress on PDGF signalling pathways 
Having established that PDGF signalling was effective in these cells, it was then possible to 
investigate the additional effects of reductive stress on PDGFR signalling pathways. DTT treatment 
was given for 1 or 6 hours to BJ fibroblast cells at approximately 70 % confluency, on a background 
of 24 hour serum free treatment with, or without PDGF. Following treatment, cells were washed in 
PBS and lysed with RIPA buffer (Figure 4.7). This provided a way to compare how DTT affected 
signalling responses in quiescent cells (SFM only) versus cells activated with PDGF treatment.  
 
4.3.1 DTT induces an ER stress response in BJ fibroblasts 
DTT is well known to induce an ER stress response in many cell types. To demonstrate that this was 
also the case in the BJ fibroblasts, two assays were performed for markers of ER stress: reverse 
transcription-polymerase chain reaction (RT-PCR) and PstI digestion of XBP1 cDNA; and an 
immunoblot of cell lysates with an antibody against phosphorylated-eIF2. The effects of DTT 
treatment on ER stress markers was assessed both in the presence and absence of PDGF to evaluate 
whether PDGF modulated the stress response.  
XBP1 is a transcription factor that, once activated, binds to DNA and initiates the transcription of 
UPR genes. Activation occurs through the splicing and removal of a hairpin loop region of the XBP1 
mRNA by IRE1 (Figure 1.7), which contains within it a specific digestion site for PstI189,190. Thus, 
under normal conditions it is possible to visualise two bands on an agarose gel of XBP1 RT-PCR 
products following PstI digestion, whereas under stressed conditions, the PstI digestion site has 
been removed and only one band is visible (Figure 4.8A).  To observe XBP1 splicing in BJ fibroblasts, 
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Figure 4.7: Scheme of treatment of cells with DTT  PDGF. When BJ fibroblasts reached 
approximately 70 % confluency they were transferred to serum free media with or without 
10 ng ml-1 PDGF. After 24 hours under these conditions cells were washed and lysed in RIPA buffer. 
For DTT treatments, 5 mM DTT was added to cells either 1 or 6 hours prior to lysis.  
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cells were treated as described above (section 4.3) and lysed in TRI reagent. RNA was extracted 
from TRI reagent lysates using chloroform precipitation and subject to RT-PCR with forward and 
reverse primers for XBP1. RT-PCR using the same RNA extracts was also performed with primers for 
-actin to act as a loading control. Prior to visualisation of products on a 2 % agarose gel, XBP1 
RT-PCR products were incubated for 2 hours with PstI at 37 C. As expected, a single band was 
visible in all samples treated with DTT consistent with the concept that DTT induces ER stress (Figure 
4.8B,C).  
Phosphorylation of eIF2 is also known to increase under conditions of ER stress (Figure 1.8). eIF2 
is a subunit of the eukaryotic translation initiation factor 2, which is required for the formation of 
the 43S translation initiation complex made up of small ribosomal subunit, Met-tRNA, GTP and eIF2. 
When eIF2 is phosphorylated this 43S translation initiation complex is unable to assemble and 
protein synthesis is inhibited191. To test the phosphorylation state of eIF2, cell lysates were 
prepared from treated BJ fibroblasts using RIPA buffer with protease and phosphatase inhibitors, 
and these were subject to separation by SDS-PAGE, transfer to PVDF membrane and 
immunoblotted for p-eIF2 and -actin as a loading control. The signal for phosphorylated eIF2 
was increased in DTT treated samples providing further evidence for the induction of ER stress 
(Figure 4.8D,E). Neither eIF2 phosphorylation or XBP1 splicing was altered by co-treatment with 
PDGF (Figure 4.8B,D).  
 
Figure 4.8: DTT induces ER stress in BJ Fibroblasts. A. Schematic describing the expected PCR 
products of XBP1 depending on activation status. PstI restriction endonuclease site exists only in 
the hairpin loop of the un-spliced (inactive) form of XBP1. When XBP1 is activated, this restriction 
site is removed and PstI digestion no longer occurs. B. RT-PCR products from XBP1 assay and C.
-Actin was visualised with ethidium bromide in 2 % agarose gel. D. Immunoblot for phosphorylated 




4.3.2 DTT induces growth factor-independent phosphorylation of Akt  
As expected from the initial assessment of signalling following PDGF activity, the lysates from cells 
treated for 24 hours in serum free media  PDGF only (i.e. no DTT treatment) displayed 
phosphorylation of p44/42 (ERK1/2) but only very weak phosphorylation of Akt (Figure 4.9A,B, 
lanes 1 and 2). The same signalling pattern was also seen after 1 hour DTT in both + and – PDGF 
cases (Figure 4.9A,B, lanes 3 and 4). Surprisingly, however, after 6 hours DTT there was a strong 
signal for p-Akt and the signal for p-p44/42 appeared greatly diminished. The same signalling 
pattern was seen both in the presence and absence of PDGF stimulation (Figure 4.9A,B, lanes 5 and 
6). This demonstrates a signalling pattern that has not been previously described whereby DTT 
treatment stimulated growth factor-independent activation of the Akt pathway, with concomitant 
de-activation of the p44/42 pathway.  
  
Figure 4.9: DTT stimulates Akt phosphorylation with or without PDGF. Lysates from BJ fibroblasts 
treated with 0, 1, or 6 hours 5 mM DTT in serum free media with or without 10 ng ml-1 PDGF-bb 
were analysed by 10 % SDS PAGE and immunoblotted with a western blotting antibody cocktail 




The Akt pathway is well known to be involved in many pro-survival mechanisms including cell 
growth, proliferation, inhibition of apoptosis, angiogenesis, metabolism and even migration and 
invasion (reviewed by Manning and Cantley in 2009192). p44/42 are members of the MAPK family 
and participate in the Ras-Raf-MEK-ERK signalling cascade. The targets of this signalling pathway 
are wide and in some cases opposing, including cell migration, cell cycle progression and 
differentiation but also cell death and apoptosis under certain conditions193. The contrasting 
phosphorylation states of these two signalling pathways suggests that a persistent reducing 
environment requires the cell to carefully balance the pro-survival stress response with a need to 
remove those cells which are beyond repair.    
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4.3.3 Signalling response is unique to redox stress 
 
To test whether the Akt/p-44/42 response is a result of ER stress in general, or specifically results 
from redox stress, cells were treated with thapsigargin. Thapsigargin blocks the ATP-dependant 
calcium pump in the ER, leading to loss of calcium homeostasis. This dysregulation of the usually 
tightly controlled calcium levels triggers ER stress and the UPR in a way that is not redox related194.  
Cells were treated with 2 µM thapsigargin for 1 or 6 hours in serum free media with or without 
PDGF before being lysed in RIPA buffer, and lysates were immunoblotted for p-Akt, p-p44/42 and 
-actin as a loading control. Whereas with DTT treatment a substantial increase in Akt 
phosphorylation was seen at 6 hours, with thapsigargin there appeared to be an increase in 
phosphorylation levels with the 1 hour treatment, which then returned to the initial levels at the 6 
hour time point. This suggests that the Akt phosphorylation occurs earlier in the cellular response 
to thapsigargin than in the cellular response to DTT.  In contrast to the results seen with DTT, the 
signal from p-p44/42 increased with thapsigargin treatment where it had previously decreased with 
DTT (Figure 4.10). Together, these results demonstrate a uniqueness to the phosphorylation events 
seen following DTT treatment suggesting a redox-specific response within the cells. 
4.3.4 Other reductants illicit similar, but not identical, signalling responses 
 
Figure 4.10: Thapsigargin does not stimulate the same signalling responses as DTT. In contrast to 
the responses seen with DTT treatment, thapsigargin treatment elicits A. phosphorylation of Akt 
that peaks at 1 hour before reducing again by 6 hours, and B.  increased p44/42 phosphorylation. 
C. -Actin loading control.  
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Other chemicals that may affect the redox condition of cells were used to establish whether the 
phosphorylation of Akt and de-phosphorylation of p44/42 seen was specific to DTT or occurred 
more generally in response to redox imbalance.  
The -amino acid taurine, also known as 2-aminoethanesulfonic acid, is a potent anti-oxidant that 
occurs naturally from methionine and cysteine metabolism. It is known to be involved in many 
functions within the body including anti-oxidation and detoxification195 and has also been shown to 
have anti-fibrotic properties196–198. Whilst taurine is found naturally within the body, these 
anti-fibrotic characteristics have led to its use in cosmetics such as skin treatments designed to 
reduce scarring and anti-ageing creams. Thioglycolate is present in many depilatory creams and 
lotions used for cosmetic hair removal199 and works by reducing disulfide bonds in keratin such that 
the hairs are weakened and easily removed. Thioglycolate salts are also commonly used in hair 
permanent and straightening treatments. Finally, hydrogen peroxide is a well-known chemical that 
induces oxidative stress in cells and has previously been shown to induce a peak of Akt 
phosphorylation with short term treatment that then reduces to basal levels after long-term 
exposure200. This induces an oxidative, rather than reductive, stress in cells and was used to 
compare the signalling responses in this cell type to determine whether they were part of a redox 
or specifically reductive stress response.  
BJ fibroblasts were grown to 70% confluency before being treated with 5 mM taurine, 5 mM 
potassium thioglycolate, or 5 mM hydrogen peroxide for 10 minutes, 1 or 6 hours. Cells were then 
lysed in RIPA buffer and the lysates analysed by immunoblot for p-Akt and p-44/42. As expected 
from the literature, hydrogen peroxide treatment induced a rapid and significant increase in Akt 
phosphorylation within 10 minutes and this declined following long-term exposure (Figure 
4.11A)201. The same pattern of phosphorylation was seen with p-44/42 (Figure 4.11B). With taurine 
treatment, a p-Akt signal was seen at all time points (Figure 4.11C) and p-44/42 phosphorylation 
reduced after an initial increase at 10 minutes (Figure 4.11D). Though these responses are not as 
well-defined as seen with DTT treatment, they do demonstrate a similar pattern. Thioglycolate 
induced a pattern of signalling more like hydrogen peroxide than DTT. An increase in 
phosphorylated-Akt signal was seen at 10 minutes, but this was then greatly reduced after 
extended exposure (Figure 4.11E) and the same pattern was seen with phosphorylation of p44/42 






These results do not clearly define a specificity of the response to DTT treatment as being reducing 
or redox specific, and it is possible that the signalling responses seen are the result of a fine balance 
in the redox state of the cells. The changes to Akt phosphorylation seen with DTT are clearly 
different to those observed with hydrogen peroxide, suggesting a reductive stress specificity of the 
response. However, thioglycolate, which is also a reducing agent, does not appear to elicit the same 
pattern of Akt phosphorylation. Perhaps thioglycolate is less potent than DTT and therefore the 
redox balance within the cell is disrupted to a lesser extent reducing the requirement for activation 
of the protective, anti-apoptotic effects of the Akt signalling pathway. However, this would require 
further testing of a range of concentrations and timepoints. The mode of action of taurine is less 
well known and is thought to function more generally as an anti-oxidant than specifically as a 
reducing agent. Jong et. al., described the role of taurine in the mitochondria to protect against 
superoxide generation by increasing the production of proteins involved in the electron transport 
chain202. However, studies have also implicated taurine in the modulation of intracellular levels of 
the reducing equivalents NADH and NADPH203. This suggests that taurine may affect the overall 
redox state of the cells by modulating the intracellular production of ROS, as well as the levels of 
NADH and NADPH. It is possible that the signalling responses seen in response to DTT are not just 
due to a reductive stress but more a reflection on the level of disruption to the cells redox 
homeostasis, and the potential ability for the cell to survive this stress.  
To further characterise the signalling responses seen following DTT treatment, an extended time 
course was used to determine the time periods over which Akt phosphorylation was seen.  
Figure 4.11: Signalling responses to treatments that alter the redox balance of cells. Lysates from 
BJ fibroblasts treated with 5 mM hydrogen peroxide (A, D, G, J), Taurine (B, E, H, K) or Thioglycolate
(C, F, I, L) were analysed by 10% SDS-PAGE followed by immunoblotting for p-Akt (A, B, C), p-p44/42 
(D, E, F), -Actin (G, H, I) or total Akt (J, K, L). Representative images from n=2 biological replicates.
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4.3.5 Extended time course of DTT treatment reveals chronic Akt 
phosphorylation 
BJ fibroblasts were treated for 10 minutes, 30 minutes, 1, 2, 3, 4, 5, or 6 hours with 5mM DTT in 
serum free media with or without PDGF before blotting for p-Akt and p-p44/42 with total Akt as a 
loading control (Figure 4.12). Although obviously stronger in the early timepoints, the signal for 
phosphorylated Akt was present at all time points in the presence of PDGF with the signal 
weakening from about 3 hours DTT (Figure 4.12A). Conversely, phosphorylated Akt in the absence 
of PDGF only appeared very weakly at 10 minutes, with the signal becoming gradually stronger 
between 1 and 3 hours from which point it remained strong (Figure 4.12B). The p-p44/42 signal 
behaved similarly both with and without PDGF: there was an increase at the 10 minute timepoint, 
but this was greatly reduced, if not missing completely by 6 hours DTT. With PDGF, the signal began 
to diminish from 2 hours and by 4 hours was no longer visible (Figure 4.12C) whereas in the absence 
of PDGF, the signal lasted longer, diminishing only from 3 hours and was only completely absent at 
the 6-hour timepoint (Figure 4.12D).  
The precise interactions of the signalling responses to PDGF and DTT are not known. It is possible 
to suggest, however, that after 2 hours of DTT exposure the anti-apoptotic effects of the Akt 
signalling pathway are no longer sufficient to protect cell survival and are therefore alleviated in 
PDGF stimulated cells under chronic DTT stress. In addition, it is possible that the reduction in 
p44/42 phosphorylation is indicative of a reduction in the promotion of cell growth and 
proliferation, which has an earlier onset in the more sensitive, PDGF treated cells. It is likely that 
the fate of the cells is determined by a careful balance between these two signalling events and it 
is therefore of interest to further investigate the response in terms of cell viability and proliferation 
potential.   
Figure 4.12: Chronic Akt phosphorylation in response to DTT treatment. Lysates from BJ 
fibroblasts treated with DTT in the presence (A, C, E) or absence (B, D, F) of 10 ng ml-1 PDGF-bb
were analysed by 10% SDS-PAGE followed by immunoblotting for p-Akt (A, B), p-p44/42 (C, D), or 
total-Akt (E, F). 
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4.4 Consequences of chronic Akt phosphorylation  
4.4.1 Akt inhibition by perifosine 
To test whether the Akt signalling seen in Figure 4.12 was beneficial or detrimental to the cells, an 
inhibitor of Akt was used and the effect on cell proliferation observed (Figure 4.13). Perifosine is a 
synthetic alkyl-phospholipid designed to inhibit the erroneous activation of Akt often seen in cancer 
cells. Studies have shown that perifosine directly blocks Akt activity, preventing both constitutive 
and induced phosphorylation without affecting upstream components of the signalling 
pathway204,205.  
BJ fibroblast cells were treated for 0, 1 or 6 hours with 5 mM DTT in serum free media with or 
without 10 ng ml-1 PDGF-bb. Cells were given 5 µM perifosine, 5 minutes before treatments began. 
Following treatment, cells were lysed in RIPA buffer and the lysates analysed by immunoblot for 
p-Akt, and p-p44/42 alongside a positive control lysate from a previous experiment (Figure 4.13A, 
B). Cell proliferation was tested using the Orangu™ assay developed by Cell Guidance Systems. This 
assay is based on the reduction of the tetrazolium salt WST-8 by viable cells to an orange-coloured 
formazan dye, where the amount of dye formed is directly proportional to the number of viable 
cells. WST-8 is added to cells and incubated for 2 hours before reading the absorbance at 450 nm 
to determine the amount of formazan dye generated. In healthy and proliferating cells, it is 
expected that the absorbance would increase between 3 and 4-fold over a period of 6 days. BJ 
fibroblast cells were seeded into 96 well plates and allowed to settle overnight before treatment 
for 6 hours with 5 mM DTT either alone or with 5 µM perifosine, 5 µM perifosine alone, or 12.5 µM 
etoposide. Etoposide was used as a positive control as it is known to reduce cell proliferation (see 
chapter 3). Orangu ™ assay WST-8 reagent was added and incubated for 2 hours prior to reading 
absorbance at 450 nm on day 0, day 2 and day 4 (Figure 4.13C). 
Perifosine treatment successfully abolished Akt phosphorylation across all timepoints with no 
effect seen on p44/42 phosphorylation (Figure 4.13A,B). The cell proliferation assay demonstrated 
a small but insignificant increase in cell proliferation of cells treated with DTT and perifosine 
compared to those treated with DTT alone (Figure 4.13C). Treatment with perifosine alone also 
seemed to increase cell proliferation compared to the untreated control suggesting that in some 
cases Akt can indeed impede cell proliferation rather than wholly promoting it. These results 
suggest that perhaps the chronic Akt phosphorylation seen in these studies is detrimental rather 




The phosphorylation of Akt in cells treated with etoposide, which reduced cell proliferation 
between day 2 and day 4 (Figure 4.13C), was next tested to investigate whether the Akt response 
was like that seen with DTT. BJ fibroblasts were treated with 12.5 µM etoposide for 10 minutes, 6 
or 24 hours and lysed in RIPA buffer. Lysates were immunoblotted for p-Akt, p-p44/42 and total Akt 
as a loading control (Figure 4.14A, B, C). Long-term etoposide treatment of cells also led to 
increased Akt phosphorylation and reduced p44/42 phosphorylation similarly to that seen in DTT 
treated cells.  
The proliferation of DTT and etoposide treated cells was also compared. BJ fibroblasts were plated 
in a 96-well plate and allowed to settle overnight. Treatments of 5 mM DTT or 12.5 µM Etoposide 
were added for 6 hours before washing and replacing with fresh media. Orangu™ reagent 
containing WST-8 was added to the cells immediately after treatment was removed (day 0), on day 
2 or day 6 and absorbance at 450 nm measured after 2 hours incubation.  With both DTT and 
etoposide treatment, the proliferation of fibroblasts was significantly reduced (Figure 4.14D) and 
the change in absorbance, which is proportional to the change in number of cells, was also 
significantly different to the untreated cells (one-way ANOVA (F(2,6)=30, p=0.0008)) (Figure 4.14E).  
Several recent studies have implicated signalling through the Akt pathway, particularly chronic Akt 
activation, in the development of cellular senescence206–208. Senescent cells have a distinct 
phenotype which was reviewed by Höhn et al. in 2016209 and described as an increased cell size and 
protein content, increased number and size of lysosomes and stable growth arrest, as well as a 
SASP163.  The SASP is broadly divided into three categories namely, signalling factors such as 
Figure 4.13: Perifosine abolishes Akt phosphorylation. BJ fibroblast cells were given 5 µM 
perifosine 5 minutes prior to treatment for 0, 1, or 6 hours with 5 mM DTT in serum free media 
with or without 10 ng ml-1 PDGF-bb.  Lysates were analysed by 10 % SDS-PAGE and immunoblotted
for (A) p-Akt, (B) p-p44/42 and (C) total Akt alongside a positive control from a previous experiment 
(lane 7). D. The Orangu ™ colorimetric assay was used to estimate cell proliferation in response to 
treatments by incubating WST-8 with cells for 2 hours before reading absorbance at 450 nm at day 
0, day 2 and day 4 (n=3).  
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interleukins, proteases, and insoluble proteins and extracellular matrix components. Together 
these factors influence the surrounding tissue microenvironment which often leads to 
inflammation and in some cases may enable cancer development163.  
Etoposide induces senescence, as discussed in chapter 3, and it was therefore thought possible that 
chronic reductive stress, as generated through long-term DTT treatment, might also drive cells 
towards senescence. Senescent cells do not proliferate so if a large proportion of DTT treated cells 
had undergone senescence, the proliferation rate of the population would be significantly reduced, 
consistent with the data in Figure 4.14. However, a reduced level of proliferation could be caused 





Figure 4.14: Etoposide also induces chronic Akt phosphorylation and both DTT and Etoposide 
significantly reduce cell proliferation. Lysates from BJ fibroblasts were treated with 12.5 µM 
etoposide for 10 minutes, 6 or 24 hours were analysed by 10 % SDS PAGE followed by immunoblot 
for A. p-Akt B. p-p44/42 and C. total Akt. BJ fibroblast cells were also treated for 6 hours in a 96 
well plate with either 5 mM DTT or 12.5 µM etoposide. D. The Orangu ™ colorimetric assay was 
used to estimate cell proliferation by incubating WST-8 with cells for 2 hours before reading 
absorbance at 450 nm at day 0, day 2 and day 6. E. The change in absorbance was calculated and a 
significant difference between means detected using a one-way ANOVA (F(2,6)=30, p=0.0008). A 
Dunnett’s multiple comparison post-hoc test compared each treatment to untreated and a 
significant difference was seen with both comparisons. Untreated to Etoposide p=0.0019 and 
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To test for senescence in response to chronic DTT-induced reductive stress a senescence-associated 
-galactosidase (SAGal) assay was used (Figure 4.15). -galactosidase is a lysosomal enzyme with 
maximal activity at pH 4 - 4.5. Under conditions of senescence, the cells lysosomal content increases 
and -galactosidase activity is detectable at the sub-optimal pH of 6210. At pH 6, senescent cells may 
be stained using the chromogenic substrate X-gal that is converted to a blue precipitate by 
-galactosidase.  
BJ fibroblast cells were grown to 50% confluency before treatment for 6 hours with 5 mM DTT or 
12.5 µM etoposide on a background of 24 hours serum free media. After this time the cells were 
washed twice with PBS before being returned in to fresh, serum-containing media to recover for 4 
days. The cells were then washed and stained overnight with SAGal staining solution after which 
they were washed and stored in glycerol before imaging with a light microscope. Following imaging 
it appeared that, as expected, there were many more blue-stained cells in the etoposide treated 
sample (Figure 4.15D, E, F) than untreated (Figure 4.15G, H, I). Interestingly, the DTT treated sample 
(Figure 4.15A, B, C) exhibited blue-staining more like the etoposide sample than the untreated 
sample suggesting that long-term DTT treatment might indeed induce senescence. However, the 
results from repetitions of this assay were variable and the background staining from untreated 
cells could be high, making the results ambiguous. It was also noted that there was no reliable 
method of quantitation in the SAGal assay and so determination of differences between 
treatments relied solely on visual judgements.  
Figure 4.15: Staining for senescence-associated -galactosidase initially suggests chronic DTT 
treatment drives cells to senescence. BJ fibroblasts were treated for 6 hours with 5 mM DTT or 
12.5 µM etoposide before recovery for 4 days and staining for SAGal. Three representative 
images were taken from one biological replicate of DTT treated cells (A, B, C), etoposide treated 
cells (D, E, F) and untreated cells (G, H, I).  
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Therefore, this assay was re-visited with the addition of DAPI as a co-stain such that the nuclei of 
the cells were visible and quantifiable. The samples were then imaged using an inverted wide-field 
fluorescence microscope with phase contrast filter (Figure 4.16). An additional treatment condition 
of 5 mM DTT and 5 µM perifosine was also used to help determine whether any effects seen could 
be reversed by inhibition of Akt phosphorylation.  
BJ fibroblast cells on cover slips at 50% confluency were treated with 5 mM DTT  5 µM perifosine 
or 12.5 µM etoposide for 6 hours before being washed and replaced into fresh media to recover. 
On day 4 after treatment, the cells were washed, fixed and stained for SAGal as described 
previously. Following SAGal staining, the cover slips were washed in PBS and stained with DAPI 
before mounting on microscope slides. Representative images were then taken from 3 biological 





Figure 4.16: Semi-quantitation of SABGal assay. BJ fibroblasts were seeded onto coverslips and 
treated with A. 5 mM DTT, B. 5 mM DTT and 5 µM perifosine, C. 12.5 µM etoposide or D. left 
untreated. After treatment cells were returned to fresh media to recover for 4 days before fixing 
and staining for SAGal and DAPI. Representative images from 3 biological replicates were taken 
using an inverted wide-field fluorescence microscope with phase-contrast filter and analysed in Fiji. 
The number of darkly stained cells (indicated by red arrows) in each replicate sample was divided 
by the total number of cells visible to obtain the average percentage of darkly stained cells from 
each treatment condition (E). These were compared using a one-way ANOVA (n=3) to determine
no statistically significant difference between means (F(3,8)=2.863, p=0.1041). A Dunnett’s multiple 
comparison post-hoc test was used which additionally confirmed that there was no significant 




In these experiments, nearly all the cells appeared to have some positive staining for SAGal. It was, 
however, noted that there were some cells with a much heavier, darker staining pattern than others 
(denoted by red arrowheads in Figure 4.16) and therefore these could potentially be used as a point 
of comparison between the different treatment conditions. The total number of cells in each image 
were counted, as were the number of heavily stained cells and the percentages calculated (Figure 
4.16E). Using a one-way ANOVA, it was determined that there was no statistically significant 
difference between the means of any treatment, and a Dunnett’s multiple comparison post-hoc 
test confirmed this, which suggested that DTT, with or without perifosine, did not cause a significant 
increase in the number of senescent cells. It was therefore determined that reductive stress 
induced by DTT treatment is unlikely to result in senescence. This is consistent with the data shown 





4.5 Discussion and Conclusion 
This chapter has described the ability of DTT to induce a growth factor-independent signalling 
response in the phosphorylation of Akt, and the diminished phosphorylation of p44/42, that has 
not been previously described. The phosphorylation patterns of these signalling molecules appear 
to be specific responses to redox stress as they are not seen with the redox-neutral ER stress 
inducer thapsigargin. However, they cannot be attributed to a specific type of redox reagent as the 
reducing agent thioglycolate causes a response more like that of the oxidising agent hydrogen 
peroxide than DTT.   
The potential consequences of the chronic Akt phosphorylation seen in response to long-term DTT 
treatment have been investigated by exploring the possibility of the induction of cell senescence 
(section 4.4). The SAGal assay was used to compare the number of senescent cells between 
treatment with DTT and etoposide, a positive control for senescence. However, there was not 
sufficient evidence to conclude that reductive stress can drive cells into senescence.  
Additional markers of senescence may lend themselves more easily to confident quantitation of 
senescent cells in differing treatment groups. For example, Debacq-Chainiaux et. al., described the 
use of 5-dodecanoylaminofluorescein di-β-D-galactopyranoside (C12FDG), a fluorogenic 
-galactosidase substrate, for the quantitative analysis of SAGal activity211. This permits 
quantitation of positively stained cells by fluorescence intensity, which could also be used to set a 
threshold level whereby cells that stain weakly positive, for example due to contact inhibition, could 
be excluded from analysis.  
Senescent cells are known to accumulate in aged tissues and have become an attractive target for 
therapies directed at improving the condition and appearance of aged skin. The pro-inflammatory 
cytokines and matrix-remodelling proteases released in SASP lead to breakdown of the ECM and 
loss of skin structural integrity212. However, advantages of this activity have been demonstrated in 
the healing of cutaneous wounds where the anti-fibrotic properties of the SASP that facilitate ECM 
remodelling may reduce excessive collagen deposition that occurs in rapidly forming fibrotic scar 
tissue213,214.  
The activation of the Akt and/or p44/42 pathway by reductants could open a new avenue for the 
treatment of ageing in dermal fibroblasts and optimising wound healing. It is possible to imagine a 
situation where application of a bespoke reducing agent to wounded skin may encourage positive 
signalling outcomes in cells to improve appearance of scars through its anti-fibrotic mechanisms.  
Of course, it is also important to consider the role of p44/42 signalling in this picture. Here it was 
shown that long-term DTT treatment led to the dephosphorylation of these kinases and the 
downstream effects of this signalling pattern have not been investigated. The Ras/Ref/ERK pathway 
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in which p44/42 are implicated is known to induce both cell proliferation (survival) and cell death. 
The dephosphorylation and inactivation of this pathway may then be a protective or aggressive 
response towards cells potentially damaged by reductive stress.  
The following chapter of this thesis will use proteomics to further investigate the response to DTT 
and PDGF at the protein level. This will give an integrated understanding of the biological 
consequences of the signalling responses seen here, and how these events may be translated into 
proteomic changes within the cell. It also provides opportunity to further explore the subtle but 








Chapter 5: The effect of reductive 









Signalling events that may trigger changes to cellular proteomes often rely on the post-translational 
modification of effector proteins that may occur very rapidly. These effector proteins trigger 
changes to the abundances of other proteins by the promotion of gene transcription to increase 
mRNA copy number, and translation of this mRNA into functional proteins. However, alterations to 
protein abundance within cells does not occur uniquely by the up and down regulation of genes 
and mRNA transcription. Rather, the addition of post translational modifications to proteins already 
resident in the cell can modulate their turnover; for example, ubiquitination targets proteins for 
degradation reducing the protein copy number per cell215,216.  
The proteome of a cell is dynamic, with each protein having a specific half-life that may range from 
10 minutes to many hours216. The time taken for 50% of the HeLa cell’s proteome to turn over is 
estimated to be approximately 24 hours217. Thus, when investigating proteomic changes in 
response to stress, for example, a balance must be struck in determining the time-frame to 
examine: too long a recovery time and the cells will likely have regained equilibrium or died; too 
short and the cells will not have had sufficient time for changes in protein abundance to take effect.  
This chapter describes the proteomic analysis of DTT treated BJ fibroblasts in the presence and 
absence of PDGF. PDGF was given for 24 hours and DTT was added for the final 6 hours of this 
treatment period before lysis and proteome analysis. It was expected that 6 hours of DTT treatment 
would allow protein responses to be detected without inducing cell death, consistent with the 
observations in chapter 4. DDA was first used to gain a broad overview into the similarities of 
protein profiles detected in the lysates from different treatments. DIA by SWATH acquisition was 
then used to provide quantitative proteomic data on the relative abundances of protein 
identifications and how these may change between treatments. An analysis of the variance in 
protein quantification by SWATH acquisition will be discussed first before evaluating the changes 
seen with each treatment condition. The GO annotations associated with significantly changing 
proteins will also be analysed for overrepresentation or enrichment of terms in the data set. Finally, 





5.2 Experimental set-up for the proteomic analysis of cellular 
response to PDGF and DTT treatment 
BJ fibroblasts were treated for 24 hours serum free media either alone (untreated); with 5 mM DTT 
for the last 6 hours (DTT only); with 10 ng ml-1 PDGF-bb in serum free media (PDGF only); or with 
PDGF-bb in the serum free media and 5 mM DTT for the last 6 hours (PDGF and DTT). Following 
treatments, three biological replicates of each condition were lysed in RIPA buffer and prepared for 
mass spectrometry analysis using FASP. For SWATH acquisition, three technical replicate runs were 
undertaken for each biological replicate providing a total of 9 replicates for each condition (Figure 
5.1). A total of 4487 proteins were successfully quantified using SWATH acquisition; 45 showed a 
significant (FDR adjusted p < 0.05) fold change (FC) greater than 2 with DTT treatment alone, and 
28 showed a significant change with DTT and PDGF, whilst only 10 met these criteria when 
comparing PDGF to Untreated samples.  
  
Figure 5.1: Schematic of treatment for proteomic analysis. BJ fibroblasts were treated with serum 
free media with or without 10 ng ml-1 PDGF-bb for 24 hours, with or without 5mM DTT added 6 
hours before the end of treatment. Three biological replicates were made for treatments, each of 
which was used for three technical replicates in MS analysis.  
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5.2.1 DDA reveals unique protein profiles for each treatment condition 
 
Prior to quantitative proteomic analysis, lysates were subject to DDA to profile the proteins 
detected in each condition. Across the four treatments, a total of 2243 proteins were identified 
using this technique. Comparing the identifications demonstrated that, while a substantial 
proportion of the proteins were the same across all categories, there was a subset of unique 
proteins seen in each treatment (Figure 5.2). As expected, proteins identified in the DTT treated 
categories included chaperone-associated proteins such as members of the DNAJ superfamily that 
are involved in the stimulation of Hsp70 ATPase activity to mediate its binding to unfolded peptides. 
Stress inducible members of the DNAJ superfamily of proteins have been identified218. Therefore, 
it is plausible that DTT treatment is inducing the upregulation of these proteins as part of a response 
to ER stress.   
Whilst DDA data can indicate which proteins may be involved in responses to treatment, without 
quantitation it is difficult to determine whether there is a real difference. Precursor ions only 
fragmented for protein identification in the DTT treated lysate may correspond to a protein 
genuinely upregulated in response to treatment. However, they may have been selected for 
fragmentation in only the DTT treated sample due to variation in MS1 precursor ion selection 
between samples. Therefore, DIA was employed to provide relative quantitation of proteins 
identified in the lysates from the four samples. DIA by SWATH acquisition fragments all peptide 
precursor ions and so it is possible to compare the relative abundance of proteins across the 
samples from different treatments.   
Figure 5.2: Comparison of DDA protein identifications between treatment groups. Venn diagram 




5.2.2 Microflow SWATH acquisition is more stable than nanoflow 
There are two options for SWATH acquisition with SCIEX TripleTOF mass spectrometers: nanoflow 
or microflow. In nanoflow mode, an ionisation source is used that permits very low flow rates from 
the liquid chromatography (LC) component of 300 nl min-1. This mode generally has increased 
sensitivity, and only requires 1 µl sample to be injected which is beneficial in cases were sample 
availability is low. Microflow mode uses a duospray ion source that permits ionisation of peptides 
by both electrospray ionisation (ESI) and atmospheric pressure chemical ionisation (APCI) and thus 
allows complete separation of sample and calibrant material. The peptide sample is ionised using 
ESI while the calibrant injections are ionised using APCI. This means that there is no contamination 
of sample from calibration injections that occur between samples in a large batch, for example219. 
The microflow running mode for SWATH acquisition permits flow rates of down to 5 µl min-1 
requiring a larger injection volume of 4 µl. This slightly reduces the sensitivity of the identifications 
possible, but the runtime is reduced and stability of retention times increased lending itself to more 
robust quantitative data sets220.  
When comparing the total ion chromatograms from nanoflow and microflow injections (Figure 5.3A 
and B respectively), decreased variation in the traces was also seen with microflow injections. This 
variation does not directly affect quantitation, as intensities are normalised for total peak areas 
during analysis, but the more variability there is the more adjustment will need to be made which 





Figure 5.3: Total ion chromatograms from Micro flow SWATH acquisition overlay more tightly 
than Nano flow. Total Ion chromatograms from technical replicates of a single sample from A. Nano 
flow and B. micro flow sources were overlaid to assess stability and reproducibility of ion intensities. 





A comparison of the results from the two flow sources demonstrated that 495 more proteins were 
identified with nanoflow alone than microflow alone, although there were unique identifications in 
both cases (Figure 5.4A). Comparing the number of peptides identified per protein in the two 
methods demonstrated only minimal differences: while nanoflow showed a slightly higher 
proportion of proteins identified by more peptides (Figure 5.4B), microflow has a smaller range of 
values, as well as proteins identified with the maximum number of peptides seen (Figure 5.4C).  
As there was sufficient protein in the samples, it was decided to run all the injections in microflow 
mode due to its increased stability and decreased run times in comparison to nanoflow. There were 
not sufficient differences in the protein identifications to suggest that nanoflow was better after 
accounting for the higher levels of variability known to occur in retention time and TICs. It is 
interesting to note, however, the differences in protein identification and the possibility that a more 
complete data set for proteome profiling may be obtained by combining data from both flow types.   
  
Figure 5.4 : Comparison of results from Nano and Micro flow sources. A. Venn diagram comparing 
the number of proteins identified in Nano and Micro flow acquisition modes. B. Comparison of the 
number of proteins with varying numbers of peptide matches. C. Box plot to compare variation in 
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5.2.3 Analysis of variance amongst replicates 
Both biological and technical replicates were used to control for reproducibility of protein 
identifications within the samples. The average peak area across all 9 result sets was used in 
comparisons but analysis into the variation between replicate samples was also performed to 
establish if, for example, there was a replicate lying outside the trend for the data set. To compare 
the variance within samples, the coefficient of variance (CV) was used. The CV provides a measure 
of the variance as a percentage of the mean, which gives an indication of how relevant the variation 
is to the sample. For example, a difference of 1 away from a mean of 100 is much less significant 
than a difference of 1 away from a mean of 10 however, the standard deviation does not describe 
this. Dividing the standard deviation by the mean of the data gives the percentage CV, which will 
be 10-fold greater for a difference of 1 away from a mean of 10 than from a mean of 100. Generally, 
a %CV value of up to 20% is accepted for technical replicates, and up to 30% in biological replicates 
(personal communication with Hubbard group, Manchester University).  
Therefore, the %CV was calculated for the technical and biological replicates for all identifications 
with FDR < 5% (Figure 5.5). This demonstrated that most of the peptides were within the accepted 
thresholds for CV. Within the DTT technical and total replicates analysis, 85 and 86% of the 
identifications were within the CV thresholds respectively. For the untreated samples this increased 
to 93 and 97%. The increased variance in the treated sample across all replicates was expected 
because the response of cells to treatment will inevitably be more variable than cells in their natural 
state. Even within tissue in vivo it is unlikely that cells would respond uniformly to an environmental 
change. The percentage of identifications that were within the CV threshold in the analysis of 
technical replicates for PDGF and DTT treated and the PDGF only treated samples were 86 and 88% 
respectively. The same values were seen for the analysis of all replicates, including biological, 
together.  
Another, and arguably more accurate, way of analysing the proportional variances with respect to 
the mean is to log transform the peak area values. The logarithmic scale separates values 
proportionately such that a doubling event and a halving event are both given the same absolute 
value. In a scale that is not logarithmic, if a value of 10 doubled, the result would be 20, whereas if 
it halved the result would be 5. Proportionately both are a 2-fold change, but the changes (i.e. 
resulting value minus original value) are listed as 10 and -5 respectively, which are very different. 
On a logarithmic scale log(20) = 1.3, log(10) = 1, and log(5) = 0.7 and therefore the changes for the 
doubling and halving events are 0.3 and -0.3 respectively, both the same absolute value. The log 
transformation also means that the variances, and therefore standard deviations, are proportional 
to the mean. Looking at the data from the mass spectrometers, it is possible to use log 
transformations to measure the proportional standard deviation of the replicate data (Figure 5.6). 
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This comparison of the standard deviations of log values demonstrates a difference in the variance 
of PDGF treated samples compared to that of the DTT only or untreated samples. This difference is 
not as obvious in the CV comparisons and may provide an explanation as to why there are fewer 
significantly changing proteins in the PDGF treated samples, as increased variation will increase the 






Figure 5.5: Histograms display distribution of coefficient of variance values across replicates. A-D 
show coefficient of variance values for technical replicates in each of three biological replicates. E 
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Figure 5.6: Histograms display distribution of standard deviation of log values. A – D show 
standard deviation of log values for technical replicates in each of three biological replicates. E and 
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5.3 Protein responses to PDGF and DTT treatments 
Proteins were determined as significantly changing when their fold change was greater than 2 
(doubling event), or less than 0.5 (halving event) and the FDR adjusted p-value from a Student’s 
t-test was less than 0.05. To determine the spread of differential quantifications the log fold change 
was plotted against the negative log of FDR adjusted p-value in each of three comparisons (PDGF 
to untreated; DTT to untreated; and PDGF and DTT to PDGF only) (Figure 5.7, Figure 5.8, and Figure 
5.9 respectively).  
As can be seen from these plots the response is predominantly a down-regulation of proteins in 
response to DTT treatment both with and without PDGF. The response to PDGF alone appears more 
balanced, although there are substantially fewer proteins showing a significant response in this 
comparison. It is possible that with a 24-hour stimulation, as was given in these experiments, the 
cells are recovering from their initial response by the time of lysis and therefore protein changes 
are more difficult to detect at a fold change of more than 2.  
Histone H4 (HIST1H4A) was shown to be decreased in response to PDGF (Fold change=0.41; 
adjusted p-value = 5.55 ×10-5) in this data set. Previously, PDGF-bb has been shown to reduce the 
expression of structural maintenance of chromosomes (SMC) genes, which was mediated by a 
variety of mechanisms including the deacetylation of histones221. Histone deacetylation induces 
closer interactions between histone proteins and DNA, making the DNA less accessible to 
transcriptional machinery and therefore represses gene expression. DNA, and any tightly associated 
proteins, is removed by centrifugation following cell lysis. It is possible that, if PDGF stimulated 
histone deacetylation of some genes, the histones now tightly associated with DNA were not 
identified in our proteomic analysis leading to an apparent reduction in histone proteins following 
PDGF treatment.  
Pre-laminA/C (LMNA), which is cleaved into Lamin A/C, was identified as being significantly 
upregulated in response to PDGF. The Lamin gene contains an alternative 5’ splice site (SS) termed 
the “progerin 5’SS” because the alternative splicing of the lamin gene by this SS leads to the excision 
of intron 11 and production of the defective progerin protein222. In healthy cells, this occurs only at 
a very low level but in Hutchinson Gilford Progeria Syndrome (HGPS) the progerin 5’SS is activated 
leading to the accumulation of progerin and defective nuclear envelope morphology222. Vautrot et 
al., demonstrated that treatment with PDGF-bb led to decreased usage of this SS and increased 
accumulation of correct lamin mRNA and protein within HGPS cells222. It is possible that, in healthy 
cells, PDGF is still able to promote correct splicing of lamin to increase its expression. Alternatively, 
the increase seen may be a simple product of increased cell proliferation leading to upregulation of 
nuclear structural proteins in order to support the nuclear division required for mitosis. This theory 




Figure 5.7: Volcano plots display distribution of significantly changing proteins across fold change and significance values (part A). Log10Fold change is plotted against 




Figure 5.8: Volcano plots display distribution of significantly changing proteins across fold change and significance values (part B). Log10Fold change is plotted against 




Figure 5.9: Volcano plots display distribution of significantly changing proteins across fold change and significance values (part C). Log10Fold change is plotted against 
the negative log10FDR-adjusted p-value for proteins quantified in the comparison of PDGF and DTT to PDGF only samples. 
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Comparing those proteins that were identified as significantly changing in DTT treated samples with 
and without PDGF, it became obvious that there was a significant overlap in the two responses. 
Almost all the significantly changing proteins in the PDGF treated comparison were also identified 
in the DTT only to untreated comparison, however there were an additional set of proteins only 
seen when PDGF treatment was absent (Figure 5.10). The single protein that is unique to the PDGF 
treated comparison is the only upregulated protein seen: TIMP1, which demonstrated a fold change 
of 2.17 and adjusted p-value of 8.62×10 . TIMP1 inhibits the proteolysis of ECM components and 
it has also been suggested that TIMP1 is involved in the reduction of inflammation at wound sites223. 
PDGF-bb has been previously shown to increase TIMP1 production in fibroblasts224,225, implicating 
TIMP1 in the regulation of ECM re-modelling in response to mitogenic signals and this is therefore 
an expected response. It is interesting to note the opposing down regulation of TIMP3 (fold change: 
0.23; adjusted p-value: 9.25×10-7). TIMP3 is uniquely involved in the inhibition of ADAM17, a 
protease which cleaves the membrane bound tumour necrosis factor alpha (TNF) into its soluble 
form. Release of TNF into the ECM triggers inflammation, and it is therefore suggested that TIMP3 
is a key regulator of this effect226. It seems contradictory that there is an upregulation of TIMP1 that 
may play a role in reducing inflammation while TIMP3, whose absence may lead to increased 
release of the pro-inflammatory cytokine TNF is reduced. It has been suggested in the literature 
that the TIMP family members may have opposing effects on cell survival with TIMP1 and 2 
indicated as suppressors of apoptosis while TIMP3 and 4 promote apoptosis in a cell-type specific 
manner (reviewed by Gardener and Ghorpade227).  Thus, it is possible to theorise that the 
apparently opposing responses of TIMP1 and TIMP3 seen in PDGF and DTT treated fibroblasts here, 






Figure 5.10: The response of BJ fibroblasts to DTT is broadly similar in the presence and absence 
of PDGF, and distinct from the response to PDGF alone. The proteins identified as significantly 
changing with DTT treatment were compared between treatments with and without PDGF, and to 
those identified as significantly changing in response to PDGF alone. This demonstrated that fewer 
proteins responded to DTT in the presence of PDGF, and that the proteomic response to PDGF alone 
was less than, and completely distinct from, the proteomic response to DTT.  
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The downregulated proteins (+ DTT,  PDGF) were directly compared (Figure 5.11), with all of them 
centring around a 2-fold change (≤0.5). The changes seen in the PDGF treated cells were slightly 
different to those seen in the cells treated without PDGF, often with fold changes slightly 
diminished. However, comparing these by a Student’s t-test determined that the only difference 
that was statistically significant was that seen in COL6A3 where the fold change with DTT alone is 
0.456 but 0.436 in the presence of PDGF. This indicates a slightly greater decrease in COL6A3 in 
response to DTT with PDGF than without.  
 
  
Figure 5.11: Fold changes appear slightly diminished with PDGF than without. The fold change of 
proteins identified to be significantly reduced following DTT treatment is plotted on heatmap for
DTT to Untreated comparison and PDGF and DTT to PDGF only comparison. Proteins which were 
not significantly reduced in the presence of PDGF are coloured grey.  
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5.3.1 Statistical enrichment test reveals enrichment of biological adhesion 
in response to DTT 
The statistical enrichment test determines whether the distribution of fold change values for a GO 
term is significantly different from the overall distribution of all values using a Mann Whitney U 
test. Using the complete GO biological process annotation there was no statistically significant 
enrichment seen in either comparison (DTT to Untreated, or PDGF and DTT to PDGF only). However, 
using the PANTHER GO Slim annotation for biological process, a significant enrichment was seen 
for the term ‘biological adhesion’ in the DTT to Untreated comparison only (Figure 5.12).  
PANTHER GO Slim is a reduced version of the full GO database where only the main terms are used, 
reducing the specificity and complexity of the annotations, thus providing a broader overview of 
the content of data sets. These broader GO Slim terms will therefore contain more annotated 
proteins than each of the specific terms from the full GO and this is likely why statistically significant 
enrichment is only seen with this database. With a term that only holds a few protein annotations, 
the distribution of values would have to be much more specific to be identified as significantly 
different from the overall distribution of all terms. In the GO Slim database terms have a higher 
number of annotated proteins, and distributions are therefore more able to withstand some 
variances while still demonstrating statistically significant differences to the overall pattern of 
terms.  
‘Biological adhesion’ is defined as “the attachment of a cell or organism to a substrate or other 
organism” and was annotated to 119 proteins in this data set including, for example, ECM proteins 
such as collagens, cell junction proteins including integrins and cadherins, as well as signalling 
proteins such as the Ras related protein RAP1A. The enrichment shows that the distribution of 
proteins annotated to this term is shifted more towards the lower values than the overall 
distribution pattern of all proteins. This suggests that proteins associated with ‘biological adhesion’ 
are disproportionately downregulated following DTT treatment compared to the global proteome 
response. Anoikis, a form of apoptosis, is triggered in cells by insufficient cell-matrix attachments228. 
A downregulation in integrin proteins, which are transmembrane proteins that play a fundamental 
role in the attachment of the intracellular cytoskeleton to the ECM, may indicate a reduction in 
possible attachment points of the cell. Equally, a loss of collagen proteins (also annotated here as 
belonging to the subset of proteins labelled with the term “biological adhesion”) may also lead to 
the breakage of integrin/collagen linkages and prevent sufficient cell-matrix attachments from 




The integrin proteins were not seen in the list of proteins with a statistically significant response 
(Figure 5.11), however re-examining the data for these proteins showed fold changes of just below 
the threshold of 2 or 0.5. Integrins 2, 5 and 1 showed a fold change of 0.66 (p=0.012), 0.64 
(p=3.47×10-10), and 0.61 (p=7.19×10-6) respectively. These fold changes suggest a change in protein 
abundance of approximately 1.5 times in the negative direction. It will be important to consider the 




Figure 5.12: Biological adhesion is significantly enriched in DTT to Untreated comparison results. 
Cumulative fraction plotted against uploaded value of fold change for all proteins quantified in DTT 
to untreated comparison. Distribution of overall values shown in blue, and distribution of values 
annotated to biological adhesion shown in red. PANTHER Enrichment Test (Released 20170413) 
was used with PANTHER version 13.1 Released 2018-02-03 and PANTHER Go-Slim biological process 
annotation data set. Bonferroni correction for multiple testing used for significance values. 
Biological adhesion found to be significantly enriched with p-value of 2.33 ×10-4.  
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5.3.2 Statistical overrepresentation testing suggests disproportionate 
response to ECM related proteins 
The GO terms annotated to the proteins identified as significantly changing in response to DTT 
treatment were next tested for statistical overrepresentation using the Panther overrepresentation 
test143,166 (Figure 5.13).  This uses a Fisher’s exact test with FDR correction for multiple testing to 
determine whether the proportion of results in the input annotated to a specific GO term is 
significantly different to the proportion of results in a reference list annotated to the same term. 
Thus, it provides an idea as to which terms have more than the expected number of genes 
annotated to them based on a reference data set. The significantly changing proteins were tested 
against all proteins identified in the lysates. Overrepresented terms were divided into three 
categories: those that were only overrepresented in PDGF treated results, those that were only 
overrepresented in results where PDGF was absent, and those that were overrepresented in both 
conditions (PDGF).  
Due to the hierarchical nature of the GO database there is varying specificity in the terms. For 
example, CYR61 is annotated to ‘regulation of cell migration’ in +PDGF but ‘cell migration’ in -PDGF. 
The higher level the term in the GO, the more annotations it holds. It is probable, therefore, that a 
higher number of proteins annotated to ‘cell motility’ (a high-level term) are required for 
overrepresentation to be significant than are required for ‘regulation of cell migration’ (a lower 
level term).  As expected, 8 terms were annotated to ‘regulation of cell migration’ in the presence 
of PDGF, while 11 terms were annotated to ‘cell migration’ in the absence of PDGF. As all proteins, 
except for TIMP1, were downregulated in response to DTT, overrepresentation here indicates that 
the number of proteins associated with a given term is more than would be expected if 
downregulation was uniform and proportional across all proteins identified. It therefore suggests 
that cell migration is disproportionally down regulated in response to DTT. With fewer proteins 
associated with cell migration in the presence of PDGF, it is possible that the migration promoting 
effects of PDGF treatment offer the cell some protection from the downregulation induced by DTT 
treatment. This would therefore reduce the number of proteins associated with cell migration in 
the PDGF treated samples such that overrepresentation of the broader term ‘cell migration’ is not 
statistically significant.  
The hierarchical nature of the GO database also means that a single protein is annotated with 
several terms. As such, there are annotations that are deemed overrepresented and seem out of 
place in a study of dermal fibroblasts. For example, ‘heart development’ (+ PDGF) and ‘embryonic 
morphogenesis’ (- PDGF) are not terms expected amongst proteins responding to DTT treatment in 
the skin. However, the proteins associated with these terms are also associated with signalling 
events and other, more obviously relevant terms.  
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‘Regulation of ERK1 and ERK2 cascade’ was overrepresented in the significantly changing proteins 
from DTT treatment both with and without PDGF (Figure 5.13). This suggests that proteins involved 
in ERK1/2 regulation are disproportionately downregulated compared to the total quantifiable 
proteome detected in these studies. This is in concordance with the results from the signalling event 
analysis discussed in chapter 4 (see section 4.3) in which DTT treatment induced dephosphorylation 
of ERK1/2. In both cases, with and without PDGF, the proteins annotated to this term were CYR61, 
NOTCH2, CTGF, TIMP3, GAS6 and FBLN1. CYR61 has been linked to induction of the ERK1/2 cascade 
in osteosarcoma cells undergoing epithelial to mesenchymal transition (EMT)229; inactivation of 
ERK1/2 inhibited the Jagged/Notch signalling pathway in lens epithelial cells, also in a study of EMT 
230; GAS6 induced ERK1/2 phosphorylation in metastatic prostate cancer cells found in bone231 and 
ERK1/2 signalling was shown to upregulate CTGF in mediation of myocardial fibrosis232. These 
findings would all agree with a downregulation of these proteins associated with a decrease in 
ERK1/2 phosphorylation, in so much as increases in ERK1/2 signalling in the cited literature are 
associated with increase in the proteins of interest. Thus, conversely, it could be expected that 
decreases in the protein can be associated with decreased ERK1/2 signalling.  
There were no GO terms associated with senescence, which are daughter terms of ‘cell ageing’ and 
‘cellular response to stress’, seen to be overrepresented in the significantly changing proteins. Two 
of the proteins in these sets were annotated to senescence: SERPINE1 and CDKN1A. SERPINE1, also 
known as plasminogen activator inhibitor 1, is a target gene of p53 that was shown to be necessary 
and sufficient to induce replicative senescence in cells including BJ fibroblasts233.  Cyclin dependant 
kinase inhibitor 1, CDKN1A, is controlled by p53 and blocks cell cycle progression by inhibition of 
cyclin dependant kinases leading to senescence234,235. However, as these proteins are decreased in 
response to DTT, this only confirms that there is no evidence of senescence following DTT treatment 
in these cells. 
Several terms appeared overrepresented in the DTT responding proteins that seemed to be 
associated with modification of the ECM. These included ‘extracellular matrix organisation’ 
overrepresented both with and without PDGF, ‘regulation of cell migration’ and ‘cell migration’ as 
discussed above, and ‘collagen catabolic process’ overrepresented without PDGF. In addition, the 
enrichment testing showed that proteins annotated to ‘biological adhesion’, many of which are 
ECM proteins, were disproportionately downregulated with DTT treatment (see section 5.3.1). This 
triggered an interest in the changes that were occurring in ECM proteins secreted by fibroblasts in 
response to DTT. Fibroblasts are the main producers of collagen to support ECM structure and 
function and therefore collagen proteins in the complete data set were revisited, to further 





Figure 5.13: Analysis of significantly changing proteins in response to DTT reveals statistically 
significant overrepresentation of GO terms. Percentage overrepresentation is plotted for GO 
biological process terms found to be statistically significantly overrepresented in those proteins 
that significantly changed in response to DTT either with or without PDGF. Significantly changing 
proteins were tested against a reference list of all quantified proteins in the data set using 
PANTHER Overrepresentation Test (Released 20171205) and PANTHER version 13.1 Released 
2018-02-03. A Fisher’s exact test with FDR multiple test correction was carried out using the GO 
biological process complete annotation set. For ease of viewing, where both parent and daughter 
terms were found to be overrepresented, only the parent term is displayed. 
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5.3.3 A set of collagen proteins are diminished following DTT treatment 
It was noted that, amongst the 18 collagen proteins identified in the data sets, there were only 3 
that met the threshold of 2-fold change. However, a further 6 collagen proteins had a fold change 
of more than 1.5 (or less than 0.67) with very low adjusted p-values suggesting high levels of 
significance. They also had many more peptide matches than the 2 usually required to confidently 
identify proteins from mass spectrometry data (Table 5.1).  
Table 5.1: Coverage information for collagen proteins identified as changing in response to DTT. 
The percentage coverage for collagen proteins with fold change (FC) greater than 1.5 and FDR 
adjusted p-value less than 0.05 was calculated from peptide matches. Identified peptides used for 
coverage determination were quantified in all data sets, whether treated or otherwise. Data ranked 









DTT to Untreated 






COL1A1 32 32 0.57 2.25E-03 0.68 2.25E-03 
COL1A2 30 31 0.22 1.25E-06 0.28 1.25E-06 
COL6A3 63 20 0.46 7.05E-08 0.44 7.05E-08 
COL12A1 44 18 0.52 5.94E-10 0.66 5.94E-10 
COL3A1 14 14 0.65 1.72E-02 0.78 1.72E-02 
COL6A2 15 14 0.33 9.38E-07 0.33 9.38E-07 
COL6A1 13 12 0.54 1.20E-03 0.65 1.20E-03 
COL18A1 7 5 0.61 4.08E-04 0.54 4.08E-04 
COL5A2 4 4 0.64 5.23E-03 0.76 5.23E-03 
 
Comparing the percentage change in peak area of the collagens from untreated to DTT treated, 
either with or without PDGF demonstrated that in nearly all cases, the response of collagens was 
greater in the absence of PDGF (Figure 5.14). This is consistent with the trend seen previously where 
the proteins seen to be significantly changing in PDGF treated cells are fewer in number, with fewer 
statistically significant overrepresented GO terms and no enrichment. It is possible that the growth 
promoting effects of PDGF treatment provided the cells with some protection against the harmful 





Oxidative stress has been shown to reduce collagen synthesis in rat cardiac fibroblasts236 however 
it has previously been demonstrated that renal injury associated with increased collagen 
production is increased in rats fed on an antioxidant deficient diet that limits peroxide clearance237. 
Whilst research has focussed on the effects of redox agents on collagen in situations such as 
cardiovascular disease, little is known about the effects of reductants on ECM content in dermal 
fibroblast cells.  
Bleomycin is a drug used in chemotherapy but is associated with the development of pulmonary 
fibrosis, which may be due to the production of ROS within cells following treatment. In 1989, Wang 
et. al., demonstrated that treating hamsters with taurine at the same time as bleomycin reduced 
pulmonary fibrosis including the reduction of bleomycin induced increases in collagen content197. 
Taurine was also shown to inhibit increased collagen production triggered by high levels of glucose 
in mesangial cells, but not epithelial cells and was thus deemed to be cell-type specific198. Although 
now dated, these investigations suggest a role for redox regulation in the maintenance of collagen 
production in a physiological setting. Taurine induced signalling responses similar to those seen 
with DTT treatment (see section 4.3.4) and so this may indicate a role for reductants in the 
regulation of collagen production in BJ fibroblast cells.  
 
  
Figure 5.14: Reduction of collagen proteins is enhanced in the absence of PDGF. The percentage 
change of peak areas quantified for collagen proteins in response to DTT treatment was calculated 
and compared between conditions with and without PDGF. For most collagen proteins, there was 
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5.4 Discussion and Conclusion 
This chapter has described the proteomic responses to DTT treatment seen in BJ fibroblasts with 
and without PDGF. Variance analysis from proteomic quantification was carried out before 
determining and investigating significantly changing proteins. The response seen in both cases was 
broadly similar, although the addition of PDGF decreased both the number of responding proteins 
and the overrepresentation/enrichment of GO terms. Finally, the effect of DTT on ECM collagens 
was investigated demonstrating a significant decrease in the amount of collagen that was just 
below the 2-fold-change threshold used to select responding proteins.  
PDGF is known to induce an increase in intracellular ROS which can be counteracted by antioxidants 
such as N-acetylcysteine (NAC)238. NAC is an N-acetyl modified version of the amino acid cysteine 
that is thought to act primarily through increasing intracellular glutathione levels239.  It has also 
been shown that NAC may directly reduce proteins by thiol-disulfide exchange240,241. It is possible 
therefore that, to some extent, the DTT treatment balances the increase in intracellular ROS that 
occurs in response to PDGF such that the redox balance of the cell is less perturbed than when 
treated with DTT alone. This would provide a mechanism by which to explain the apparently lesser 
response of cells to DTT when also treated with PDGF. It is possible that PDGF ultimately provides 
some protection against the effects of reductive stress caused by DTT alone.  
However, it was noted that there was more variance in the quantification of proteins from PDGF 
treated samples than those treated with DTT alone. As discussed in section 5.2.3, this may mean 
that proteins that are changing in response to DTT treatment in the presence of PDGF are not 
deemed significant due to increased levels of variance. It would therefore be necessary to validate 
the differences between PDGF and DTT treated and DTT only treated samples to determine if the 
changes are indeed less with PDGF. It would also be interesting to investigate the potential 
protective effects of PDGF on the downstream cell survival to establish whether there is indeed a 
benefit to PDGF treatment at the same time as induction of reductive stress by DTT.   
The findings that DTT treatment reduces the amount of ECM proteins, particularly collagen in 
fibroblast cells has potential relevance to clinical presentations. Fibrosis is a prevalent symptom of 
age related diseases, as well as a major debilitating effect of SSc, associated with erroneous 
deposition of excess collagen into the ECM. Fibrosis-inducing events and signalling cascades are 
known to generate intracellular ROS and oxidative stress242. The “western diet”, increased 
environmental toxicity and tobacco have all been implicated in increased pressure on our innate 
antioxidant system and it has been hypothesised than diet supplementation of antioxidants may 
provide some benefit242. A 2015 study by Conte et al., suggested some benefit of the anti-oxidant 
resveratrol in treating fibrotic diseases of the lung, although large scale clinical trials are yet to be 
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performed243. However, trials of antioxidants such as -carotene, vitamin A and vitamin E as 
nutritional supplements have limited evidence of any beneficial effects244. Although nutritional 
supplementation may be of limited value for the treatment of fibrotic disorders, the potential use 
of reductants in topical treatments of dermal fibrosis to try and reduce erroneous collagen 
production should not be excluded.  
These suggestions are built on the assumption that the reduction in ECM proteins is specific to 
reductive stress, and not also caused by oxidative stress. To determine whether the proteomic 
effects described in this chapter are indeed specific to reductive stress, it is necessary to make a 
comparison to oxidative stress. UV-A radiation makes up most of the ultraviolet light that comes 
from the sun and is therefore a major source of oxidative stress to the skin. The final results chapter 
of this thesis will therefore investigate the proteomic response to UV-A radiation-induced oxidative 
stress and compare these responses to those seen with DTT. The relevance of UV-A radiation to 
conditions such as skin cancer has led to extensive characterisation of the response of skin cells to 
this treatment. Thus, this investigation also provides opportunity to compare the proteomic 
responses seen in these quantitative proteomic analyses using the relatively new SWATH 
acquisition technique, to established responses already published in the literature. This will provide 
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6 The effect of ultraviolet-A (UV-A) radiation on the 
proteome of human dermal fibroblasts 
 
6.1 Introduction 
UV radiation emitted by the sun is categorised into three types according to wavelength. UV-A, 
which makes up 95% of the UV radiation that reaches the earth from sunlight, is classed as UV 
radiation with wavelength in the range 320-400 nm. Excessive exposure of the skin to harmful UV 
radiation is closely linked to the occurrence of skin cancers, with malignant melanoma accounting 
for 4% of all new cancer cases in the UK245. UV-B radiation, which causes direct damage to the DNA, 
has previously been assumed to be the main factor in skin cancers caused by sun-damage. However, 
in the last 15 years epidemiological evidence has arisen to suggest that in fact, the effects of UV-A 
radiation (the intensity of which varies with geographical location) are more closely linked to higher 
mortality rates246.  As such, much research has been done to map specific effects of UV radiation 
on skin cells, particularly at the genetic level, to try and identify potential therapeutic targets. Whilst 
proteomic investigations have been done, there are no unbiased studies published that elucidate 
global proteomic responses to UV-A radiation, using quantitative gel-free technology.  
UV-A radiation is absorbed by intracellular proteins or lipids including porphyrins and flavins for 
example riboflavin/FAD and haem, which then react to generate free radicals or singlet 
oxygen123,247,248 . Increased ROS within cells leads to oxidative stress that has been associated with 
skin disease and photoaged phenotypes which include disrupted ECM, inflammation and increased 
apoptosis249,250. UV-A radiation has also been shown to stimulate an ER stress response in HDFs 
through XBP1 splicing and PERK mediated phosphorylation of eIF2122.  
In contrast to the decreased ERK1/2 phosphorylation described in this thesis in response to 
DTT-induced reductive stress (Chapter 5), in some cell lines UV radiation has been shown to activate 
this signalling pathway as a way to promote survival and evade apoptosis251. UV radiation has also 
been shown to activate NFB to promote release of pro-inflammatory cytokines, as well as 
stimulate expression of MMPs that lead to ECM degredation252. NFB is a transcription factor that 
regulates the transcription of more than 60 pro-inflammatory genes involved in a range of functions 
including immune stimulation, apoptosis, cell adhesion and extracellular matrix degradation253. 
Under normal conditions NFB is held in the cytoplasm by IB proteins, which mask its nuclear 
localisation signal. Following UV-A radiation, these proteins are phosphorylated and targeted for 
degradation via the proteasome, allowing NFB to transit to the nucleus to function254,255. The 
proteolytic degradation of ECM components, particularly collagens and elastic fibres, which is 
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associated with inflammation is one of the main recognised hallmarks of photodamaged skin. This 
leads to the typical wrinkled appearance of skin with reduced ability to resist stretching256.  
In this chapter, SWATH acquisition proteomics will be used to assess the global response of the BJ 
fibroblast proteome to UV-A radiation. Proteins that demonstrate a significant change will be tested 
for overrepresentation and enrichment of GO terms to assess whether any functional groups are 
disproportionately regulated. Responses of proteins associated with the extracellular matrix, and 
the breakdown thereof will also be investigated, and the global proteomic response compared to 





6.2 UV-A radiation treatment for proteomic analysis 
BJ fibroblasts were grown to 75% confluency before conditioned media was removed and cells 
treated with 5 J cm-2 UV-A radiation. Following treatment, the conditioned media was replaced and 
the cells left to recover for 18 h in a 37 C humidified incubator. Conditioned media from control 
samples was also removed and dishes wrapped in tin foil for mock “exposure” to control for heating 
effects before recovery as with UV treated samples. Three biological replicates were set up, and 
the lysates used for three technical replicates of proteomic analysis by SWATH acquisition (Figure 
6.1).  
Following proteomic analysis, 3258 proteins were successfully quantified across the 9 total 
replicates. Of these, 515 proteins had a fold change of greater than 2 and FDR adjusted p-value of 
less than 0.05 when comparing control and UV treated quantifications. An increase, i.e. fold change 
of more than 2, was seen in 101 of the proteins whilst the remaining 414 proteins decreased with 












t = 0 h t = 18 h 
Figure 6.1: Outline of treatment of BJ fibroblasts with UV-A radiation. BJ fibroblasts were grown 
to 75% confluency before being subjected to 5 J cm-2 UV-A radiation. Prior to radiation conditioned 
media was removed and cells washed once in PBS. Control samples were then wrapped in foil to 
prevent exposure. Following treatment, conditioned media was replaced, and cells left to recover 
for 18 hours in a 37 C humidified incubator before lysis in RIPA buffer containing phosphatase and 
protease inhibitors and analysis by quantitative LC-MS/MS (SWATH acquisition). Three biological 
replicates were set up, and three technical replicates were analysed from each of these leading to 
a total of 9 replicate samples.  
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6.3 Analysis of variance among replicates 
The variation in quantification of proteins was analysed using the coefficient of variation (CV) and 
the standard deviation of log peak areas, as described for DTT and PDGF treatments in chapter 5 
(see section 5.2.3). Whilst for the previous data 80 – 90% quantified proteins had variation within 
the desired range of these two measures, in this UV dataset only 50% of protein identifications met 
these criteria (Figure 6.2). There was, however, little difference in the spread of variation measured 
in UV-A or control samples, as was seen between DTT treated and PDGF and DTT treated samples 
in the previous chapter.  
The additional variation could be due to several factors. With large numbers of proteins changing 
it may be that the cells response to UV-A radiation is more volatile and therefore there is a higher 
level of variation between biological samples. Alternatively, there may have been technical factors 
that impacted on the reproducibility of results. For example, where the ion intensity for a protein 
is close to the level of background noise, the FDR score from identification by comparison to the 
spectral library may be stochastically above or below the threshold for identification. Although 
SWATH acquisition is generally regarded as more reproducible than DDA, some variability between 






Figure 6.2: Histograms display distribution of coefficient of variance and standard deviation of 
log (peak areas) values across replicates. A – D show distributions of values in control samples and 
E-H show distribution of values in UV treated samples. A and E show %CV values from technical 
replicates; B and F show standard deviation of log values from technical replicates; C and G show 
%CV values from all replicates combined and D and H show standard deviation of log values from 


























































































































































































































To try and identify whether there was a specific replicate or replicates that were different from the 
others a principal components analysis was performed (Figure 6.3). Principal components analysis 
(PCA) provides a way to reduce data with a high number of variables, such as that obtained from 
mass spectrometry analysis, into a series of principal components that demonstrate the biggest 
separations between samples. The plot of principal components 1 and 2 (PC1 and PC2) shown in 
Figure 6.3 re-plots the samples on two vectors (PC1 and PC2), across which samples show the 
biggest separation. As such the PCA provides a method by which it is possible to determine whether 
there are components of the data that can separate samples in to distinct groups as would be 
expected with a specific response to treatment.  
The two conditions were separated well, with UV treated samples on the opposite side of the plot 
to the control samples. However, as expected, there was some obvious variation. The third 
biological replicate of UV-A treated samples (UV3) appeared somewhat separated from the main. 
The control samples were perhaps more closely clustered together, although a single technical 
replicate from biological replicate 1 (Cx1) sat away from the other technical replicates of that 
sample. It was therefore decided that there was not an obvious candidate or two that could be 
removed from the analysis without substantially reducing the data set. Instead, protein 
identifications were also filtered on the percentage CV value and those with %CV<30 across all 
replicates, both biological and technical, analysed separately from those that only met the fold 
change and p-value filters set previously.  
The loadings plot for the PCA provides an indication as to which proteins are contributing the most 
to the principal component score. Loading values range between -1 and 1, with a value close to 
either extreme suggesting a substantial contribution of that variable on the corresponding principal 
component. Although there were no variables with a particularly high loadings score (i.e. >0.3), it 
was noted that a group of chaperone proteins including PDI (P4HB), as well as PPIB and SERPINH1 
(two chaperone proteins heavily involved in the correct folding of collagen), lay outside the main 
cluster of proteins in the bottom right quadrant of this plot. This suggests that these proteins may 
be particularly involved in the separation of UV-A treated samples from control samples on the PCA 
plot. The two proteins with the highest loadings were serum albumin (ALB; top right quadrant) and 
vimentin (VIM; bottom right quadrant). The peak area for VIM in the UV-A treated samples was 
nearly double that in the control samples, indicating levels of vimentin are increased in response to 
UV-A treatment. Vimentin has previously been shown to play a role in the binding and stabilisation 
of collagen mRNAs258 suggesting that, in contrast to the effects seen with DTT treatment, UV-A may 
lead to the stabilisation of collagen levels within these cells. This will be investigated further in 
section 6.5.2.  





Figure 6.3: Principal components analysis of UV and control treated BJ fibroblast samples. A. 
Scores for PC1 (75.7%) versus PC2 (6.9%) with pareto scaling. Samples are labelled according to 
























6.4 Proteomic responses to UV-A radiation 
Proteins were plotted on a volcano plot to visualise the distribution of significant identifications 
following filtering for CV, fold change and FDR adjusted p-value (Figure 6.4). The number of proteins 
that met all three filtering criteria was 161, of which only 19 were increased compared to the 
control. This suggests the fibroblast response to UV treatment involved the downregulation of 
many more proteins than are upregulated. Even considering all proteins visible on the plot, there is 
an obvious bias towards the left-hand side, indicative of a general trend of decreasing relative 




Figure 6.4: Volcano plot displays distribution of significantly changing proteins across fold change 
and significance values. Log10Fold change is plotted against the negative log10FDR-adjusted p-value 
for proteins quantified in the comparison of UV treated to control samples. 
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Copine-1 (CPNE1), an evolutionarily conserved calcium-dependent lipid-binding protein, was 
decreased in UV treated samples (fold change: 0.49; p-value: 3.09×10-6). Ramsey et al., have 
previously showed that CPNE1 directs N-terminal proteolytic processing of the p65 subunit of 
NFB259.  NFB is a transcription factor whose activity is known to be induced by UV radiation252. As 
described in the introduction to this chapter, its regulation is primarily through the cytosolic 
sequestering of NFB by IB proteins. The processing by CPNE1 renders NFB unable to bind to 
DNA and therefore inhibits NFB promoted transcription259. The decrease in relative CPNE1 
amounts in the UV treated samples may suggest reduced NFB inhibition, and therefore increased 
NFB activity that is thought to occur in response to UV. NFB target genes include cytokines and 
chemokines associated with the inflammatory response, as well as anti-apoptotic factors and cell 
cycle regulators that promote cell survival and proliferation260. DNAJA1 showed a decrease in 
response to UV-A treatment (fold change: 0.33; p-value: 2.31×10-9). DNAJA1, whilst not known to 
be an NFB target gene, has been associated with the promotion of apoptosis under stress 
conditions by inhibiting the JNK-mediated hyperphosphorylation of c-Jun, thus relieving the anti-
apoptotic state. Its decrease, therefore, may serve as a protective and anti-apoptotic mechanism 
that could act synergistically with the expected survival responses of NFB signalling.  
Another transcription factor thought to be activated following UV radiation is p53. This is a tumour 
suppressor, and functions to promote transcription of a range of target genes including those 
associated with cell cycle arrest, DNA repair, and apoptosis261. Interrogating the data set presented 
in this chapter for the presence of p53 target genes resulted in the identification of 7 targets (Table 
6.1).  Unexpectedly, the target genes identified showed either no response (TRAF4), or a slight 
reduction in relative protein amount following UV radiation (all others). Latonen et al., have 
previously demonstrated a dose dependency of the p53 response to UV radiation, where low dose 
UV resulted only in a transient response by p53 and a high dosage was required for a sustained 
response262.  In their study, Latonen et al., used 10 J cm-2 UV-B and UV-C radiation for their low 
dose, as opposed to the 5 J cm-2 UV-A that was used in the experiments presented here. Although 
UV-A is considered a more damaging wavelength due to its ability to penetrate further in to the 
skin, it is possible that this dose is still not sufficient to induce sustained p53 activation. Instead, the 
decrease seen in the relative amounts of these proteins may be anti-apoptotic, promoting cell 
survival rather than clearance of terminally damaged cells. The proteins proliferating cell nuclear 
antigen (PCNA), and ribonucleoside-diphosphate reductase subunit M2 B (RRM2B) are both 
involved in DNA damage repair following p53 activation. In the context of skin, it is possible then to 
consider the possibility that low dose UV-A exposure may in fact permit cells to maintain damaged 
DNA, with the potential to accumulate mutations that may eventually lead to carcinogenesis. In 
future experiments it would be interesting to compare the proteomic responses to different UV-A 
doses to fully investigate this possibility.  
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Table 6.1: p53 target genes. The UV versus control proteomic data set was interrogated for the 
presence of p53 target genes. Identified proteins are listed, along with their associated fold change 
and FDR adjusted p-value in the UV to untreated comparison. Statistically significant identifications 
(i.e. with an adjusted p-value < 0.05) are highlighted. Student’s t-test, n=3.  
Gene name Function Fold change FDR adjusted p-value 
TRAF4 Apoptosis 1.00 0.99 
BAX Apoptosis 0.84 7.89×10-4 
FDXR Metabolism 0.84 0.53 
TIGAR Metabolism 0.41 1.27×10-5 
DDB2 DNA repair 0.76 0.53 
PCNA DNA repair 0.74 7.11×10-4 
RRM2B DNA repair 0.53 0.011 
 
Contrary to what might have been expected, there is limited evidence of an ER stress response 
amongst the proteins identified as increased in response to UV-A radiation. However, Stromal 
interaction molecule 2 (STIM2) was found to be higher in UV treated cells compared to control (fold 
change: 2.79; p-value: 2.82×10-7; average %CV: 7.95). STIM2 is known to act as a sensor for ER Ca2+ 
levels, activating Ca2+ influx following depletion by re-locating to ER-plasma membrane junction 
sites and regulating plasma membrane Ca2+ channels to trigger Ca2+ influx.  Farrukh et al., found 
that the ROS generated upon UV irradiation of fibroblast cells led to a rapid depletion of ER Ca2+ 
levels and induction of ER stress263. It is possible that the increase in the relative amount of this 
protein, which is seen in the data presented here, indicates a mechanism of cell recovery from 
oxidative stress induced by UV-A radiation. The recovery time allocated to the fibroblasts before 
lysis was 18 hours, which may have allowed for an ER stress response to be successful and regain 
homeostasis thereby reducing the potential for identifying proteomic changes more commonly 
associated with these pathways such as an increase in chaperone proteins.  
Several cytoskeletal proteins were also identified as being significantly decreased following UV 
radiation (Table 6.2). The cytoskeleton primarily consists of microtubules, made up of tubulin 
proteins; and microfilaments, made up of actin proteins, as well as various other associated 
proteins involved in forming bridges between structures and providing transport along them. 
Previous studies have implicated UV radiation in the disruption of the cytoskeleton of fibroblasts, 
particularly with reference to microtubules264,265. These studies have suggested that UV-A radiation 
led to the destruction of microtubules and microfilaments, however the decrease in relative protein 
amounts presented in this thesis may suggest that this structural damage is accompanied by 
degradation of the proteins involved. Whilst tubulin proteins are amongst those proteins identified 
as significantly decreased, actin proteins themselves are not. Instead, it is mostly actin related or 
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filament associated proteins that are decreased in response to UV. The actin protein ACTA1 was 
found in the data set but with a fold change of 1.09 and adjusted p-value of 0.84. This might suggest 
that there are differing mechanisms behind the destruction of the different components of the 
cytoskeleton seen in response to UV, which may not have been fully investigated previously.   
Table 6.2: Cytoskeleton associated proteins display a decrease in relative protein amount in 
response to UV radiation. Cytoskeletal or cytoskeleton-associated proteins are listed with their 
function, fold change and FDR-adjusted p-value in the UV to untreated comparison. Student’s t-test, 
n=3. Data ranked by p-value.  
Gene Name Function Fold change p-value 
MAP1A Cross-linking between microtubules 
and other cytoskeletal elements 
0.46 7.44E-05 
TUBB3 Tubulin 3 chain 0.48 3.89E-06 
TRIOBP Actin cytoskeleton organisation 0.47 1.59E-06 
PALLD Actin cytoskeleton organisation 0.32 6.53E-07 
CFL1 Actin filament depolymerisation 0.48 1.41E-07 
PFN2 Actin binding 0.45 4.70E-08 
TUBB6 Tubulin 6 chain 0.47 7.61E-10 
TUBB Tubulin  chain 0.47 7.61E-10 
TUBB4B Tubulin 4B chain 0.42 2.81E-10 
PDLIM1 Protein adaptor; stress fibre formation 0.44 1.01E-10 
LASP1 Regulation of actin cytoskeletal activity 0.48 3.91E-11 
CNN2 Filament associated protein 0.42 3.91E-11 
DSTN Actin filament depolymerisation 0.47 6.34E-12 
DYNC1LI2 Accessory protein for vesicle transport 
along microtubules 
0.46 5.79E-12 






6.4.1 The STRING-db tool identifies protein-protein interactions with groups 
of proteins that show a significant response to UV-A treatment 
 
The STRING-db tool was used to determine if any of the proteins that showed a significant response 
to UV interacted with each other (Figure 6.5 and Figure 6.6). Proteins that displayed a fold change 
greater than 2, with an adjusted p-value less than 0.05, were entered as input for multiple protein 
analysis in STRING version 10.5 and tested for experimentally determined interactions, or those 
listed in curated databases. Disconnected nodes, which were those proteins who did not interact 
with any others in the input, were not displayed.  
Amongst the proteins that showed an increase in response to UV there were only a few, usually 
single stranded, connections between a subset of the proteins (Figure 6.5). These proteins were all 
associated with serine proteinase or endopeptidase inhibition. Serine proteinases are distinct from 
the MMPs that are classically thought of as ECM degradative enzymes. The serpin family of serine 
proteinase inhibitors, of which two members are implicated in the network depicted in Figure 6.5, 
have been shown to inhibit the activity of a recently described membrane-anchored serine 
protease matriptase-3266. Matriptase-3 has been shown to promote tumour growth where a cancer 
cell line transfected with matripase-3 produced subcutaneous tumours in mice of a higher mass 
than those formed from mock transfected cell implants267. An increase in the inhibition of this, and 
other serine proteases, may therefore suggest protection against excessive proteinase activity. 
Further evidence for these identifications being associated with a protective response is gained 
from the GO annotations associated with these proteins. ALB is also annotated to the GO term 
‘negative regulation of apoptotic process’ and ‘negative regulation of programmed cell death’, and 
SERPING2 is annotated to ‘positive regulation of collagen biosynthesis’. This suggests a role for 
these proteins in the recovery of damaged ECM and protection against apoptosis that may 





In the significantly decreased set of proteins, this analysis identified a cluster of interacting proteins 
(highlighted with a purple box in Figure 6.6) that were all associated with mRNA splicing, processing 
or maturation in some way. Synthesis of mRNA is repressed in response to DNA damage and 
therefore the lower abundance of these proteins is predictable. It is interesting to contrast the 
decrease in p53-mediated DNA damage repair proteins identified previously (Table 6.1) with the 
downregulation of mRNA synthesis-associated proteins that is often associated with DNA damage. 
It might be expected that DNA damage repair would be increased while mRNA synthesis is 
repressed. However, the depletion of hnRNP H/F, two of the proteins identified in this data set, has 
also been shown to compromise p53-mediated apoptosis268.  hnRNPs are known to function in the 
processing of heterogeneous nuclear RNA to mature RNA, and stabilising this for transport. They 
are also involved in the regulation of mRNA alternative splicing events269. hnRNP H1 has been 
implicated in regulating the splicing of MAPK and ubiquitin pathway genes270, and its loss may be 
associated with a more oncogenic phenotype in breast cancer cells271. It is possible, therefore, that 
these responses are focussed on promoting cell survival rather than damage repair. Different 
aspects of the UV response are likely to occur at different time points after exposure, and it would 
be interesting to try and isolate these stages of recovery in future work.  
  
Figure 6.5: Protein-protein interactions amongst proteins increased in response to UV 
determined using the STRING-db tool. The multiple protein search function of the STRING-db tool 
found at string-db.org was used to identify interactions between proteins identified as significantly 
decreased in response to UV radiation. This identified a small cluster of interacting proteins 
involved in serine proteinase inhibition. Known interactions from curated databases (turquoise) or 
experimentally determined (pink) with the highest confidence (minimum required interaction score 




Overall, the responses seen here in response to UV radiation are indicative of a protective response 
against the effects of UV-A induced damage to the cell layer. Cell survival, rather than apoptosis, 
seems to be promoted and excessive ECM degradation protected against by increased levels of 
proteinase inhibitors. In the following section, identifications are tested for significant 
overrepresentation or enrichment of specific GO terms to gain further insight in to the predominant 
responses seen in this data.  
  
Figure 6.6: Protein-protein interactions amongst proteins decreased in response to UV 
determined using the STRING-db tool. The multiple protein search function of the STRING-db tool 
found at string-db.org was used to identify interactions between proteins identified as significantly 
decreased in response to UV radiation. This identified a cluster of interacting proteins involved in 
mRNA splicing, transport or transcription (highlighted by purple box). Known interactions from 
curated databases (turquoise) or experimentally determined (pink) with the highest confidence 
(minimum required interaction score 0.9) were used. Disconnected nodes were hidden. Produced 
using STRING version 10.5.  
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6.4.2 Statistical overrepresentation is seen predominantly in proteins 
upregulated in response to UV-A radiation 
Testing the increasing and decreasing proteins for statistically significant overrepresentation or 
enrichment of GO terms revealed surprising results (Figure 6.7). Although most proteins seemed to 
decrease in response to UV treatment, overrepresentation was much more prevalent in the 
increasing proteins. Significant GO overrepresentation was only seen when testing the decreasing 
proteins against the PANTHER GO Slim database, without filtering for %CV. Under these conditions 
‘mRNA splicing, via spliceosome’ displayed overrepresentation, compared to all proteins identified 
in the data set, of 257%. This means that there were 2.5 times as many proteins annotated to this 
term as would be expected based on the distribution of terms within the whole data set. This 
overrepresentation accords with the cluster of proteins associated with mRNA splicing seen in and 
discussed in the analysis of decreasing proteins using the STRING database above (Figure 6.6).  
  
Figure 6.7: Analysis of significantly changing proteins in response to DTT reveals statistically 
significant overrepresentation of GO terms. Percentage overrepresentation is plotted for GO 
biological process terms found to be statistically significantly overrepresented in those proteins 
that changed in response to UV treatment. Significantly changing proteins were tested against a 
reference list of all quantified proteins in the data set using PANTHER Overrepresentation Test 
(Released 20171205) and PANTHER version 13.1 Released 2018-02-03. A Fisher’s exact test with 
FDR multiple test correction was carried out using the GO biological process complete or the 
PANTHER GO Slim annotation set. For ease of viewing, where both parent and daughter terms were 
found to be overrepresented, only the parent term is displayed. 
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Overrepresentation of GO terms was seen in more cases when looking at the proteins that 
increased in response to UV-A radiation. With no filtering for %CV, overrepresentation was seen in 
the GO complete database for ‘negative regulation of endopeptidase activity’, ‘cornification’, 
‘complement activation’ and ‘intermediate filament organisation’. With %CV filtering, 
overrepresentation was seen with the GO Slim database for ‘proteolysis’ and with the GO complete 
database for ‘platelet degranulation’, ‘negative regulation of endopeptidase activity’, and 
‘hyaluronan metabolic process’.  
‘Negative regulation of endopeptidase activity’, which was overrepresented in both %CV filtered 
and unfiltered results using the GO complete database, was annotated to the same proteins that 
mapped to ‘proteolysis’ using the GO slim database. These proteins were a series of serine protease 
inhibitors including the inter-alpha-trypsin inhibitor family members H1, 2 and 3. These serine 
protease inhibitors are involved in the stabilisation of the extracellular matrix, in part by binding to 
hyaluronan272, and can inhibit tumour progression and metastasis of cancerous cells273. Their 
upregulation suggests an ECM stabilisation response that may be protective against the direct 
damage to ECM proteins caused by UV-A radiation274.  
Also annotated to these terms, as well as to ‘complement activation’, was complement component 
3 (C3). It has been suggested that the alternative complement pathway may act as a UV sensor, 
leading to the upregulation of C3 as has been seen here in this data (fold change: 2.62; p-value: 
7.58 ×10-9; average %CV: 12.65)275. Other components of the terminal complement complexes C5 
and C9 were also mapped to ‘complement activation’ in the test without %CV filtering. CD59, an 
inhibitor of the complement membrane attack complex (MAC), shows a very slight but significant 
decrease in response to UV (fold change: 0.90; p-value: 0.034; average %CV: 1.53).   These suggest 
the complement pathway may be upregulated in response to UV-A radiation, perhaps to clear 
apoptotic cells.  
Functional enrichment testing was also carried out on the data set to determine whether the 
proteins annotated to any GO terms displayed a statistically significant difference in distribution of 
fold changes, compared to the distribution of all proteins identified. No enrichment existed for 
biological process terms; however, proteins annotated to the cellular compartment term 
“extracellular region” were enriched with a p-value of 0.017. Many of these proteins were either 
ECM components themselves, or protease inhibitors as discussed previously. The distribution of 
fold changes for these proteins was shifted towards higher values compared to the distribution of 
fold changes for all identifications (Figure 6.8) suggesting an increase of extracellular proteins in 
response to UV-A radiation treatment. This provides further evidence that, in cells treated under 
the experimental conditions described in this chapter, there is perhaps a protective or damage 
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limitation response whereby ECM components are being secreted to re-populate or support a 
potentially damaged ECM and protected from degradation by proteinase inhibitors.  
 
  
Figure 6.8: Extracellular region is significantly enriched in UV-A treated to Untreated comparison. 
Cumulative fraction plotted against uploaded value of fold change for all proteins quantified in UV-
A treated to untreated comparison. Distribution of overall values shown in blue, and distribution of 
values annotated to extracellular region shown in red. PANTHER Enrichment Test (Released 
20170413) was used with PANTHER version 13.1 (Released 2018-02-03) and PANTHER Go-Slim 
cellular compartment annotation data set. Bonferroni correction for multiple testing used for 




6.5 Comparison of UV-A and DTT responding proteins 
Having surveyed the proteomic changes that occurred following UV-A radiation, these responses 
were then compared to the changes seen in DTT treated cells (Chapter 5). Both treatments will 
have caused stress due a redox imbalance in the cell: DTT acting as a reductive stress and UV-A as 
an oxidising stress. It was therefore interesting to determine whether the responses are common, 
and therefore likely to be general responses to redox stress, or specific to perturbations of a 
reducing or oxidising nature. 
6.5.1 A small subset of proteins changes significantly, and similarly, in 
response to both DTT and UV-A radiation treatments 
Of the 45 proteins that were significantly changed in response to DTT treatment (without PDGF), 9 
were also significantly changed in response to UV-A radiation (Table 6.3). All these proteins were 
downregulated in both cases, though in some cases the downregulation was greater with UV 
treatment than DTT.  
Table 6.3: Comparison of fold change and p-values for proteins identified as significantly changing 
in both DTT and UV treated data sets. The fold change, p-value and average %CV is displayed for 
the proteins identified in the DTT and UV treated data sets as significantly changing (ie. fold 








p value %CV 
Fold 
change 
p value %CV 
P29279 CTGF 0.41 5.50E-06 22.15 0.40 1.77E-03 40.99 
Q9HCU0 CD248 0.49 1.03E-06 14.73 0.34 4.90E-11 10.88 
Q8WUJ3 CEMIP 0.39 1.88E-08 14.88 0.30 6.65E-06 37.17 
Q9BZL1 UBL5 0.49 2.22E-02 39.43 0.29 7.43E-07 39.48 
Q6EMK4 VASN 0.50 3.59E-07 11.76 0.25 9.22E-05 39.54 
P07686 HEXB 0.47 8.01E-04 19.80 0.22 4.90E-11 24.30 
O00622 CYR61 0.26 5.10E-05 25.02 0.22 1.02E-11 19.49 
P48729 CSNK1A1 0.48 2.62E-02 41.09 0.20 1.33E-06 65.68 
P35625 TIMP3 0.21 9.25E-07 24.55 0.14 2.46E-11 28.26 
TIMP3 was downregulated in both DTT and UV treated cells, although the downregulation was 
more pronounced in UV treated cells (fold change: 0.14; p-value: 2.46 ×10-11), equivalent to a 7-fold 
decrease in relative protein amount. TIMP3 irreversibly inactivates MMPs and therefore its 
decrease is suggestive of an environment that supports increased MMP activity, such as that 
expected to occur in response to UV radiation. The regulation of this protein indicates that both 
treatments support increased MMP activity. This contrasts with the increase in serine proteinase 
inhibitors seen in UV-A treated cells and suggests that the distinct classes of proteinases that act 
on the ECM are regulated differently in response to treatment. 
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Several of the other proteins downregulated in response to both DTT and UV-A treatment are 
associated with the promotion of angiogenesis, cell proliferation and cell adhesion (CYR61, CTGF, 
and CD248) suggesting that these activities may be inhibited. CD248, otherwise known as 
endosialin, has been shown to bind to fibronectin (FN1) as well as type I and type IV collagen 
proteins276. One study has shown that cells overexpressing CD248 adhere faster to ECM-coated 
culture surfaces than controls276. As there was only a moderate decrease in the relative amount of 
fibronectin that was seen in response to either treatment (UV fold change: 0.85, p-value: 0.02; DTT 
fold change: 0.63, p-value 0.0043), it is possible that reduced cell adhesion seen in response to 
treatment is partly mediated by reduction in proteins such as CD248.  
A study published in 2000 demonstrated that CYR61 and CTGF mediate cell adhesion through 
binding to integrins, including integrin 61 and cell surface heparin sulfate proteoglycans 
(HSPGs)277,278. More recently, fibroblast binding of integrin 61 and the HSPG syndecan-4 to CYR61 
has been shown to induce apoptosis, in contrast to the enhanced cell survival displayed when 
binding to endothelial cells279. It is possible, then, that the substantial decrease in the relative 
amount of this protein quantified in response to either DTT or UV treatment acts as a protective 
mechanism to reduce apoptosis across the cell population.  
Finally, CEMIP showed a fold change of 0.3 in response to UV radiation (indicative of a 3-fold 
decrease in relative protein amount). CEMIP mediates the depolymerisation of hyaluronan via the 
cell membrane-associated clathrin coated pit endocytic pathway280. The increase in 
inter-alpha-trypsin inhibitor family members H1, 2 and 3 following UV-A treatment was discussed 
in GO overrepresentation analysis and these findings combined suggest an environment of 
increased hyaluronan stabilisation. Hyaluronan usually has a rapid turnover but it is implicated in 
wound healing, promoting fibroblast migration to the wound site, and as a major component of 
ECM in wound closure281. It has also been implicated in aiding the migration of inflammatory 
response cells to wound sites281. It is possible, therefore, that stabilisation of hyaluronan in 
response to treatment are part of a wound healing response to allow recruitment of fibroblasts and 





6.5.2 Collagen proteins respond differently with DTT and UV-A radiation 
treatments 
Collagen proteins were identified in the DTT treatments as significantly decreased, though often 
just below the threshold of 2-fold change set during the initial proteomic analysis. To compare the 
response of collagen proteins in UV-A treated cells to that seen in DTT treated cells, the data set 
was interrogated for collagen proteins. Many collagen proteins were also identified in the UV 
treated samples, however the fold changes seen in response to UV-A treatment centred more 
around a value of 1, suggesting a more limited response than those seen in response to DTT (Figure 
6.9). The only collagen protein that showed a fold change of greater than 1.5 in the UV treated 
sample was COL1A1 (Table 6.4). Interestingly, DTT treatment induced an almost opposite response: 
UV-A treated cells showed an increase of this protein compared to untreated (fold change: 1.52; 
p-value: 2.8×10-5; %CV: 12.3) whereas DTT treated cells showed a decrease compared to untreated 
(fold change: 0.57; p-value: 2.25×10-3; %CV: 19.48). This suggests that the decrease of collagen 
proteins is unique to the reductive stress response in BJ fibroblasts.  
  
Figure 6.9: Fold changes of collagen proteins are greater with DTT treatment than with UV-A 
radiation. The fold change of collagen proteins identified in the DTT treated data set is plotted as a 
heatmap to compare the responses to DTT treatment with UV-A irradiation. Collagen proteins 
which were not identified in the UV-A treated data set are coloured grey. Data ranked by fold 
change in DTT/Untreated comparison. 
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Table 6.4: Comparison of fold change and p-values for collagen proteins identified in DTT and UV 
treated data sets. The fold change, p-value and average %CV is displayed for the collagen proteins 
identified in the DTT treated data set. These are compared to the values associated with the same 
proteins, where present, in the UV treated data set. Fold changes of greater than 1.5 in either 
direction are highlighted. Data ranked by gene name (alphabetical). 
Gene Name 
DTT UV 
Fold Change P-value %CV Fold Change P-value %CV 
COL11A1 0.83 0.85 58.40       
COL12A1 0.52 5.94E-10 5.55 0.85 4.86E-03 8.33 
COL14A1 0.89 0.94 89.17 1.14 0.67 44.51 
COL15A1 0.68 0.28 29.51 0.82 0.83 135.06 
COL18A1 0.61 4.08E-04 15.04 0.76 9.05E-03 16.15 
COL1A1 0.57 2.25E-03 19.48 1.52 2.80E-05 12.30 
COL1A2 0.22 1.25E-06 20.08 1.33 1.53E-04 10.15 
COL2A1 0.73 0.67 51.26       
COL3A1 0.65 0.02 18.33 1.33 2.95E-04 11.41 
COL4A2 0.85 0.77 36.06 0.84 0.35 28.53 
COL4A3 0.62 0.25 5.29    
COL5A1 0.69 2.24E-03 12.29 1.27 1.05E-03 9.24 
COL5A2 0.64 5.23E-03 19.11 1.15 0.63 44.72 
COL6A1 0.54 1.20E-03 18.87 0.96 0.44 7.95 
COL6A2 0.33 9.38E-07 15.33 1.01 0.80 8.10 
COL6A3 0.46 7.05E-08 6.96 1.16 1.13E-03 6.12 
COL7A1 0.81 0.80 56.25       
COL8A1 1.20 0.69 30.88       
 
Photoaged skin is usually associated with a loss of collagen, however the relative amount of 
collagen proteins themselves in this data set show little change in response to UV at the recovery 
timepoints tested here. A decrease in the relative amounts of TIMP proteins was seen (see section 
6.5.1) which may suggest an environment that is supportive of MMP collagenase activity in the 
ECM, although the MMPs associated with this activity were not detected. As discussed earlier in 
this chapter with reference to ER stress (see section 6.4), it is possible that 18 hours recovery after 
exposure permitted cells enough time to begin to repair any damage caused or was not sufficient 
to detect longer-term changes in more stable/long-lived proteins.  A study focussed on the recovery 
of the microtubule cytoskeleton in mouse fibroblasts exposed to UV radiation found that after 48 
hours, recovery was complete and cells showed normal morphology265. It is therefore possible that, 
at the timepoints considered in the study presented in this thesis, some recovery mechanisms to 




6.6 Discussion and Conclusion 
This chapter has described the proteomic response of BJ fibroblasts to UV-A radiation and 
demonstrated both similarities and differences between this and the response to DTT described in 
chapter 5. Whilst UV-A radiation appeared to alter many more proteins than DTT treatment (515 
significantly changing proteins compared to 45 with DTT) there were fewer significantly 
overrepresented GO terms associated with these identifications. This perhaps indicates a more 
global protein response than one associated with the reaction of a specific set of proteins. This may 
be because the ROS generated in response to UV-A radiation affects many aspects of the cell 
physiology including damaging the DNA, oxidising membrane phospholipids as well as inducing a 
general oxidative and ER stress response.  
ECM degradation has previously been implicated as a major response to UV-A radiation through 
upregulation of proteases that damage key proteins such as collagens and elastic fibres282,283. In this 
data set there was a distinction between the responses of serine proteinase inhibitors, which 
increased in response to UV-A radiation, and metalloproteinase inhibitors (TIMPs), which 
decreased. The two classes of proteinases on which these inhibitors act have different targets 
within the ECM suggesting a finer tuned response in the ECM than uniform degradation.   
Stabilisation of the ECM protein hyaluronan appeared from several angles of analysis, which 
suggested that this may be a distinct response of these cells to UV-A radiation, not recognised 
before in the literature.  Both a significant decrease in the hyaluronan depolymerising protein 
CEMIP, and an increase in the inter-alpha-trypsin inhibitor family members H1, 2 and 3 which are 
involved in ECM stabilisation suggest a response that promotes the stability of hyaluronan following 
UV-A radiation. This may help to counteract the degradation of other ECM components seen, as 
well as acting as a signal to promote inflammation and wound healing281. CEMIP was also decreased 
in response to DTT treatment, however no significant change was observed in the 
inter-alpha-trypsin inhibitor family proteins suggesting that the stabilisation of hyaluronan may be 
specific to the UV-A response.  
The behaviour of collagen proteins after UV-A radiation was distinct from that seen with DTT 
treatment in the previous chapter. It was noted that the recovery times afforded to the cells under 
different treatment conditions were not the same and it is possible that, in the UV-A treated cells, 
some level of recovery has already occurred. In future studies it would be interesting to titrate both 
the dose- and time- dependency of the proteomic responses to UV-A radiation and further compare 
these to the reductive stress response. Similarly, it would be interesting to look at the secretome 




This data has provided evidence that the responses of BJ fibroblasts to DTT, including the relative 
decrease in collagen proteins, could be specific to reductive stress. As little research has been done 
on the specific effects of reductive stressors on dermal skin cells, it is interesting to consider the 
effects of reductants on skin physiology and the potential relevance of changes in collagen 
composition to the skin care market for both medical and cosmetic purposes. The final chapter of 
this thesis will discuss the results described in these chapters and their potential impact on the 
function of dermal fibroblasts in the skin. Suggestions of future study will also be made to further 













This thesis has described the responses of human dermal fibroblasts to DTT-induced reductive 
stress from both a signalling and proteomic perspective. The studies revealed a previously 
undescribed growth factor-independent activation of chronic Akt phosphorylation in response to 
DTT, which was accompanied by a dephosphorylation of the extracellular signal regulated kinases 
p44/42. This response appeared to be specific to reductive stress and was not seen following 
treatment with redox-independent ER stress reagents. In addition, DTT treatment induced a 
reduction in the relative collagen amounts detectable in cell lysates, which was subsequently 
demonstrated not to occur in response to oxidative stress induced by UV-A radiation.  
This chapter will discuss the novel signalling responses to DTT, and the potential modulation of this 
response by PDGF. The effects of reductants on the ECM will then be discussed in contrast to the 
effects of UV-A radiation on the same. Finally, the use of SWATH MS as a proteomic tool will be 
discussed with reference to the data presented here, and suggestions made for future work. The 




7.1 DTT induces a growth factor independent signalling response 
The treatment of cells with DTT led to a chronic phosphorylation of Akt, independently of growth 
factor stimulation, which has not been previously described in the literature (Figure 4.9). A study 
by Murata et al., has previously reported growth factor-independent, long-term Akt 
phosphorylation following treatment with hydrogen peroxide in cardiac myocytes transfected with 
glutaredoxin284. They went on to demonstrate the anti-apoptotic effect of this response and 
suggested it was due to the modulation of the redox state of Akt by glutaredoxin284. A disulfide 
bond between Cys297 and Cys311, in the activation loop of Akt, has been shown to be sensitive to 
reductants, being broken by incubation of the protein with 20 mM DTT285. The formation of this 
disulfide bond was shown to be accompanied by an increased association of protein phosphatase 
2A (PP2A), which dephosphorylates Akt, preventing its long-term signalling284. Glutaredoxin 
prevented the formation of this disulfide bond and therefore reduced the association of PP2A 
allowing phosphorylation of Akt to persist284. It is possible that the stimulation of chronic Akt 
phosphorylation by DTT that was seen in this thesis may occur in a similar manner, with DTT 
reducing and preventing the formation of the Cys297-Cys311 disulfide bond.  
The study by Murata et al., suggests that chronic Akt phosphorylation is associated with an 
anti-apoptotic response. As discussed in chapter 4, chronic Akt phosphorylation has also been 
associated with the establishment of senescence206,207, a cellular phenotype where cells have 
resisted apoptosis to become stable but under a state of permanent growth arrest (See section 
4.4.2). Although there was no conclusive evidence for induction of senescence in the studies 
presented in this thesis, it is possible that chronic Akt phosphorylation may be a signalling response 
that is beneficial to cell survival be that in a way that is senescence inducing, or simply anti-
apoptotic.  
7.1.1 PDGF modulates the response to DTT 
There are distinct differences in the proteomic response of cells to DTT treatment depending on 
whether PDGF is present or not. This finding provides evidence of a modulatory effect of PDGF on 
the cells’ response to reductive stress induced by DTT, though the precise nature of this is not yet 
clear.  
Treatment of BJ fibroblasts resulted in chronic phosphorylation of Akt and dephosphorylation of 
p42/44, as observed over an extended time course. However, in the presence of PDGF, the Akt 
phosphorylation decreased towards the end of the time course, and the dephosphorylation of 
p42/44 occurred from an earlier point (Figure 4.12). As described above, chronic Akt 
phosphorylation has been associated with an anti-apoptotic response. However, these published 
studies did not stimulate the cells for as long as 6 hours and it is possible that after a certain time 
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point Akt phosphorylation is no longer beneficial. Inhibition of Akt with perifosine induced a small 
but insignificant increase in the proliferation of cells following DTT treatment (Figure 4.13), which 
may indicate that the reduced Akt phosphorylation, seen in later time points with PDGF and DTT 
together, benefits cell recovery and proliferation.  
Alternatively, there is some evidence that suggests downregulation of both Akt and ERK may 
increase apoptosis. Jin et al., demonstrated that where apoptosis is a result of tumour necrosis 
factor-related apoptosis-inducing ligand (TRAIL), expression and activation of the apoptosis 
proteins Bax, Bid and caspase-3 was mediated by decreased ERK and Akt signalling286. Therefore, 
there is a possibility that the decrease in Akt signalling seen in the present study may be an effect 
of PDGF sensitising cells to the damaging effects of DTT and thus promoting apoptosis. Further 
insight in to this was gained from the proteomic data.  
Statistically significant overrepresentation of the GO term ‘regulation of ERK1 and ERK2 cascade’ 
was seen among those proteins that demonstrated a significant change in response to DTT 
treatment (Figure 5.13). The proteins associated with this term were decreasing with DTT 
treatment, which would be linked to a decrease in ERK1/2 (p42/44) phosphorylation, in agreement 
with the signalling responses seen. There was little or no difference between the fold changes of 
these proteins seen in response to DTT alone, or PDGF and DTT together, suggesting a broad 
similarity in the response under the two conditions. However, there was a lesser decline of collagen 
proteins in response to DTT seen with PDGF and a greater, and significant, increase in TIMP1. These 
results suggest that the addition of PDGF lessens the degradation of collagen ECM in response to 
DTT, which is likely to be beneficial to the cells. 
The significant decrease of mitochondrial iron-sulfur cluster assembly enzyme ISCU, seen after 
PDGF and DTT combined treatment, suggests there may be some responses occurring that reflect 
the combined effects of both treatments. This ISCU protein was significantly decreased in PDGF and 
DTT treated cells compared to DTT or PDGF only and decreased (though insignificantly) when 
compared to untreated cells, suggesting the response only occurred in response to both treatments 
together. A decrease in ISCU has been associated with a decrease in Krebs cycle enzyme activity 
and mitochondrial function, leading to an increase in ROS generation287. ROS generation from 
decreased ISCU has been associated with increased apoptosis of cells288; however it may also be 
acting to rebalance the redox state of cells in response to DTT mediated reductive stress.  
Overall, whilst there is clear evidence of PDGF modulating the effect of DTT on these cells the 
precise nature of this modulation is not clear. Further investigations into the long-term viability 
and/or recovery of cells following DTT treatment with and without PDGF were beyond the scope of 
this thesis. In future, such studies would provide further insight as to whether the addition of 
growth-factor is protective or harmful with respect to the response to DTT-induced stress.   
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7.2 DTT and UV-A stressors induce different changes in the ECM 
7.2.1 DTT treated cells have decreased relative amounts of collagen proteins 
A study by Reunanen et al., in 2000 used primary fibroblast cells from a healthy adult male donor 
and demonstrated that C2-cermaide treatment reduced mRNA levels of collagen which could be 
reversed by the inhibition ERK1/2 and p38 MAPK 289. Some years later, in 2010, another study by 
Kim et al., demonstrated the involvement of ERK1/2 activation on the IL-18 triggered 
downregulation of collagen at both the mRNA and protein level in skin fibroblasts extracted from 
new-born male foreskin290. In addition, STAT3 has recently been shown to enhance upregulation of 
collagen protein COL1A2. Activation of STAT3 is thought to allow the binding of STAT3 to the 
COL1A2 enhancer region and an increase in COL1A2 gene transcription291. Phosphorylation of 
STAT3 at Tyr705 is required for effective translocation to the nucleus where it can promote 
transcription of its target genes. There is some evidence to suggest that phosphorylation at Ser727 
may impair subsequent phosphorylation of Tyr705 and this serine phosphorylation may be 
mediated by ERK-dependant or independent mechanisms292.  
In the investigations described in this thesis, reduced levels of collagen were seen with DTT 
treatment in BJ fibroblasts, a treatment that was also associated with dephosphorylation of p42/44 
(ERK1/2) (Figure 4.12 and Figure 5.14). These investigations were carried out under serum free 
conditions which inactivate ERK signalling pathways293. This may explain the discrepancy in the 
connection between ERK phosphorylation and collagen production in the results presented in this 
thesis and those in the literature. It could, however imply that the reduction in collagen proteins 
seen in this data occurs independently of p42/44 activation. 
Collagen proteins are characterised by the repeating “XaaYaaGly” motif, which runs along the 
central portion of the pro-collagen molecule. Most often amino acids X and Y are hydroxyproline 
and proline respectively and helical chains are formed from this repeating sequence. Three chains 
then assemble into a triple-helical procollagen fibril, bound at the N and C termini by two 
non-helical domains which are cleaved within the extracellular space to allow spontaneous 
assembly into collagen fibres294. Procollagen peptides are aligned before fibril formation in the ER 
by formation of intra- and inter-chain disulfide bonds at the C terminal pro-peptide domain295. 
Formation of the triple helix then proceeds from the C to N terminus. DTT treatment, which 
prohibits the formation of disulfide bonds within the ER, may therefore prevent correct formation 
of procollagen fibrils. Proteins that are unable to form the required disulfide bonds are targeted for 
degradation. This may provide an explanation for the reduction in collagen proteins seen following 
DTT treatment, which may be occurring independently of the signalling events detected.  
This would also provide insight as to why a distinct reduction in relative collagen amount was not 
seen with UV-A radiation (Figure 6.9). Whilst UV-A radiation induces a redox stress response 
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associated with ROS generation following treatment, these ROS do not directly inhibit disulfide 
bond formation within the ER. Under these conditions, then, it is possible that correct formation of 
procollagen fibrils is still possible, resulting in the limited changes seen in relative collagen amounts. 
UV-damaged, or photo-aged skin is often associated with a decrease in the collagen ECM however 
evidence of this was not seen in the experimental model used for this thesis. It is likely that changes 
in collagen are, at least initially, mediated by an increased expression of collagenase enzymes 
including MMPs. Again, no evidence of increased relative amounts of MMPs was detected using 
this model system. It would be interesting, therefore, to assay the MMP activity in response to UV-A 
radiation to survey this further. It may also be important to identify the time-frame and UV-A 
radiation conditions under which collagen degradation occurs in these cells to fully investigate the 
specifics of their response.  
7.2.2 UV-A radiation of cells promotes hyaluronan stability 
Although no change in collagen proteins was detected in the UV-A treated sample data, there was 
some evidence of a change in the ECM environment that would promote stability of hyaluronan 
(see section 6.4). Hyaluronan, which is a glycosaminoglycan, is not possible to identify using a purely 
proteomic approach so the proteins that are involved in its synthesis and degradation were 
examined as a proxy. Although the hyaluronan synthesising enzymes, hyaluronan synthase 1,2 or 3 
were not identified in the UV-A irradiated fibroblast data sets described here, there was a significant 
decrease in the relative levels of CEMIP, which mediates hyaluronan depolymerisation. In addition, 
there was a significant increase in inter-alpha-trypsin inhibitor (ITI) heavy chains H1, H2 and H3 
which are known to bind hyaluronan, preventing its depolymerisation272,296. These changes are 
reflected in the significant overrepresentation of GO (biological process) terms ‘negative regulation 
of endopeptidase activity’, and ‘hyaluronan metabolic process’.   
Hyaluronan bound to ITI proteins has been detected in inflamed tissues297,298. In addition, 
hyaluronan has been shown to have antioxidant effects and promote Nrf2 activity within 
chondrocyte cells299. Chondrocytes are responsible for the secretion of ECM in cartilage, and the 
activity of Nrf2 transcription factor promotes transcription of antioxidant molecules and detoxifying 
enzymes to reduce the effects of oxidative stress299. The effects of UV-A radiation on hyaluronan 
specifically have not been studied. Rather, the published ECM-associated effects have focussed on 
regulation of collagenase enzymes and ECM protein degradation. However, it is possible that the 
hyaluronan stabilisation effects presented here may, in line with previous studies, be part of a UV-A 
induced inflammatory response, and cellular detoxification of ROS generated as a result of 
irradiation300. Repeating these experiments with chondrocytes may provide further insight into the 
regulation of hyaluronan stability and Nrf2 activity within a previously studied context.  
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Zoltan-Jones et al., demonstrated the ability of hyaluronan to drive the epithelial-mesenchymal 
transition (EMT) in normal epithelial cells301 providing a link between hyaluronan and 
carcinogenesis, a well-known side-effect of excessive UV exposure. Prompted by this study, Jenkins 
et al., investigated the involvement of hyaluronan in the differentiation of fibroblasts to 
myofibroblasts302. Myofibroblasts are an activated class of fibroblast cell, typified by the apparently 
similar morphology to smooth muscle cells, and implicated in many diseased tissues including 
hypertrophic scar tissue and liver fibrosis303. Additionally, myofibroblasts have also been found 
associated with epithelial tumours, termed cancer-associated fibroblasts303.  Jenkins et al., 
demonstrated that rather than driving differentiation (as was shown by Zoltan-Jones et al., with 
respect to the EMT), hyaluronan accumulated as a result of differentiation to myofibroblasts 
through a reduction in its turnover i.e. through stabilisation302. Although fibrosis, which is typically 
associated with excessive collagen deposition, is not associated with UV-A radiation, these studies 
pose the possibility that hyaluronan stabilisation may have more wide-reaching implications for 
differentiation of fibroblasts or stimulation of carcinogenesis. Given this potentially important role, 
and the indications of changes promoting hyaluronan stability found in the current data, it would 
be informative to investigate further the effect of UV-A radiation on hyaluronan by assaying for this 
non-sulfated glycosaminoglycan directly. 
7.2.3 Comparison of the ECM response between DTT and UV-A radiation 
The difference in responses seen between DTT treated and UV-A irradiated cells provides evidence 
for the specificity of the BJ fibroblast response to reductive stress, rather than a generalised 
response to redox imbalance. Treatment of cells with hydrogen peroxide induced signalling 
responses that were distinct from those seen with DTT treatment (Figure 4.11), and the responses 
of ECM proteins described above are distinct between DTT and UV-A treatments. Defined 
responses of the cells to oxidative versus reductive stress have been previously described for the 
ER chaperone protein BiP304. It therefore holds that there should be independent responses to 
reductive and oxidative stress that are distinct from a generalised redox stress response. Whilst 
much research has been done into the effects of oxidative stress, there is potential benefit to be 
harnessed from investigations into specific responses to reductive stress such as those described in 
this thesis. Although passive exposure to reductants is arguably less common than agents that 
induce an oxidative stress, it may be possible to actively use induction of mild reductive stresses to 





7.3 SWATH as an investigative proteomic tool 
This thesis has described the use of quantitative SWATH acquisition proteomics to profile the 
proteome of human dermal fibroblasts (BJ fibroblasts), and its response to both reducing (DTT) and 
oxidative (UV-A radiation) stress (Chapters 5 and 6 respectively). The ability of this technology to 
detect changes in secreted proteins from samples of conditioned media has also been tested, with 
some success.  
7.3.1 Replicate variability 
Perhaps not unsurprisingly, variability in SWATH quantification is higher in lower abundance 
peptides, namely those with a lower peak area305. In a study comparing the ability of SWATH to 
selected reaction monitoring (SRM), another popular technique in quantitative proteomics that is 
like SWATH but on a smaller scale, a low peak area was described as less than 1,000,000. In the DTT 
and PDGF treated sample data set approximately 10% of protein identifications were made with a 
summed peptide peak area of greater than 1,000,000. However, in the UV treated sample data set 
only 5% of protein identifications were made under this criterion, which may provide some 
explanation as to the increased variation seen in the UV data set. Here substantially fewer 
identifications met the %CV cut-off of 30% across all replicates compared to the number within this 
threshold from the DTT and PDGF data set.  
The method used for SWATH acquisition described in this thesis used 100 variable Q1 isolation 
windows with 25 msec accumulation time, a standard protocol whereby narrower isolation 
windows are used for regions where peptide signals are most dense. A custom-designed protocol 
to determine the optimum isolation windows for each data set can be used and may improve 
identification and sample reproducibility in the results306. However, the 100 variable window 
method is largely accepted in the proteomic community (online307 and through personal 
communication with Hubbard group, Manchester University, UK), and a trade-off must be made 
between minor gains to be had from custom-made window widths and the time and man-hours 
this takes on top of SWATH acquisition alone.  
7.3.2 Secretome identifications 
The use of SWATH acquisition afforded substantial benefit over DDA for the identification of 
proteins in conditioned media of cells, with over 700 proteins identified and quantified (see section 
3.5). There was statistically significant overrepresentation of GO terms associated with the ECM 
confirming the detection of secreted proteins. Comparison of the secretome detected in DTT or 
etoposide treated cells had few statistically significant results, which may have been due to the low 
abundance of peptides detected. Only about 3% of protein identifications had summed peak area 
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of peptide peaks greater than 1,000,000 suggesting the peptide abundance was generally low. 
Some studies have used immunoaffinity peptide enrichment to increase abundance of low level 
peptides when looking at candidate biomarkers in patient serum or plasma308,309. These biomarkers 
are often only present at very low levels, but their presence is of clinical significance and the ability 
to employ MS improves sensitivity of assays compared to standard immunological techniques. It is 
possible that such a technique could be employed to mine for specific proteins of interest, for 
example to enrich conditioned media samples for MMP enzymes to detect changes that might 
occur in the relative abundance of these enzymes with DTT or UV-A treatment.  
Concanavalin A purification was used in chapter 3 to enrich for secreted proteins in conditioned 
media before secretome analysis using a gel-based proteomic method. It is possible that returning 
to this technique and combining it with the increased power for SWATH MS would enable further 
detection of peptides, and confident identification of significantly changing proteins in the data. 
7.3.3 Absolute vs relative quantification 
Most large scale quantitative proteomic investigations employ relative quantification, comparing 
the signal intensities of peptides between samples from different treatment conditions. However, 
a drive from biomedical research, where it is beneficial to be able to quantify absolute amounts of 
biomarkers in patient samples, has led to the development of methods for absolute quantification. 
Schubert et al., developed a SWATH-based method for absolute quantification to investigate 
proteome dynamics in Mycobacterium tuberculosis310. This was based on a strategy first described 
by Ludwig et al., using SRM data, which details a linear correlation between the summed intensity 
of the top fragment ions from the most intense peptides and the absolute protein concentration311. 
Schubert et al., determined the correlation between signal intensities and absolute protein 
concentrations using spiked-in stable-isotope-labelled synthetic peptide standards and then 
applied this correlation to proteins identified in the SWATH data set.    
Changes in relative amounts of enzyme may or may not have substantial impact on the activity of 
the cell depending on other variables such as the rate of turnover, and the basal expression level 
of that enzyme. The availability of absolute protein amounts allows the estimation of Vmax values 
by multiplying absolute protein amounts with reported kcat values of enzyme turnover. This data 
allows the investigation into the contribution of changes in enzyme amounts to the flux of 
metabolites within the cell310.  
It therefore may be of some value to measure the absolute protein concentrations during 
proteomic analysis, particularly when looking at enzymes. However, there is an additional cost from 
stable-isotope labelled standards for defining linear correlations used for absolute quantification 
and the more complex data analysis involved in interpreting this data. For the studies described in 
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this thesis, relative quantification by SWATH provides a good insight into the types of global 
proteomic changes that may be occurring in response to stress in these fibroblasts. These satisfy 
the aims of this thesis, which are not compromised by the lack of absolute quantification. Validation 
of the current findings could therefore be made by the use of absolute quantification, which 
wouldn’t necessarily have to be done using label-free mass-spectrometry methodology. 
Alternatively, enzyme activity assays could accompany data to determine the relative impact of any 
change in relative protein amount, although these types of validations, while important, were 




7.4 Considerations for future work 
There are two main areas that could be considered in future proteomic investigations, following 
those described here.  
First, the role of post-translational modifications in response to stress. It is well known that proteins 
may be modulated both in terms of their absolute abundance, as well as in the activation state of 
enzymes or targeting of proteins to specific subcellular compartments where they may or may not 
be able to function. Several studies have developed methods for the proteomic analysis of 
post-translational modifications, including those that occur in response to perturbations of the 
redox state for example glutathionylation312–314.  The consideration of these modifications will add 
an extra layer to the proteomic investigations, allowing the functional analysis of a range of proteins 
that may not be regulated by changes in their absolute abundance. This may be of relevance to 
studies such as the one in this thesis, investigating the effect of redox modulating stress that may 
affect protein structures, for example with respect to the formation of disulfide bonds as was 
described for Akt at the beginning of this chapter.  
Secondly, the culture conditions of the fibroblast cells. Fibroblasts, being the cells responsible for 
the secretion of the ECM, are normally resident amongst a complex network of ECM proteins, and 
not in densely packed monolayers as occur in the culture on 2D plastic culture flasks. Growth in a 
3D environment, one example being the use of hydrogel scaffolds, may permit a more complete 
and representative formation of the ECM that may influence the cell behaviours observed. 
Additionally, it may also be possible to generate a model of the skin with multiple cell types to gain 
further insight in to the potential physiological relevance of the response to reductive or UV-A stress 
on a wider scale. 
The investigations presented in this thesis provide good insight into the responses of fibroblasts to 
reductive stress, as well as providing a frame work through which to develop proteomic techniques 
with new quantitative capabilities. The inclusion of these factors would provide a fuller picture of 
the global proteomic response of dermal fibroblasts and the impact this may have on skin 





This thesis has described several novel findings with respect to the responses of human dermal (BJ) 
fibroblasts to reductive stress and UV stress.  
1. DTT stress induced a growth factor independent signalling response involving the chronic 
phosphorylation of Akt, and concomitant dephosphorylation of extracellular-signal 
regulated kinases p42 and p44.  
2. PDGF modulated the cells global response to DTT treatment. 
3. SWATH acquisition proteomics revealed a significant decrease in the relative amounts of 
several collagen proteins following DTT treatment. 
4. Comparison of this response to oxidative stress induced by UV-A radiation suggests a 
response specific to reductive stress. This has been subject to limited specific investigations 
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Appendix 1: R scripts 
 
The scripts presented here were written by the author of this thesis.  
Contents 
GO analysis ..................................................................................................................................... 201 
GO analysis was used to assess the distribution of GO terms amongst protein identifications. 
Box plots ......................................................................................................................................... 202 
Box plots were used to depict the variability of the quantitative data. 
Venn diagrams ................................................................................................................................ 205 
Pairwise Venn – Nano to Micro flow comparison ...................................................................... 205 
Quadruple Venn .......................................................................................................................... 205 
Venn diagrams were used to assess the overlap of data sets between treatment conditions. 
P-value Adjustment ........................................................................................................................ 206 
The p.adjust script was used to adjust p-values from t-test of quantitative SWATH data for multiple 
testing, using false discovery rate (FDR). 
Volcano plots .................................................................................................................................. 207 
Colour coded volcano plots ........................................................................................................ 207 
Significant Collagen labelled volcano plots ................................................................................. 208 
Volcano plots were used to display the distribution of quantified proteins by p-value and fold change. 
Plots were either labelled with significantly changing proteins of interest (Collagens in DTT data, 
chapter 5) or colour coded according to significance thresholds (UV data, chapter 6). 
Heatmaps ........................................................................................................................................ 211 
Comparison of significantly changing proteins ........................................................................... 211 
Comparison of collagen proteins ................................................................................................ 212 
Heatmaps were used to compare fold change in subsets of proteins of particular interest between 













#load clusterprofiler and human annotations, then create vector with IDs required as 
GeneName from MS Excel export 
GeneNameTest <- read.csv("~/R/GeneNameTest.csv") 
View(GeneNameTest) 
 
#Create vector with just Gene Name as IDs 
IDs <- as.vector(GeneNameTest$Gene.Name) 
 
#convert IDs from gene name to entrezid 
ConvertedIDs = bitr(IDs, fromType = "SYMBOL", toType = "ENTREZID", OrgDb 
= "org.Hs.eg.db") 
 
#Identify unmapped gene names 
lost <- GeneNameTest$Gene.Name[!(GeneNameTest$Gene.Name %in% 
ConvertedIDs$SYMBOL)] 
 
#Correct unmapped gene names in excel file 
GeneNameTestCorrected <- read.csv("~/R/GeneNameTestCorrected.csv") 
 
#Re-run vector formation and convertion to entrezids 
CorrectedIDs <- as.vector(GeneNameTestCorrected$Corrected.Gene.Name) 
ConvertedCorrectedIDs =bitr(CorrectedIDs, fromType = "SYMBOL", toType = 
"ENTREZID", OrgDb = "org.Hs.eg.db") 
 
#Keep checking until 1:1 mapping returned. This may require searching for Entrez ID 
online 
#Make sure when looking for lost again that vector names etc are updated 
#Make vector of corrected and converted IDs 
Genes <- c(ConvertedCorrectedIDs[[2]]) 
 
#Use GroupGO to annotate. BP = biological process, CC = cellular compartment, MF = 
molecular function 
 
#Use ShowCategory to change how many bars on the graph 
GenesGOCC <- groupGO(Genes, OrgDb = "org.Hs.eg.db", keytype = 
"ENTREZID", ont = "CC", level = 2,readable = FALSE) 
barplot(GenesGOCC, drop=TRUE, showCategory=12) 
GenesGOBP <-groupGO(Genes, OrgDb = "org.Hs.eg.db", keytype = "ENTREZID", 
ont = "BP", level = 2,readable = FALSE) 




#Set working directory and load required packages 





NanoMicro <- read.csv("NanoMicro.csv") 
boxplot(NanoMicro, range = 0, ylab= "Number of peptides", xlab= "Flow source") 
 
#replicates analysis PDGFDTT to PDGF only 
PDGFDTTPDGFpeaksall <- read.csv("PDGFDTTPDGF peaksall.csv") 
PDGFDTTPDGFpeaksallBP <- melt(PDGFDTTPDGFpeaksall, id.vars = "Gene.Name") 
PDGFDTTBP <- PDGFDTTPDGFpeaksallBP[c(1:252),] 
PDGFDTTBP$variable="PDGF and DTT" 
PDGFonlyBP <- PDGFDTTPDGFpeaksallBP[c(253:504),] 
PDGFonlyBP$variable="PDGF only" 
PDGFDTTBPtotal <- rbind(PDGFDTTBP,PDGFonlyBP) 
 
ggplot(PDGFDTTBPtotal, aes(x=Gene.Name, y=value, fill=variable)) +  
  geom_boxplot() + labs (x=" Gene Name", y= "Peak area")+ theme_classic()+ 
  theme(panel.grid.major = element_blank(), panel.grid.minor = element_blank()) 
 
#PDGFDTT technical replicates box plot 
PDGFDTTPDGFpeaksreps <- read.csv("PDGFDTTPDGF peaksreplicates.csv") 
PDGFDTTPDGFpeaksrepsBP <- melt(PDGFDTTPDGFpeaksreps, id.vars = "Gene.Name") 
PDGFDTT1BP <- PDGFDTTPDGFpeaksrepsBP[c(1:84),] 
PDGFDTT1BP$variable="Biological replicate 1" 
PDGFDTT2BP <- PDGFDTTPDGFpeaksrepsBP[c(85:168),] 
PDGFDTT2BP$variable="Biological replicate 2" 
PDGFDTT3BP <- PDGFDTTPDGFpeaksrepsBP[c(169:252),] 
PDGFDTT3BP$variable="Biological replicate 3" 
PDGFDTTrepsBPtotal <- rbind(PDGFDTT1BP, PDGFDTT2BP, PDGFDTT3BP) 
 
ggplot(PDGFDTTrepsBPtotal, aes(x=Gene.Name, y=value, fill=variable)) +  
  geom_boxplot() + labs (x=" Gene Name", y= "Peak area")+ theme_classic()+ 
  theme(panel.grid.major = element_blank(), panel.grid.minor = element_blank(), text = 
element_text(size=20), 
                axis.text.x = element_text(angle=90, hjust=1)) + theme(legend.justification = c(1, 1), 





#PDGF only technical replicates box plot 
PDGFonly1BP <- PDGFDTTPDGFpeaksrepsBP[c(253:336),] 
PDGFonly1BP$variable="Biological replicate 1" 
PDGFonly2BP <- PDGFDTTPDGFpeaksrepsBP[c(337:420),] 
PDGFonly2BP$variable="Biological replicate 2" 
PDGFonly3BP <- PDGFDTTPDGFpeaksrepsBP[c(421:504),] 
PDGFonly3BP$variable="Biological replicate 3" 
PDGFonlyrepsBPtotal <- rbind(PDGFonly1BP, PDGFonly2BP, PDGFonly3BP) 
 
ggplot(PDGFonlyrepsBPtotal, aes(x=Gene.Name, y=value, fill=variable)) +  
  geom_boxplot() + labs (x=" Gene Name", y= "Peak area")+ theme_classic()+ 
  theme(panel.grid.major = element_blank(), panel.grid.minor = element_blank(), text = 
element_text(size=20), 
        axis.text.x = element_text(angle=90, hjust=1)) + theme(legend.justification = c(1, 1), 
legend.position = c(1, 1)) 
 
#replicates analysis DTT to Untreated box plot 
DTTUntreatedpeaksall <- read.csv("DTTUntreated peaksall.csv") 
DTTUntreatedpeaksallBP <- melt(DTTUntreatedpeaksall, id.vars = "Gene.Name") 
DTTBP <- DTTUntreatedpeaksallBP[c(1:405),] 
DTTBP$variable="DTT" 
UntreatedBP <- DTTUntreatedpeaksallBP[c(406:810),] 
UntreatedBP$variable="Untreated" 
DTTUntreatedBPtotal <- rbind(DTTBP,UntreatedBP) 
 
ggplot(DTTUntreatedBPtotal, aes(x=Gene.Name, y=value, fill=variable)) +  
  geom_boxplot() + labs (x=" Gene Name", y= "Peak area")+ theme_classic()+ 
  theme(panel.grid.major = element_blank(), panel.grid.minor = element_blank()) 
 
#DTT technical replicates box plot 
DTTUpeaksreps <- read.csv("DTTUntreated peaksreplicates.csv") 
DTTUpeaksrepsBP <- melt(DTTUpeaksreps, id.vars = "Gene.Name") 
DTT1BP <- DTTUpeaksrepsBP[c(1:135),] 
DTT1BP$variable="Biological replicate 1" 
DTT2BP <- DTTUpeaksrepsBP[c(136:270),] 
DTT2BP$variable="Biological replicate 2" 
DTT3BP <- DTTUpeaksrepsBP[c(271:405),] 
DTT3BP$variable="Biological replicate 3" 
DTTrepsBPtotal <- rbind(DTT1BP, DTT2BP, DTT3BP) 
 
ggplot(DTTrepsBPtotal, aes(x=Gene.Name, y=value, fill=variable)) +  
  geom_boxplot() + labs (x=" Gene Name", y= "Peak area")+ theme_classic()+ 
  theme(panel.grid.major = element_blank(), panel.grid.minor = element_blank(), text = 
element_text(size=20), 
        axis.text.x = element_text(angle=90, hjust=1)) + theme(legend.justification = c(1, 1), 





#Untreated technical replicates box plot 
Untreated1BP <- DTTUpeaksrepsBP[c(406:540),] 
Untreated1BP$variable="Biological replicate 1" 
Untreated2BP <- DTTUpeaksrepsBP[c(541:675),] 
Untreated2BP$variable="Biological replicate 2" 
Untreated3BP <- DTTUpeaksrepsBP[c(676:810),] 
Untreated3BP$variable="Biological replicate 3" 
UntreatedrepsBPtotal <- rbind(Untreated1BP, Untreated2BP, Untreated3BP) 
 
ggplot(UntreatedrepsBPtotal, aes(x=Gene.Name, y=value, fill=variable)) +  
  geom_boxplot() + labs (x=" Gene Name", y= "Peak area")+ theme_classic()+ 
  theme(panel.grid.major = element_blank(), panel.grid.minor = element_blank(), text = 
element_text(size=20), 
        axis.text.x = element_text(angle=90, hjust=1)) + theme(legend.justification = c(1, 1), 





Pairwise Venn – Nano to Micro flow comparison 
setwd("C:/Users/naomi/Documents/Postgrad/Thesis MS Data") 
NanoMicrolists <- read.csv("NanoMicrolists.csv") 
Nano <- c(as.character(NanoMicrolists$Nano)) 
Micro <- c(as.character(NanoMicrolists$Micro)) 
NanonotMicro <- c(setdiff(Nano, Micro)) 
MicronotNano <- c(setdiff(Micro, Nano)) 
library(VennDiagram) 
draw.pairwise.venn(4487,4982,3759, category=c("Nano flow", "Micro 
flow"), scaled = FALSE, ext.text = FALSE, cex=c(2,2,2), fontface = 









PComb <- read.csv("PComb.csv") 
PCombC <- c(as.character(PComb$P)) 
PDComb <- read.csv("PDComb.csv") 
PDCombC <- c(as.character(PDComb$PD)) 
DComb <- read.csv("DComb.csv") 
DCombC <- c(as.character(DComb$D)) 
UComb <- read.csv("UComb.csv") 
UCombC <- c(as.character(UComb$U)) 
OverlapComb <- calculate.overlap(x=list("PDCombC" = PDCombC, "PCombC" = 
PCombC, "DCombC" = DCombC, "UCombC" = UCombC)) 
#draw quad venn. Using numbers: (area1, area2, area3, area4, 
(SUMa2,11,12,6), (SUMa4,5,6,12), (SUMa5,6,10,11), (SUMa6,7,12,13), 
(SUMa6,7,8,11), (SUMa5,6,7,15),(SUMa12,6),(SUMa11,6), (a5+a6), (a7+a6), 
a6) 
 
gR1 = draw.quad.venn(2060, 1996, 2035, 
2044,(43+51+57+1629),(52+89+1629+57),(89+1629+41+51), (1629+52+57+28), 
(1629+52+48+51), (89+1629+52+38), (1629+57), (51+1629), (1629+89), 
(52+1629), 1629, category = c("PDGF and DTT", "PDGF only", "DTT only", 
"Untreated"), col = "black", fill = c("#DF3034","#28A197","#FFBF47", 
"#912B88"),fontface = rep("bold", 15),fontfamily = rep("sans", 15), cex 
= rep(2,15), cat.cex = rep(2, 4), cat.fontface = rep("bold", 4), 
cat.fontfamily = rep("sans", 4)) 
require(gridExtra) 
grid.arrange(gTree(children=gR1), top=textGrob("Combined Repeats", 






p.values <- read.csv(“.csv”) 
p.values$p.adjusted <- (p.adjust(p.values$p, method = “fdr”) 
write.csv(p.values, “adjustedpvalues.csv”) 
 
#Where p.values is dual column csv of gene name and corresponding p values. FC can also be 




Colour coded volcano plots 
#set working directory and load required packages 








#import data from file and transform relevant vectors as required 
UVA <- read.csv("UVCVFP.csv") 
UVA$neglog.p.adj = -log10(UVA$p.adjusted) 
 
#subset data 
UVAsig <- subset(UVA,UVA$neglog.p.adj>1.3 & 
UVA$iLog.FC>0.3|UVA$iLog.FC<(-0.3)) 
UVAsigsig <- subset(UVAsig, UVAsig$p.adjusted<0.05) 
UVAsigsigCVC <- subset(UVAsigsig, UVAsigsig$CVC<30) 
UVAsigsigCVCCVUV <- subset(UVAsigsigCVC, UVAsigsigCVC$CVUV<30) 
 
#create volcano plot data frame 
VolcanoUVA = mutate(UVA, sig=ifelse(UVA$neglog.p.adj>1.3 & 
(UVA$iLog.FC>0.3|UVA$iLog.FC<(-0.3)), "Significant", "Not")) 
Volcanovariance = mutate(VolcanoUVA, 
variance=ifelse(VolcanoUVA$CVC<30&(VolcanoUVA$CVUV<30), 
"tight","variable")) 
VolcanoUVAcoloured = mutate(Volcanovariance, 
key=ifelse(grepl("Significant",sig)&(grepl("tight", variance)),"%CV<30, 
p<0.05 and fold change>2", 
ifelse(grepl("Significant",sig)&(grepl("variable", variance)), "p<0.05 
and fold change>2", "not significant"))) 
 
#create volcano plot 
ggplot(VolcanoUVAcoloured,aes(iLog.FC, (neglog.p.adj))) +   
  geom_point(aes(col=key), size=2) +   
  scale_color_manual(name = "Significance filter", values=c("#7E317B", 
"dark grey", "#D8ACE0"), breaks=c("%CV<30, p<0.05 and fold change>2", 
"p<0.05 and fold change>2", "not significant")) + 
  theme_classic() + 
  xlab("Log(10) Fold Change") + 
  ylab("-log(10) Adjusted p-value") +  
  ggtitle("UV to control comparison")+ 
  theme(plot.title = element_text(hjust = 0.5))+  
  theme(legend.title=element_blank())+ 
  theme(text = element_text(size=20)) + 
  theme(axis.line = element_line(size=1.25)) + 
  theme(plot.margin=unit(c(0.5,0.5,1,0.5),"cm"))  
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Significant collagen labelled volcano plots 
#set working directory and install relevant packages 







#DTT to Untreated comparison 
#import data from file and convert to numerical vectors  
DTTUntreated <- read.csv("DTTUntreatedComparison.csv") 
DTTUntreated$p.valueNumber = 
as.numeric(as.character(DTTUntreated$p.value.adjusted)) 






#assign labels to collagen genes and all others 
DTTUntreated$group <- "not important" 
DTTUntreated$group[DTTUntreated$Gene.Name.1 %in% 
c("COL1A1","COL2A1","COL3A1", "COL5A1", "COL6A1", "COL7A1", "COL8A1", 
"COL11A1", "COL12A1", "COL14A1", "COL15A1", "COL18A1", "COL1A2", 
"COL4A2", "COL5A2", "COL6A2", "TAGLN", "COL6A3")] <- "Collagen" 
 
#subset data 
DTTUntreatedsub <- subset(DTTUntreated, DTTUntreated$group=="Collagen") 









#create data frame for volcano plot 
VolcanoDTTUntreatedlogs = mutate(DTTUntreated, 
sig=ifelse(DTTUntreated$logp.valueNumber>1.3 & 
(DTTUntreated$Log.Fold.ChangeNumber>0.3|DTTUntreated$Log.Fold.ChangeNumb





#create volcano plot 
vDTTUlogs = ggplot(VolcanoDTTUntreatedlogs,  
                   aes(Log.Fold.ChangeNumber, (logp.valueNumber))) +   
  geom_point(aes(col=sig), size=2) +   
  scale_color_manual(values=c("grey", "black")) + 
  theme_classic() + 
  xlab("Log(10) Fold Change") + 
  ylab("-log(10) Adjusted p-value") +  
  ggtitle("DTT to Untreated Comparison")+ 
  theme(plot.title = element_text(hjust = 0.5))+  
  theme(legend.title=element_blank())+ 
  theme(text = element_text(size=20)) + 
  theme(axis.line = element_line(size=1.25)) + 
  theme(plot.margin=unit(c(0.5,0.5,1,0.5),"cm")) + 
  theme(legend.justification = c(1,1), legend.position = c(1,0.75)) + 
  xlim(-1,1.5) + 
  geom_text_repel(data = DTTUntreatedsub2, aes(label = Gene.Name.1), 
hjust = 0, size = 4, min.segment.length = 0, fontface = "bold") + 
  geom_text_repel(data = DTTUntreatedsub1.5, aes(label = Gene.Name.1), 




#PDGF and DTT to PDGF only comparison 
#import data from file and convert to numerical vectors 
PDGFDTTPDGF <- read.csv("PDGFDTTDTTComparison.csv") 
PDGFDTTPDGF$p.valueNumber = 
as.numeric(as.character(PDGFDTTPDGF$p.value.adjusted)) 
PDGFDTTPDGF$logp.valueNumber = -log10(PDGFDTTPDGF$p.valueNumber) 
PDGFDTTPDGF$Fold.ChangeNumber = 
as.numeric(as.character(PDGFDTTPDGF$Fold.Change)) 
PDGFDTTPDGF$Log.Fold.ChangeNumber = log10(PDGFDTTPDGF$Fold.ChangeNumber) 
 
#assign labels to collagen genes and all others 
PDGFDTTPDGF$group <- "not important" 
PDGFDTTPDGF$group[PDGFDTTPDGF$Gene.Name.1 %in% 
c("COL1A1","COL2A1","COL3A1", "COL5A1", "COL6A1", "COL7A1", "COL8A1", 
"COL11A1", "COL12A1", "COL14A1", "COL15A1", "COL18A1", "COL1A2", 
"COL4A2", "COL5A2", "COL6A2", "TAGLN", "COL6A3")] <- "Collagen" 
 
#subset significant collagens as those with p<0.05 and FC>1.5 or FC>2 
PDGFDTTPDGFsub <- subset(PDGFDTTPDGF, PDGFDTTPDGF$group=="Collagen") 









#create data frame for volcano plot 





<(-0.3)), "P<0.05 and Fold Change>2", "Not Significant")) 
 
#create volcano plot 
vPDGFDTTPDGFlogs = ggplot(VolcanoPDGFDTTPDGFlogs,  
                         aes(Log.Fold.ChangeNumber, (logp.valueNumber))) 
+   
  geom_point(aes(col=sig), size=2) +   
  scale_color_manual(values=c("grey", "black")) + 
  theme_classic() + 
  xlab("Log(10) Fold Change") + 
  ylab("-log(10) Adjusted p-value") +  
  ggtitle("PDGF and DTT to PDGF only Comparison")+ 
  theme(plot.title = element_text(hjust = 0.5))+  
  theme(legend.title=element_blank())+ 
  theme(text = element_text(size=20)) + 
  theme(axis.line = element_line(size=1.25))+ 
  theme(plot.margin=unit(c(0.5,0.5,1,0.5),"cm"))+ 
  theme(legend.justification = c(1,1), legend.position = c(1,0.75)) + 
  xlim(-1,1.5) + 
  geom_text_repel(data = PDGFDTTPDGFsub2, aes(label = Gene.Name.1), 
hjust = 0, size = 4, min.segment.length = 0, fontface = "bold") + 
  geom_text_repel(data = PDGFDTTPDGFsub1.5, aes(label = Gene.Name.1), 








Comparison of significantly changing proteins 




SignificantDTTU <- read.csv("SignificantDTTU.csv") 
names(SignificantDTTU)[1:3] <- c("Gene.Name", "DTT/Untreated", 
"PDGFDTT/PDGFonly") 
 
SignificantPDGFDTTPDGF <- read.csv("SignificantPDGFDTTPDGF.csv") 
names(SignificantPDGFDTTPDGF)[1:2] <- c("Gene.Name", "PDGFDTT/PDGFonly") 
 
heatmapDF <- melt(SignificantDTTU[1:2], id.vars = "Gene.Name") 
names(heatmapDF)[2:3] <- c("Comparison", "Fold_change") 
 
heatmapDFPDGF <- melt(SignificantPDGFDTTPDGF, id.vars = "Gene.Name") 
names(heatmapDFPDGF)[2:3] <- c("Comparison", "Fold_change") 
 
ggplot(heatmapDF, aes(x=Comparison, y=reorder(Gene.Name, Fold_change, 
order=TRUE))) + 
  geom_tile(aes(fill = Fold_change), color = "white") + 
  scale_fill_gradient(low = "white", high = "#7E317B", na.value = 
"black") + 
  ylab("Gene Name") + 
  xlab("Comparison") + 
  theme(legend.title = element_text(size = 10), 
        legend.text = element_text(size = 12), 
        plot.title = element_text(size=16), 
        axis.title=element_text(size=14,face="bold"), 
        axis.text.x = element_text(angle = 90, hjust = 1)) + 
  labs(fill = "Fold Change") + theme_minimal() + 
  theme(panel.grid.major = element_blank(), panel.grid.minor = 
element_blank()) + 
  scale_x_discrete(expand = c(0, 0)) + scale_y_discrete(expand = c(0, 
0)) +  
  theme(axis.ticks = element_blank()) 
 
ggplot(heatmapDFPDGF, aes(x=Comparison, y=reorder(Gene.Name, 
Fold_change, order=TRUE))) + 
  geom_tile(aes(fill = Fold_change), color = "white") + 
  scale_fill_gradient(low = "white", high = "#7E317B", na.value = 
"black") + 
  ylab("Gene Name") + 
  xlab("Comparison") + 
  theme(legend.title = element_text(size = 10), 
        legend.text = element_text(size = 12), 
        plot.title = element_text(size=16), 
        axis.title=element_text(size=14,face="bold"), 
        axis.text.x = element_text(angle = 90, hjust = 1)) + 
  labs(fill = "Fold Change") + theme_minimal() + 
  theme(panel.grid.major = element_blank(), panel.grid.minor = 
element_blank()) + 
  scale_x_discrete(expand = c(0, 0)) + scale_y_discrete(expand = c(0, 
0)) +  
  theme(axis.ticks = element_blank()) 
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Comparison of collagen proteins 
 




Collagens <- read.csv("iCollagen comparison.csv") 
names(Collagens)[1:3] <- c("Gene.Name", "DTT/Untreated", 
"UVA/Untreated") 
heatmapCollagens <- melt(Collagens, id.vars = "Gene.Name") 
heatmapCollagens$forder <- as.numeric(1:17) 
 
 
ggplot(heatmapCollagens, aes(x=variable, y=reorder(Gene.Name, forder, 
median, order=TRUE))) + 
  geom_tile(aes(fill = value), color = "white") + 
  scale_fill_gradient2(low = ("#006388"), mid = "white", 
                       high = ("#7E317B"), midpoint = 1, space = "Lab", 
                       na.value = "grey50", guide = "colourbar", 
aesthetics = "fill") + 
  ylab("Gene Name") + 
  xlab("Comparison") + 
  theme(legend.title = element_text(size = 10), 
        legend.text = element_text(size = 12), 
        plot.title = element_text(size=16), 
        axis.title=element_text(size=14,face="bold"), 
        axis.text.x = element_text(angle = 90, hjust = 1)) + 
  labs(fill = "Fold Change") + theme_minimal() + 
  theme(panel.grid.major = element_blank(), panel.grid.minor = 
element_blank()) + 
  scale_x_discrete(expand = c(0, 0)) + scale_y_discrete(expand = c(0, 
0)) +  
  theme(axis.ticks = element_blank()) 
